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 Pathogenic Listeria are the causative agents of listeriosis, a severe food-borne 
infection. They are able to invade various non-phagocytic cell types including epithelial 
cells. The life cycle of these intracellular parasites involves penetrating into host cells, 
rupturing of the phagocytic vacuole, rapidly proliferating in the cytosol, and directly 
spreading cell to cell. Each step of the listerial intracellular infection involves activation of 
virulence factors dependent on PrfA, the master regulator of Listeria virulence. PrfA-
mediated virulence gene activation occurs within host cells by mechanisms that remain 
unknown.  This thesis explores several aspects of PrfA regulation and its impact in the host-
pathogen interaction.  
 
 Methods for assessing PrfA-dependent gene expression were first developed and 
standardized, including a highly sensitive and accurate quantitative reverse-transcription 
real-time PCR (RT-QPCR), as well as procedures to investigate the correlation with 
virulence using cell culture-based assays. These techniques were applied in an investigation 
into the structure-function of PrfA. We studied the role of a solvent-accessible pocket 
identified in the N-terminal domain of PrfA, homologous to the cyclic nucleotide-binding 
(CNB) domain of Crp and other cAMP-regulated proteins, in intracellular virulence gene 
activation. Site-directed PrfA mutants were constructed. Our data support the notion that 
PrfA activity is allosterically regulated and are consistent with a role for the pocket as 
putative binding site for the PrfA-activating allosteric effector. The characterization of 
spontaneously occurring PrfA mutations that identified in our laboratory as PrfA*-
suppressor or attenuator mutations, A129T, E173G and C229Y, allowed us to gain 
additional insight into PrfA structure-function. The role of the C229Y in sugar-mediated 
repression was investigated and found to explain the anomalous phenotype of strain NCTC 
7973, a prfA* (G145S) mutant that carries this second mutation and is repressed by 
cellobiose but not glucose.  
 
 We also carried out experiments to address the intriguing activation of PrfA-
dependent virulence genes upon addition of an adsorbent to the culture medium, the so-
called "charcoal effect". Using a chemically defined culture medium and resin, Amberlite™ 
XAD-4, we provided evidence that the virulence gene activation may involve the 
sequestration of a medium component rather than a bacteria-derived autorepressor, as 
initially thought. 
 
 We also explored the role of PrfA and the sigma factor σB in L. monocytogenes entry 
into host cells. ∆sigB mutants in different prfA regulation backgrounds were constructed. We 
showed that σB has no major effect on host cell invasion, and that L. monocytogenes 
invasiveness is a strictly PrfA-dependent trait. Our results also demonstrate a differential role 
of σB in L. monocytogenes serotypes. σB apparently plays no role in stress tolerance in 
serotype 4b, whereas it is important in serotype 1/2a for maintenance of bacterial fitness in 
stress conditions. 
 
 Finally, we investigated the occurrence of apoptosis in Listeria-infected cells and 
developed normalized methods to accurately determine and quantify this cellular response in 
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1.1 LISTERIA AND LISTERIOSIS 
 
 Listeria bacteria are low G+C gram-positive rods closely related 
phylogenetically to the genera Bacillus, Staphylococcus, Streptococcus, 
Enterococcus and Clostridium. They are facultatively anaerobic, non-spore forming, 
catalase positive and motile at 30°C and below but not at 35-37°C (Collins et al., 
1991, Rocourt, 1999, Grundling et al., 2004). Until very recently, the genus Listeria 
comprised six species: two of them, L. monocytogenes and L. ivanovii, are able to 
cause infection; the others, L. seeligeri, L. innocua and L. welshimeri, are considered 
non-pathogenic (Jones, 1991). In 2009, Graves et al. has proposed a new species 
named Listeria marthii sp. nov. to designate Listeria-like bacilli isolated from the 
natural environment of the Finger Lakes region in New York. Their close 
phylogenetic relatedness to L. monocytogenes and L. innocua was confirmed by 16S 
ribosomal RNA sequence analysis. Up to date, L. marthii has not been associated 
with any case of human or animal disease (Graves et al., 2009). Also in 2009, a new 
species Listeria rocourtiae sp. nov. was identified and named in honour of Jocelyne 
Rocourt, French bacteriologist, whose work greatly contributed to clarifying the 
taxonomy of the genus Listeria. This strain, isolated from a pre-cut lettuce in 
Salzburg, Austria, was found to be avirulent as assessed by cell culture assays and 
inoculation of mice (Leclercq et al., 2009). 
 
 Listeria are the causative agents of listeriosis, a severe food-borne infection. 
The first case of human listeriosis caused by L. monocytogenes was reported in 1929 
in Denmark (Nyflet, 1929). However, it was not until late 1970’s and early 1980’s 
that this species started to emerge as a serious food-borne pathogen associated with 
several epidemic outbreaks. The average occurrence of listeriosis is approximately 2-
10 cases per million people per year in European countries and in the United States 
(Ryser, 1999, Goulet et al., 2001, Roberts & Wiedmann, 2003, Anonymous, 2005, 
de Valk et al., 2005, Goulet et al., 2008). Although listeriosis remains rare when 
compared to other food-borne infections, its high mortality rate (20 - 30%) places it 
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amongst the most deadly diseases transmitted by food. For example, in years 1983-
2003, 359 and 408 cases of food-borne disease outbreaks of invasive listeriosis have 
been reported in France and the United States, with 108 and 96 deaths, respectively, 
L. monocytogenes serotype 4b was found to be involved in most of these cases. In 
the UK, an outbreak involving 366 cases was reported in years 1987-1989 due to 
contaminated pâté (Swaminathan & Gerner-Smidt, 2007). According to the report of 
the advisory committee on the microbiological safety of food (ACMSF), during the 
1990s, the annual number of reported cases of listeriosis ranged from 90 to 128 in 
England and Wales, 6 to 17 in Scotland and 1 to 6 in Northern Ireland. Furthermore, 
204 cases in England and Wales and 8 and 3 cases in Scotland and Northern Ireland, 
respectively, have been reported to Health Protection Agency’s (HPA) 
Communicable Disease Surveillance Centre (CDSC) and Food Safety Microbiology 
Laboratory (FSML) in 2003 (Anonymous, 2003). L. monocytogenes accounts for up 
to 10% of community-acquired bacterial meningitis in humans and is the primary 
cause of central nervous system infection in domestic ruminants. Listeriosis has one 
of the highest hospitalization (90%) and mortality rates of all food-borne infections. 
For example, reports from United States show that Listeria is responsible for 
approximately 20 - 65% of deaths caused by food-borne infections (Lynch et al., 
2006, Bortolussi, 2008). 
 
 
1.1.1 ECOLOGY AND DISTRIBUTION 
 
 Listeria organisms are widespread in the environment. Their primary habitat 
is soil rich in decomposing plant material but they can be isolated from many other 
sources, including silage, faeces, surface waters, sewage and many raw materials 
used in food production (Welshimer & Donker-Voet, 1971, Weis & Seeliger, 1975, 
Watkins & Sleath, 1981, Rocourt & Seeliger, 1985, McCarthy, 1990, Farber & 
Peterkin, 1991, Fenlon, 1999). 
 
 The ubiquitous distribution of Listeria in the environment and their capacity 
to grow in a wide variety of pH conditions (between pH = 4.3 and 9.6), temperatures 
 5 
(1 - 45°C) and salt concentrations (exceeding 10%) has made them a major problem 
for the food industry and a potential risk to the safety of processed foods. Pathogenic 
Listeria are frequent contaminants of fresh and processed foods, where they are able 
to survive and multiply, resulting in food-borne disease upon consumption without 
previous heat treatment (Gravany, 1999, Ryser, 1999, Vazquez-Boland et al., 2001a, 
Roberts & Wiedmann, 2003). 
 
 
1.1.2 L. MONOCYTOGENES AND L. IVANOVII DIFFER IN 
NATURAL PATHOGENICITY 
 
 L. monocytogenes was first described in 1924 by Murray, Webb, and Swann 
in Cambridge, UK. (Murray et al., 1926). The organism was found as the causative 
agent of a septicaemic disease that affected laboratory rabbits and guinea pigs. Since 
the infection was associated with an intense monocytosis, it was named Bacterium 
monocytogenes. A few years later a similar organism was isolated from the livers of 
sick gerbils by Pirie during studies of plague in Africa (Pirie, 1940). Pirie did not 
make a connection between the organism he isolated and that described by Murray et 
al. and, therefore, named it as if it were a new species, Listerella hepatolytica after 
the famous surgeon Joseph Lister. As a group of slime moulds had previously been 
called Listerella, and after taking notice that his organism was the same as that 
discovered by the Cambridge team, Pirie himself changed the name to the 
contemporary designation, “Listeria monocytogenes” (Pirie, 1940) . 
 
 The second pathogenic species of the genus, L. ivanovii, was first isolated in 
1955 in Bulgaria by the veterinary surgeon Ivan Ivanov from cases of abortion and 
neonatal septicaemia in sheep. Due to its distinctive phenotypical features (strong 
bizonal haemolysis; see section 1.3.7), in 1962 Ivanov suggested it was a different 
species and proposed the non-official name “Listeria bulgarica”. The organism 
remained, however, known as L. monocytogenes serovar 5 until detailed genotypic 
studies carried out in 1984 by J. Rocourt established it was an independent species, 
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which received the name L. ivanovii (Seeliger et al., 1984, Seeliger & Jones, 1986). 
L. ivanovii contains two subspecies, subsp. ivanovii and subsp. londoniensis (Boerlin 
et al., 1992). 
 
 Both L. monocytogenes and L. ivanovii are facultative intracellular parasites 
that use the host cell cytosol as replication niche. Although their intracellular 
infection cycle is very similar (see section 1.3), the two bacteria show clear 
differences in pathogenicity. L. monocytogenes can infect a wide range of animal 
species including humans and birds, whereas L. ivanovii appears to be only 
pathogenic for ruminants. L. ivanovii infections in humans have been recorded on 
extremely rare occasions (up to date, only 8 cases of human L. ivanovii infection 
reported) (Guillet et al., 2010) (see Appendix I).  
 
 In addition, L. monocytogenes is often associated with central nervous system 
infections, whereas L. ivanovii is only isolated from foetomaternal septicaemic 
infections. This is highly relevant because meningoencephalitis is a hallmark of 
listeriosis in ruminants, meaning that L. monocytogenes and L. ivanovii clearly differ 
in terms of pathogenic tropism. These differences are also evident in the mouse 
model: here L. monocytogenes is more virulent and proliferates in both the liver and 
the spleen, whereas L. ivanovii mainly colonizes the liver and not the spleen 
(Gonzalez-Zorn et al., 1999, Vazquez-Boland et al., 2001a). Furthermore, 
differences in susceptibility of eukaryotic cell lines between L. monocytogenes and 
L. ivanovii have been reported (Guillet et al., 2010). 
 
 
1.2 PATHOPHYSIOLOGY OF LISTERIOSIS  
 
 Listeriosis can manifest perinatally and in adult patients. Pregnant women, 
neonates and elderly people are primarily affected by the disease. Listeria is more 
likely to cause severe illness and death in those with a compromised immune 
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response (i.e. people with AIDS, cancer patients or people affected with chronic, 
debilitating diseases such as diabetes, chronic heart condition, renal disease or 
cirrhosis) or in people with immature immune systems (e.g. foetuses and newborns) 
















Figure 1.1: Schematic representation of the pathophysiology of Listeria infection. 
Adapted from Vazquez-Boland et al. (2001a). 
 
 
 There are two forms of listeriosis: non-invasive, restricted to the 
gastrointestinal tract, and invasive, involving the entry and spread of the bacterium to 
different internal organs of the body. The non-invasive form has an incubation period 
of about 20 h and is characterized by febrile gastroenteritis. This form appears 
primarily in healthy adults upon consumption of heavily contaminated food 
(approximately 109 CFU / ml). Symptoms have a sudden onset and include fever, 
severe headache, vomiting and several flu-like manifestations. Invasive listeriosis 
has a much longer incubation period, up to 20 to 30 days, and is characterized by 
severe clinical conditions including meningoencephalitis, septicaemia or abortion. 
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This form occurs primarily in immuno-compromised individuals or pregnant women 
and newborns (Schuchat et al., 1991, Ramaswamy et al., 2007). 
 
 The main portal of entry of pathogenic Listeria is the intestine. During 
invasive infection, the bacteria cross the epithelial barrier and get translocated to the 
local lymph nods, and via lymphohaematogenous dissemination they gain access to 
the primary target-organs, i.e. the spleen and liver. At this stage the infection is 
normally controlled by the immune response in immunocompetent people. In 
immuno-compromised patients, however, the immune defences are overwhelmed by 
the pathogenic bacteria and these spread to secondary target organs, such as the brain 
or the placenta, causing meningoencephalitis or abortion and neonatal septicaemia 
(figure 1.1) (Vazquez-Boland et al., 2001a, Lecuit, 2007). 
 
 
1.3 PATHOGENESIS OF LISTERIA INFECTION 
AND ITS MOLECULAR DETERMINANTS 
 
1.3.1 INTRACELLULAR INFECTION CYCLE 
 
 Listeria organisms are not only able to survive and multiply within 
macrophages but also to actively invade a wide variety of mammalian cells which 
are not normally phagocytic, like epithelial cells, fibroblasts, hepatocytes, endothelial 
cells and nerve cells. The intracellular life cycle of Listeria shares similar 
characteristic in all the above-mentioned cells (Kuhn & Goebel, 2000, Vazquez-
Boland et al., 2001a). First, the bacterium adheres to the eukaryotic cell surface and, 
then, gets internalized. Inside the host cell, the bacterium survives, proliferates and 
spreads from one cell to another without leaving the intracellular environment (Ireton 

















 Listeria interact with the surface of host cells through at least two eukaryotic 
receptors, E-cadherin present in epithelial cells, and the Met receptor for the 
hepatocyte growth factor (HGF), present in a wide variety of cell types (Cossart et 
al., 2003). At the beginning, the pathogen becomes surrounded by pseudopods, 
which adhere firmly to the bacterial surface and fuse laterally forming a membrane, a 
process that progressively surrounds by a “zipper-like” mechanism the bacterial cell. 
The bacterium becomes completely engulfed within a phagocytic vacuole. The 
secretion by Listeria of membrane-damaging factors rapidly lyse the vacuole (within 
30 minutes) and release the bacterium into the cytosol where it multiplies (Vazquez-



















Figure 1.2: Intracellular life cycle of pathogenic Listeria spp. 
The scheme includes virulence factors involved in each step of L. monocytogenes life cycle (apart 
from SmcL, which is produced only by L. ivanovii; see text for details). L. ivanovii possesses 






 In parallel, Listeria induces the polymerization of actin filaments at one of its 
poles, resulting in the formation of an “actin tail”. In this way, a motor force is 
generated which allows bacteria to propel themselves across the cytoplasm. Due to 
this actin-based motility mechanism, bacteria eventually reach the cell periphery, 
push the membrane outwards, and protrude in filopod-like structures with a 
bacterium at the tip. These structures penetrate into neighbouring cells where they 
are phagocytosed, resulting in the formation of a double-membrane vacuole (or 
“secondary phagosome”) (figure 1.2). The vacuole becomes again disrupted, 
releasing the bacteria into the cytoplasm where they begin a new cycle of replication 
and actin-based motility. Thanks to this mechanism, the bacteria spread throughout 
host tissues sheltered from the humoral effectors of the immune system. Therefore, 
only a strong cytotoxic T-cell-mediated immune response, reflected in the formation 
of granuloma-like structures that physically contain the pathogen, can prevent the 
spread of listerial infectious foci in the affected organs (Tilney & Portnoy, 1989, 
Vazquez-Boland et al., 2001a, Portnoy et al., 2002, Cossart et al., 2003, Dussurget et 
al., 2004, Hamon et al., 2006). 
 
 
1.3.2 VIRULENCE FACTORS OF LISTERIA 
 
 Different virulence factors are involved in each step of the Listeria 
intracellular life cycle (figure 1.2). Internalization by host cells involves two 
bacterial surface proteins, InlA and InlB, which recognize host-cell surface receptors 
(E-cadherin and Met, respectively). This receptor-ligand interaction activates 
intracellular signalling pathways, under active investigation, ultimately leading to 
cortical actin cytoskeletal rearrangements and phagocytosis. InlA and InlB belong to 
a multigene family exclusive to Listeria and collectively known as internalins, which 
comprises additional members coding for either surface-attached or small-excreted 
proteins. The internalin proteins are characterized by the presence of a leucine-rich 
repeat (LRR) region, which provides a structural framework for protein-protein 
interactions. InlA and InlB interact with their specific receptors via the LRR domain 
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(Vazquez-Boland et al., 2001a, Hamon et al., 2006, Cossart & Toledo-Arana, 2008, 
Mostowy & Cossart, 2009).  
 
 In order to rupture the phagosome membranes, Listeria secretes a pore-
forming toxin belonging to the family of thiol-activated or cholesterol-dependent 
cytolysins. This haemolysin is known as listeriolysin O (LLO) in case of L. 
monocytogenes and ivanolysin O (ILO) in case of L. ivanovii (Geoffroy et al., 1987). 
Furthermore, studies showed that expression of the haemolysin gene of L. 
monocytogenes in Bacillus subtilis allowed this non-pathogenic bacterium to escape 
from the phagosome and proliferate intracellularly, confirming the important role of 
LLO in the listerial intracellular life cycle (Bielecki et al., 1990). 
 
 Pathogenic Listeria produce other phagosome disrupting factors, such as the 
phospholipases C (PLC): the phosphatidylinositol-specific phospholipase C (PI-
PLC) PlcA, and the phosphatidylcholine-preferring phospholipase C (PC-PLC), 
PlcB. These two enzymes are secreted by both L. monocytogenes and L. ivanovii, 
whereas the latter species produces an additional phospholipase C specific for 
sphingomyelin, SmcL, a sphingomyelinase (SMase). Activation of pro-PlcB and 
post-secretion processing of PlcB involves a metalloprotease (Mpl) (Leighton et al., 
1975, Vazquez-Boland et al., 1989, Camilli et al., 1991, Poyart et al., 1993, 
Gonzalez-Zorn et al., 1999, Ray et al., 2009). 
 
 The replication phase in the cytoplasm is mediated by a hexose phosphate 
transporter, Hpt, a member of the organophosphate:inorganic antiporter (OPA) 
family, of the major facilitator superfamily (MFS) of permeases. Hpt transports 
glucose-6-phosphate (G-6-P) and other hexose monophosphates such as glucose-1-
phosphate (G-1-P), fructose-6-phosphate (F-6-P), and mannose-6-phosphate (M-6-
P). This transmembrane protein enables pathogenic Listeria to use sugar phosphates 
from the host cell to fuel rapid bacterial intracellular growth (Chico-Calero et al., 
2002). Actin-based motility is mediated by the listerial surface protein ActA. This 
protein induces actin polymerization via mimicry of the natural action of the Arp2/3 
complex-activating protein WASP/Scar-1 (Cossart et al., 2003, Hamon et al., 2006). 
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Recent studies have shown that InlC, a secreted L. monocytogenes virulence protein, 
is also required in order to efficiently spread from cell-to-cell (Rajabian et al., 2009). 
 
 A novel haemolytic/cytolytic factor named listeriolysin S (LLS) has been 
recently discovered in the lineage I L. monocytogenes (serotypes 1/2b and 4b), and 
was found to be associated with the majority of spontaneous and epidemic outbreaks 
of listeriosis. This second haemolysin of Listeria is only induced under oxidative 
stress conditions and contributes to murine virulence and survival in 
polymorphonuclear neutrophils (PMNs). The gene cluster encoding LLS has been 
named Listeria pathogenicity island 3 (LIPI-3), in order to distinguish it from LIPI-1 
and LIPI-2 (see below section 1.3.3 and 1.3.7, respectively). LLS belongs to a family 
of modified virulence peptides such as Streptolysin S (SLS), produced by 
Streptococccus pyogenes (Cotter et al., 2008).  
 
 
1.3.3 GENETIC ORGANIZATION OF LISTERIAL 
VIRULENCE DETERMINANTS 
 
 Most of the key listerial virulence factors such as LLO/ILO, PlcA, PlcB, Mpl, 
ActA and the positive regulatory factor A (PrfA), required for intracellular survival 
and spread, are encoded in Listeria pathogenicity island 1 (LIPI-1), a 9-kb 
chromosomal locus (figure 1.3). In the non-pathogenic Listeria spp., LIPI-1 is absent 
(L. innocua and L. welshimeri) or present in non-functional form, as in L. seeligeri, 
in which an insertion disrupts the positive autoregulatory loop between plcA and 
prfA, essential for adequate PrfA-dependent virulence gene activation (Karunasagar 
et al., 1997, Vazquez-Boland et al., 2001a). LIPI-1 has the same genetic structure 
and is inserted at the same chromosomal position in L. monocytogenes and L. 
ivanovii, indicating that this central pathogenicity island was acquired by a Listeria 
ancestor before speciation. Consistent with this, the corresponding gene homologues 
share only 73-78% identity at the level of DNA sequence, a degree of divergence 
that is compatible with the genetic distance between the two species (Vazquez-
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Boland et al., 2001b). actA is the LIPI-1 gene that shows the greatest dissimilarity 
between the two pathogenic Listeria spp., even at the protein level (only 34% 
identity), although the two proteins are equally functional (Gouin et al., 1995, Kreft 




















Figure 1.3: The PrfA virulon of L. monocytogenes.  
The schematic representation includes the physical and transcriptional organization of Listeria 
pathogenicity island-1 (LIPI-1) genes and the three other PrfA-regulated loci: the inlAB operon, and 
the inlC and hpt monocistrons; right-pointing genes are on the positive strand of the genome. PrfA-
boxes are indicated by black squares, known promoters and transcripts are indicated “P” and dotted 
lines, respectively. inlC, encoding an internalin homologue, is also regulated by PrfA (Engelbrecht et 
al., 1998). LIPI-1 genes and hpt are present in both L. monocytogenes and L. ivanovii; however, the 
two species differ in their PrfA-dependent inl gene complement. Taken from Scortti et al. (2007).  
 
 
 The central position in LIPI-1 is occupied by the hly monocistron encoding 
LLO (in L. monocytogenes) or ILO (in L. ivanovii). Downstream from hly is the 
lecithinase operon with the mpl, actA and plcB genes. Upstream and divergent from 
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hly lies the plcA-prfA operon. The prfA gene encodes PrfA, a transcription activator 
of the Crp/Cap-Fnr family (Sheehan et al., 1995, Bubert et al., 1999, Goebel et al., 
2000, Vazquez-Boland et al., 2001b, Gray et al., 2006, Scortti et al., 2007). PrfA is 
required for the transcription of all LIPI-1 genes and also coordinates the expression 
of other genes located elsewhere on the listerial chromosome and which also code 
for virulence factors involved in listerial intracellular parasitism. These are the inlAB 
operon, the inlC and the hpt monocistrons (Skoble et al., 2001, Chico-Calero et al., 




1.3.4 THE CENTRAL VIRULENCE REGULATOR PRFA 
 
 PrfA is the major regulator of virulence in Listeria. This 237-residue protein 
of 27 kDa is structurally related to the Escherichia coli regulator, cAMP receptor 
protein (Crp), also called catabolite gene activator protein (Cap) (Goebel et al., 2000, 
Kreft & Vazquez-Boland, 2001, Scortti et al., 2007). The arrangement of subunits of 
both of these homodimers is similar (figure 1.4). The structure of PrfA and Crp 
consists of three regions. In the N-terminal domain there is a β(jelly)-roll and long α-
helices that provide the majority of the monomer-monomer interface. The middle 
region is called the hinge or the inter-domain region. In the C-terminal domain there 
is the DNA-binding helix-turn-helix (HTH) motif. In the PrfA structure, the presence 
of a unique extension in the C-terminal stabilizes the HTH motif (Vega et al., 2004, 
Eiting et al., 2005). It has been shown that when the Crp protein is unliganded it 
remains inactive. However, if cAMP (cyclic adenosine 3', 5' -mono-phosphate) binds 
to the N-terminal domain of Crp, it adopts a conformation with a higher affinity for 
the target DNA (Kolb et al., 1993, Green et al., 2001). It has been suggested that due 
to the fact that PrfA is structurally similar to Crp (figure 1.5), it may also have a 
similar type of allosteric mechanism of activation (Scortti et al., 2007).  
 
 There is evidence that PrfA can adopt two functional states: weakly active as 
in the native form of the protein, and highly active after a conformational change. 
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The latter state can be found in L. monocytogenes prfA* mutants, in which PrfA-
dependent genes are constantly overexpressed due to the presence of a hyperactive 
PrfA* protein variant (Ripio et al., 1996, Ripio et al., 1997a). The prfA* bacteria 
carry a point mutation, which leads to a single amino acid substitution outside the 
HTH motif that renders the PrfA protein constitutively hyperactive, i.e. with a 




Figure 1.4: Alignment of amino-acid sequence of PrfA from L. monocytogenes and the related Crp 
and Fnr (fumerate and nitrate reductase regulator) transcription factors of E. coli.  
Adapted from Scortti et al. (2007). The secondary structure elements of PrfA are presented above the 
sequence (spirals = α-helices; arrows = β-strands). Protein domains are boxed in colour: N-terminal 
domain: red = β(jelly)-roll, pink = flanking β-strands, blue = the α-helix that gives majority of 
monomer-monomer interface; inter-domain (hinge) region represented as a green section flanked by 
the αC-helix and the αD-helix, consists of: N-terminal domain: green = αD-helix, pale green = β-
strands flanking the HTH motif, magenta = HTH motif, yellow = the PrfA “G” domain, which 
includes three C-terminal α-helices that form a wedge inserted into the inter-domain cleft and which 
stabilizes the HTH motif. The positions of ten PrfA* mutations described up to date (see text for 
details) are indicated by green triangles. The phosphate binding cassette signature motif involved in 
cAMP binding in Crp is indicated by the grey rectangle. Orange highlights indicate the critical 




Figure 1.5: Comparison of the crystal structures of the PrfA and Crp dimers.  
Colour code as in figure 1.4. In Crp structure, white spheres indicate the cAMP molecule inserted in 
each of the two β(jelly)-rolls of the dimer. Taken from Scortti et al. (2007). 
 
 
 Up to date, ten prfA* mutations have been described: G145S, G145C, 
G145R, I45S, Y63C, E77K, L140F, L148T (in literature mistakenly named as 
A148T), Y154C and G155S (Ripio et al., 1997a, Vega et al., 2004, Monk et al., 
2008, Freitag et al., 2009). These prfA* mutations target PrfA regions or positions 
equivalent to those affected by Crp* mutations in Crp with the same functional 
consequences (Vega et al., 1998, Vega et al., 2004). Transcriptional activity levels of 
Crp* proteins have been found to be similarly high to the levels of Crp proteins 
complexed with cAMP, and, interestingly, this does not require the presence of the 
activating cofactor. It has been suggested that the Crp* mutations mimic the 
conformational changes caused by cAMP (Passner et al., 2000). The structural and 
functional similarities between PrfA and Crp have led to the suggestion that the 
listerial regulator may also function through an allosteric transition mechanism, 
activation resulting from the interaction with a hypothetical small molecule or 
cofactor. The crystal structures of wild-type PrfA (PrfAWT) and PrfA*G145S mutant 
proteins have been recently obtained and compared, and the analysis seem to confirm 




 The N-terminal β(jelly)-roll structure of PrfA and the cyclic nucleotide-
binding domain of Crp are structurally very similar. In the PrfA protein, however, the 
majority of the residues responsible for cAMP binding in Crp are absent (Diller et 
al., 2001). In vitro and in vivo studies from our group have shown that PrfA-
dependent expression of the genes was not affected by the presence of cAMP (Vega 
et al., 1998). It was, therefore, concluded that this nucleotide is not the PrfA-
activating cofactor. Detailed analyses of the crystal structure of PrfA have indicated 
the presence of a tunnel, similar to the one found in Crp protein, located in the inter-
domain cleft of the PrfA protein (figure 1.6). Additionally, in order to stabilize the 
protein, glycerol or DTT were used. Interestingly, these small molecules are lodged 
in the β-roll. Overall, all these observations are consistent with the notion that a 












Figure 1.6: Representation of the PrfA monomer with combined surface and space-fill. 
A solvent-accessible tunnel at the inter-domain cleft is visualized in the middle of the structure. In Crp 
protein, the cAMP–binding pocket is accessed through a similarly located tunnel (Eiting et al., 2005). 
Broken red line indicates the dimeric interface; spheres represent buried atoms from the dimeric 
interface. Colour-code as in figure 1.4. The image has been prepared with MacPyMOL 0.99 and taken 
from Scortti et al. (2007).  
 
 
 Single residue substitutions in the PrfA protein may contribute to high 
transcriptional activity levels (as in case of prfA* mutations), however, they can also 
have the opposite effect. Up to date, thirteen single-substitution mutations have been 
described, which lead to loss of function in PrfA (table 1.1). These mutations affect 
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the N-terminal β-roll, in the HTH motif and in the GHI α-helical extension (Sheehan 
et al., 1996, Herler et al., 2001, Vega et al., 2004, Roche et al., 2005, Monk et al., 
2008). Deletions or truncations in PrfA have also been found to be associated with 
the loss of function (Herler et al., 2001, Vega et al., 2004). Additionally, Sheehan et 
al. (1996) described a point mutation (a substitution of serine for alanine obtained by 
site-directed mutagenesis) in position 183 of PrfA, located in αF of the HTH motif, 
which had no major effect on PrfA function (Sheehan et al., 1996). Collectively, 
these mutations confirmed the functional importance of the β-roll, HTH motif and C-
terminal extension in PrfA.  
 
 19 
Table 1.1: Single-substitution mutations and deletions (or truncations) associated with loss of PrfA 
function. 
 
^ - Spontaneous mutations found in L. monocytogenes belonging to phylogenetic divison II (which includes serovars such 
as 1/2a, 1/2c and 3a). In such strains PrfA* activity is always associated with the presence of two point mutations 
PrfAG145S and PrfAC229Y (Ripio et al. [1997b]). 
 
PrfA–





M58I β-roll iap-based positive selection in Bacillus Unknown 
Shows same binding as wild-type PrfA (CIII formation) 
to hly promoter but does not activate transcription. 
Herler et al. (2001) 
Vega et al. (2004) 
Y62C β-roll iap-based positive selection in Bacillus Unknown 
Reduced activity? Paper states reduced CI complex 
formation but this is unclear. CIII formation and in vitro 
transcription not tested. 





Unknown Total loss of function, however, mutation not checked with a complemented strain. 
Vega Y. (2002) 
(unpublished data) 
S71C β-roll Site-directed Unknown 
Limited data: only a slight increase in haemolysis on 
BHI agar containing sheep blood (5%) with 
sphingomyelinase, however, no halo observed on 4% 
lecithin agar, suggesting no secretion of PlcA or PlcB.  
Monk et al. (2008) 
Y83S β-roll iap-based positive selection in Bacillus Unknown 
Reduced activity? Paper states reduced CI complex 
formation but this is unclear. CIII formation and in vitro 
transcription not tested. 
Herler et al. (2001) 
Vega et al. (2004) 
A94T β-roll Site-directed Unknown 
Limited data: only a slight increase in haemolysis on 
BHI agar containing sheep blood (5%) with 
sphingomyelinase, however, no halo observed on 4% 
lecithin agar, suggesting no secretion of PlcA or PlcB, 
similar to S71C. 
Monk et al. (2008) 
D133Y End of αC iap-based positive selection in Bacillus Unknown 
No CI complex detected. CIII formation and in vitro 
transcription not tested. 
Herler et al. (2001) 
Vega et al. (2004) 
K139T 




selection in Bacillus Unknown 
No CI complex detected. CIII formation and in vitro 
transcription not tested. 
Herler et al. (2001) 
Vega et al. (2004) 




Unknown Total loss of function. Vega et al. (2004) 
S184A αF, HTH motif Site-directed Unknown 
Significant reduction of DNA-binding, PrfA-dependent 
gene expression and virulence. Sheehan et al. (1996) 
R188I αF, HTH motif 
iap-based positive 
selection in Bacillus Unknown 
Strongly impairs, abolishes CIII and CI complex 
formation.  
Herler et al. (2001) 





Spontaneous Unknown No PrfA-dependent expression and virulence. No effect on dimerization but DNA-binding (CIII) abolished. 
Roche et al. (2005) 






suppressor mutation of  
prfA*G145S 
Unknown Always found together with G145S in division II spontaneous L. monocytogenes PrfA* mutants. 
Ripio et al. (1997) 
Vega et al. (2004)  
∆ELK10
1-103 




selection in Bacillus Unknown 
No CI complex detected. CIII formation and in vitro 
transcription not tested. 
Herler et al. (2001) 
Vega et al. (2004) 
E173* αE→αI Spontaneous  Unknown Total loss of function. Roche et al. (2005) 
L193* αF→αI iap-based positive selection in Bacillus Unknown 
No CI complex detected. CIII formation and in vitro 
transcription not tested. 
Herler et al. (2001) 






selection in Bacillus Unknown 
No CI complex detected. CIII formation and in vitro 
transcription not tested. Wrongly described by Herler et 
al. (2001) as ∆FYV207-209. 
Herler et al. (2001) 










selection in Bacillus Unknown No CI and CIII complex formation.  
Herler et al. (2001) 
Vega et al. (2004) 
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1.3.5 REGULATION MECHANISMS OF PRFA 
 
 The PrfA concentration, the promoter configuration and the above-mentioned 
changes in PrfA activity are believed to be the three key mechanisms that contribute 
to the modulation of PrfA-dependent gene transcription. 
 
 During extracellular growth, e.g. in vitro growth in bacteriological culture 
media, the genes of the PrfA regulon are normally very weakly or even not expressed 
(Chakraborty et al., 1992, Ripio et al., 1996, Ripio et al., 1997a). The weakly active, 
native PrfA protein binds with low affinity to the PrfA box in the target promoters 
(Vega et al., 1998, Vega et al., 2004). However, PrfA-dependent genes are 
maximally induced after the invasion of host cells, especially when the pathogenic 
organisms reach the cytosolic compartment (Moors et al., 1999, Shetron-Rama et al., 
2002). It is believed that this extra / intracellular differential expression operates 
through changes in PrfA activity by a cofactor-mediated allosteric shift. It has been 
suggested that this positive control pathway is involved in the strong induction of 
PrfA-dependent expression occurring during intracellular growth. Data suggest that 
Listeria mutants carrying a prfA* allele reach a similar level of induction, e.g. up to 
300-fold for the actA gene, when cultured in broth media (Ripio et al., 1997a; 
Shetron-Rama et al., 2003; Vega et al., 1998 and other unpublished data from our 
laboratory). These observations support the hypothesis that during infection, the 
master regulator of Listeria adopts a conformation similar to that of the PrfA* 
mutant protein (Ripio et al., 1997a, Vega et al., 2004). L. monocytogenes wild-type 
and the prfA* mutant strains have been shown to significantly differ in their PrfA-
dependent gene expression levels in vitro. Apart from this, both microorganisms 
proved to be similar as far as their virulence is concerned, in line with the above-
mentioned hypothesis (Ripio et al., 1996; Shetron-Rama et al., 2003 and our 
unpublished observations). 
 
 Apart from the PrfA-activating pathway, two negative regulatory pathways, 
which downregulate Listeria virulence genes, have been described. One of the 
repressor pathways involves the addition of activated charcoal to the Listeria culture 
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medium (Ermolaeva et al., 2004). It has been proposed that the so-called “charcoal 
effect” is due to the adsorption of a diffusible autorepressor substance released to the 
supernatant during Listeria exponential growth. The nature of the autorepressor 
remains unknown but preliminary experimental evidence using different types of 
adsorptive resins suggests it is a small hydrophobic molecule (Ermolaeva et al., 
2004). In the prfA* mutants, PrfA is locked in its fully active form, therefore, the 
regulator is not inhibited by this small hydrophobic molecule. These observations led 
to the conclusion that activated charcoal mediates the upregulation of PrfA-
dependent genes in vitro by sequestering a diffusible autorepressor substance 
released by L. monocytogenes in the culture medium (Ermolaeva et al., 2004).  
 
 Another virulence gene negative regulatory pathway manifests when L. 
monocytogenes bacteria grow on fermentable carbohydrates such as glucose, 
fructose, mannose or β-glucosides, e.g. cellobiose. Virulence genes are repressed 
only if there is enough amount of carbohydrate allowing bacteria to grow 
(Milenbachs et al., 1997, Vega et al., 1998, Brehm et al., 1999, Kreft & Vazquez-
Boland, 2001, Ermolaeva et al., 2004, Vega et al., 2004), indicating that the 
phenomenon is connected to sugar metabolism and possibly reflects an aspect of 
carbon catabolite repression (CCR). Indeed, only sugars that are transported by 
phosphoenolpyruvate-sugar phosphotransferase system (PTS) permeases trigger 
repression. Such repression is not observed with hexose phosphates, which are 
transported by the listerial non-PTS permease Hpt (Ripio et al., 1997b, Chico-Calero 
et al., 2002), although the same glycolytic intermediates e.g. fructose-1,6-
bisphosphate are produced when these sugars are metabolized. This suggested that 
there may be a direct link between the transport of sugars through the PTS-system 
and CCR network. Further data supporting this observation showed that the 
repression caused by cellobiose was eliminated by inactivation of a β-glucoside-
specific PTS permease system (bvrABC ) (Brehm et al., 1999). Although the major 
CCR mediator CcpA does not seem to be involved in the sugar-mediated virulence 
gene repression (Behari & Youngman, 1998a), there is evidence that the PTS 
protein, Hpr-Ser-P (histidine containing protein serine phosphorylated), is involved 
in the response by acting as a corepressor of PrfA (Herro et al., 2005). Data showed 
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that the amount of PrfA protein present in bacterial cytosol did not decrease with 
repression, indicating that sugars modulate PrfA-dependent gene expression through 
changes in PrfA activity (Renzoni et al., 1999, Ermolaeva et al., 2004). It has been 
suggested that this negative regulatory pathway may play an important role in 
repressing virulence genes in the environmental habitat, where β-glucosides 
cellobiose and other plant-derived sugars are presumably abundant (Park & Kroll, 
1993, Ripio et al., 1997b). Until today, however, the exact connection between 
sugar-mediated repression and CCR and the underlying mechanism remains 
unsolved.  
 
 The amount of PrfA protein available also plays an important role in the 
expression of PrfA-dependent genes. Two types of promoters direct the transcription 
of prfA: P1prfA and P2prfA, located in the intergenic region upstream from the prfA 
gene, generate a monocistronic transcript (figure 1.3), whereas PplcA, upstream from 
the plcA gene, generates a bicistronic plcA-prfA transcript (figure 1.7) (Mengaud et 
al., 1991, Camilli et al., 1993, Freitag et al., 1993, Freitag & Portnoy, 1994). During 
extracellular bacterial growth at temperatures below 30°C, low-level prfA mRNAs is 
synthesized due to the direct contribution of the sigma A (σA)-dependent P1prfA 
promoter. The PrfA regulon is induced, however, when the environmental 
temperature is 37°C (as on entry into a warm-blooded animal host). This 
thermoregulation is mediated by a secondary structure present in the 5’ non-coding 
region of the prfA mRNA and which prevents ribosome binding unless it melts when 
the temperature reaches 35 - 37ºC, enabling translation (Johansson et al., 2002). 
Located downstream from P1prfA, the P2prfA promoter is controlled by σA and 
additionally by σB (sigma B), which is a stress-responsive alternative sigma factor 
(see section 1.3.6) (Nadon et al., 2002, Rauch et al., 2005, Schwab et al., 2005). In 
order to ensure that a minimum amount of PrfA protein is always present in the 
bacterial cytosol, both, P1prfA and P2prfA promoters are responsible for supplying 








Figure 1.7: Schematic representation of PrfA regulation. 
See text for details: a) Resting state of PrfA system: during growth at low temperatures, in the absence 
of PrfA-activating cofactor, very small amount of PrfA is generated. Synthesis of PrfA in a native 
weakly active conformation involves monocistronic prfA mRNAs, which are produced from P1prfA 
and P2prfA promoters (pink arrow). Inefficient translation from these growth-phase regulated 
promoters is due to the presence of a secondary structure, which forbids the ribosome (represented by 
grey mushroom-like structure) to access to its binding site. b) Active state of PrfA system: Efficient 
translation (represented by filled arrowhead) is possible due to the break down of the prfA mRNA 
secondary structure, as a result of an increase in temperature to 37°C (mimicking the entry into a 
warm-blooded animal host). In the cytosolic compartment of the host cell, a putative low-molecular 
weight cofactor binds to PrfA. As a consequence, the affinity of the regulatory protein for its target 
sequence (indicated by black squares) increases. The highly active form of PrfA contributes to the 
synthesis of more PrfA. The PrfA regulon is fully induced in the environmental temperature of 37°C, 
in the presence of the cofactor and the absence of repressor signals that could potentially act on the 
system. Taken from Scortti et al. (2007).  
 
 
 The PplcA promoter, on the other hand, is strictly PrfA-dependent. Through 
positive feedback, PrfA is able to stimulate its own synthesis via the plcA-prfA 
bicistronic transcript (Mengaud et al., 1991, Chakraborty et al., 1992). This loop is 
activated when the PrfA concentration increases e.g. when prfA message translation 
is de-inhibited at 37ºC, and / or when PrfA protein activity increases, presumably by 
allosteric change, as above discussed. Due to the presence of this autoregulatory 
loop, any change in PrfA activity is immediately amplified at the transcriptional 
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level. In order for Listeria to infect successfully its host cells, the bacteria need to 
synthesize sufficiently large amount of PrfA protein through activation of the 
autoregulatory loop (Mengaud et al., 1991, Camilli et al., 1993, Vega et al., 2004). 
 
 The third mechanism contributing to the regulation of PrfA-dependent gene 
expression depends on the architecture of the promoters. PrfA-dependent promoters 
stimulated by PrfA respond in different ways. These promoters bear a 14-bp “box” of 
dyad symmetry with the consensus sequence TTAACANNTGTTAA. The PrfA 
dimer uses this sequence as a binding site (Vega et al., 1998, Goebel et al., 2000, 
Kreft & Vazquez-Boland, 2001, Scortti et al., 2007). Depending on the number of 
mismatches in the target sequence the binding affinity of PrfA is affected. The more 
the sequence differs from the perfect inverted repeat the weaker the binding is. 
Promoters such as PplcA or Phly with perfectly symmetrical PrfA boxes respond 
with greater sensitivity to PrfA. In contrast, promoters such as PactA, Pmpl, Phpt and 
PinlC, carrying a nucleotide mismatch, or PinlA having two nucleotide mismatches, 
require greater amounts of the regulatory protein in order to get fully activated. As a 
consequence, these promoters have a less linear response to the PrfA input (Vega et 
al., 2004, Scortti et al., 2007). 
 
 
1.3.6 σB IN STRESS AND VIRULENCE OF LISTERIA 
 
1.3.6.1 σB and the stress response of Listeria 
 
 Listeria monocytogenes is able to respond rapidly to changing environmental 
conditions. Bacterial survival depends on several regulatory mechanisms, which can 
function at various levels, including the transcriptional level, the post-transcriptional 
level and the post-translational level (Chaturongakul et al., 2008).  
 
 Exposure to environmental stress conditions can lead to significant changes 
in the gene expression of bacteria due to the presence of alternative sigma (σ) 
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factors. Sigma factors are proteins, which form essential dissociable subunits of 
prokaryotic RNA polymerase. These factors contribute to transcriptional level 
regulation in L. monocytogenes. Under specific environmental conditions alternative 
σ factors have the ability to associate with the core RNA polymerase. They 
recognize a specific DNA sequence that is a promoter region for a certain gene and 
initiate the transcription at that promoter site. Two structurally unrelated families of 
sigma factors have been described: the σ70 and the σ54 families (Kazmierczak et al., 
2005).   
 
 One of the first bacterial alternative σ factors described is the alternative 
sigma B (σB) factor, belonging to the σ70 family, and encoded by the sigB gene. 
Specific anti-sigma-factor protein keeps σB factor in an inactive state until the 
bacterium finds itself in the environmental conditions requiring gene expression 
recognized by the σB factor (Haldenwang & Losick, 1979, 1980, Kazmierczak et al., 
2005). Staphylococcus aureus was the first pathogen in which σB (originally known 
as σ37) was found. Apart from L. monocytogenes, it has been also identified in other 
Gram-positive bacteria such as Bacillus subtilis, Bacillus anthracis, Bacillus cereus, 
Bacillus licheniformis and Staphylococcus epidermidis (Brody & Price, 1998, 
Kazmierczak et al., 2005). The σB regulon of L. monocytogenes has been found to 
have a similar size to that of B. subtilis and S. aureus, which contain 125-150 genes 
and 198 genes, respectively (Petersohn et al., 2001, Bischoff et al., 2004, Senn et al., 
2005, van Schaik et al., 2005, Hecker et al., 2007). In L. monocytogenes, the sigB 
gene is located in seventh position in an operon consisting of eight genes (rsbR, rsbS, 
rsbT, rsbU, rsbV, rsbW, sigB and rsbX), which contribute to the regulation of σB. 
The presence of a housekeeping sigma factor (σA)-dependent promoter PA upstream 
from the rsbR gene enables the co-transcription of all of these genes. Additionally, 
there is a second promoter (PB), situated upstream of rsbV gene. This σB-dependent 
promoter contributes to the increased levels of transcription of the four genes located 
downstream in the sigB operon (figure 1.8) under conditions, in which σB is 











Figure 1.8: Schematic representation of sigB operon structure in L. monocytogenes. 
Adapted from Kazmierczak et al. (2005). Arrows represent promoter sites. PA is a housekeeping σA-
dependent promoter, which is transcribed with RNAP-σA. PB is σB-dependent promoter, which is 
transcribed with RNAP-σB.  
 
 
 The L. monocytogenes sigB operon structure is identical to that of B. subtilis, 
however, the signal transduction pathway is different in both bacteria. Unlike in B. 
subtilis, environmental and energy stresses are transmitted to σB through a single 
pathway in Listeria. The single pathway consists of RsbT, RsbU, RsbV and RsbW 
proteins (Becker et al., 1998, Wiedmann et al., 1998, Chaturongakul & Boor, 2004, 
Kazmierczak et al., 2005). 
 
 Apart from two specific heat-shock responses such as HrcA regulated class I 
response and the CtsR regulated class III response, which are activated in the 
presence of increased temperatures or other stresses such as cold-shock, high salt 
concentrations and acid-shock, L. monocytogenes possesses also the class II stress 
response mechanism, which is regulated by the σB. In L. monocytogenes, σB has 
been shown to contribute to the ability of this bacteria to survive a variety of stress 
conditions, including acid stress, osmotic stress, cold stress, oxidative stress, 
nutritional stress and also intracellular survival (Duche et al., 2002, Liu et al., 2002, 
Kazmierczak et al., 2003, Gray et al., 2006, Abram et al., 2008a, Abram et al., 
2008b). 
 
 There is evidence that the transcription of genes responsible for acid 
tolerance is regulated by σB. Some of these genes encode proteins involved in the 
glutamate decarboxylase (GAD) system, which consists of glutamate decarboxylase 
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enzyme and glutamate-γ-aminobutyrate (GABA) antiporter, contributing to the 
reduction of the acidification within the bacterial cell cytoplasm (Kazmierczak et al., 
2003, Wemekamp-Kamphuis et al., 2004, Cotter et al., 2005, Kazmierczak et al., 
2006, Raengpradub et al., 2008). Studies have shown that the ability of a L. 
monocytogenes EGDe ∆sigB mutant to survive low acidic conditions (e.g. pH = 2.5) 
was significantly decreased compared to the wild-type (Chaturongakul & Boor, 
2004, Wemekamp-Kamphuis et al., 2004). 
 
 L. monocytogenes resistance to osmotic stress is also mediated by σB. The 
sigB gene showed higher activation levels with increased osmolarity of the medium 
(Becker et al., 1998, Sue et al., 2003). L. monocytogenes is able to survive under 
high osmolarity conditions due to the presence of transport systems such as OpuC, 
Gbu and BetL, which enable osmolyte compounds such as carnitine and glycine-
betaine to penetrate through the bacterial membrane from the environment to ensure 
a proper osmotic balance. σB regulates the transcription of these compatible solute 
transporters (Fraser & O'Byrne, 2002, O'Byrne & Booth, 2002, Fraser et al., 2003, 
Cetin et al., 2004). Additionally, carnitine enables L. monocytogenes to survive in 
acidic environment in the gastrointestinal tract of a mammalian host (Sleator et al., 
2001, Gahan & Hill, 2005). Studies carried out with L. monocytogenes 10403S and 
L61, both serotype 1/2a, and corresponding ∆sigB mutants showed that the latter are 
unable to utilise these osmoprotectants. However, a ∆sigB mutant of L. 
monocytogenes L99, serotype 4c, did not manifest the same phenotype. It was 
suggested that the resistance to osmotic stress and uptake of osmolytes in this strain 
is independent of the sigB gene (Becker et al., 1998, Moorhead & Dykes, 2003). 
Using a ∆sigB mutant, reverse transcription real-time quantitative PCR (RT-QPCR) 
and proteomic techniques it was found that in the presence of 0.5 M NaCl, a number 
of genes and proteins are expressed in a σB-dependent manner. Microarray 
experiments showed that σB regulates several transporters and transport systems in L. 
monocytogenes 10403S when logarithmic phase cells are exposed to 0.5 M KCl or 
0.3 M NaCl (Kazmierczak et al., 2003, Raengpradub et al., 2008, Abram et al., 
2008b). Moreover, during cold-shock, σB contributes to adaptation in a growth phase 
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dependent-manner and is necessary for efficient accumulation of betaine and 
carnitine as cryoprotectants (Becker et al., 2000).  
 
 A transcriptional profiling of the σB regulon was carried out under oxidative 
stress and several genes, including lmo0669 and lmo1433 (encoding an 
oxidoreductase and a glutathione reductase, respectively), are possibly involved in 
the oxidative stress regulation and several genes were identified as σB-dependent in 
these conditions (Kazmierczak et al., 2003, Hain et al., 2008, Raengpradub et al., 
2008). Studies carried out with stationary-phase L. monocytogenes 10403S (serotype 
1/2a) and isogenic ∆sigB mutant demonstrated that σB is required for survival during 
exposure to 13 mM cumene hydroperoxide (CHP). It appears that the contribution of 
σB to protection of L. monocytogenes against oxidative stress is variable and strain-
specific. Indeed, studies involving another strain of L. monocytogenes, L99, serotype 
4c, showed that ∆sigB mutant was more resistant than the wild-type strain when 
exposed to CHP for 15 minutes. A different observation, however, was made with 
another listerial strain, L61, serotype 1/2a, according to which the ∆sigB mutant 
responded similarly to such stress conditions as the wild-type strain (Ferreira et al., 
2001, Moorhead & Dykes, 2003, Chaturongakul & Boor, 2004).  
 
 Whole-genome transcriptional profiling of L. monocytogenes enabled to 
identify σB-dependent genes upregulated during stationary phase. This suggested that 
σB plays a major role in survival under environmental stresses related to nutrient 
limitation (Hain et al., 2008, Raengpradub et al., 2008). There is also evidence that 
σB regulates carbohydrate metabolism. lmo0398-lmo0400 and lmo0784-lmo0781, 
encoding fructose- and mannose-specific PTS systems, respectively, are σB-
dependent operons involved in carbohydrate metabolism (Raengpradub et al., 2008). 
σB was also found to be directly involved in the regulation of glycolysis and 
gluconeogenesis. A putative σB-dependent promoter, situated upstream of lmo2460, 
encodes a transcriptional regulator, CggR (central glycolytic genes regulator), which 
was involved in these metabolic processes (Raengpradub et al., 2008). Studies 
carried out by Abram et al. (2008a) revealed that σB is involved in glycerol 
metabolism (Abram et al., 2008a). The wild-type and the ∆sigB mutant strains of L. 
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monocytogenes 10403S were checked for the ability to utilize glycerol. It turned out 
that ∆sigB mutant grew slower in a chemically defined growth medium using 
glycerol as the only carbon source in comparison to the wild-type strain. 
Additionally, the mutant showed a much prolonged lag phase.  
 
 It has also been shown that σB contributes to energy-stress survival in L. 
monocytogenes. The evidence was obtained using the strain 10403S and its isogenic 
∆sigB mutant grown in BHI supplemmented with CCCP (protonophore carbonyl 
cyanide 3-chloropenylhydrazone), which inhibits ATP synthesis. The ∆sigB strain 
survived less effectively in comparison to the parental strain when incubated at 37°C 
for 36 h (Chaturongakul & Boor, 2004). In addition, RT-QPCR analyses showed that 
opuCA transcription was activated only in the presence of σB after 5-minute exposure 
to CCCP (Chaturongakul & Boor, 2006). Studies involving other strains of L. 
monocytogenes, such as L61 of serotype 1/2a and L99 of serotype 4c, however, 
showed no effect of σB on the survival in stresses related to energy and carbon 
limitation, indicating that the role of this σ factor is strain dependent (Ferreira et al., 
2001, Moorhead & Dykes, 2003).  
 
 Other stresses against which a protective role of σB has been demonstrated 
includes resistance to detergents and surface-active agents, as observed with 
benzalkoniumchloride (BC), cetylpyridinium chloride (CPC) and sodium dodecyl 
sulphate (SDS) (Ryan et al., 2008).  
 
 
1.3.6.2 PrfA-σB crosstalk 
 
 Alternative sigma factors like σB are involved in complex regulatory 
networks, which allow the controlled genes to be expressed in a variety of changing 
environmental conditions and situations, like for example those involved in the 
different stages of Listeria pathogenesis and transmission cycle. For example, L. 
monocytogenes needs to survive nutrient-limiting conditions in the environment, the 
acidity of the stomache after ingestion, and oxidative damage in the host cell 
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phagosome, and this is likely to require the coordinated expression of specific 
virulence factors and stress resistance mediators (Kazmierczak et al., 2005, Freitag et 
al., 2009).  
 
 Such coordinated expression appears to exist in L. monocytogenes between 
the prfA gene, encoding the major gene regulator PrfA, and sigB (Nadon et al., 2002, 
Chaturongakul et al., 2008). Studies have shown that σB together with PrfA co-
regulate important virulence genes, such as inlA and inlB, both involved in host cell 
invasion (figure 1.9), indicating that regulatory interactions between σB and PrfA are 
important for the transit from a non-host to host environment (Dussurget et al., 2002, 
Kazmierczak et al., 2003, Kim et al., 2004, Sleator et al., 2005, McGann et al., 2007, 
McGann et al., 2008). Studies carried out by Kim et al., (2005) have shown that σB 
contributes to L. monocytogenes invasion mainly through direct control of inlA and 
inlB expression rather than indirectly via PrfA. It has also been demonstrated using 
RT-QPCR that σB contributes to inlA and inlB expression in mainly stationary-phase 
(Kim et al., 2005). Evidence provided by Garner et al., (2006) confirmed that σB 
contributes to L. monocytogenes invasion partially, by direct effects on inlA 
transcription rather than on prfA transcription. These authors showed the important 
role of σB during the gastrointestinal stage of listeriosis in guinea pigs, which have 
the InlA-susceptible isoform of the E-cadherin receptor (Lecuit et al., 2001), but its 
dispensability for the later phases of invasive infection, i.e. systemic spread (Garner 
et al., 2006). It is unclear whether the role of σB in the gastrointestinal tract reflects 
its role in inlAB operon regulation or that L. monocytogenes confronts a set of stress 
conditions that are not found in internal host tissues.  
 
 Additionally, L. monocytogenes σB may contribute to intestinal colonization 
by mediating resistance to bile through transcriptional regulation of bilE, encoding a 
bile-exclusion system, and the bsh gene, which encodes a bile-salt hydrolase 
(Dussurget et al., 2002, Sleator et al., 2005). It is unclear whether these genes, 
together with the opuC operon, all involved in gastrointestinal stages of Listeria 
infection, are also directly or indirectly regulated by PrfA. In the transcriptomic 
study of the PrfA regulon of Milohanic et al. (2003) these bile resistance genes were 
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classifed as group III genes, characterized by apparent PrfA regulation but lacking a 
bona fide PrfA-box and being expressed from a σB-dependent promoter (Milohanic 
et al., 2003, Sleator et al., 2005, Kazmierczak et al., 2006). Corrupted PrfA boxes 
are present in front of opuCD and bsh (Milohanic et al., 2003, Scortti et al., 2007) 
but in vitro transcription studies and RT-QPCR analyses gave no evidence for direct 
PrfA-dependent activation of these genes (Rauch et al., 2005, Ollinger et al., 2008). 
Genes classified as group III genes by Milohanic et al. (2003) are in fact weakly or 
inconsistently regulated by PrfA (Scortti et al., 2007), and the observed effects of 














Figure 1.9: Hypothetical model of the regulation network of PrfA, σB and σL in L. monocytogenes. 
Adapted from Kazmierczak et al. (2005, 2006), Scortti et al. (2007) and Chaturongakul et al. (2008). 
Colour-coded arrows indicate genes regulated by PrfA (red and blue), σB (black) and σL (green). 
Direct regulation of a gene by a certain regulator (determined by the presence of either PrfA box or σB 
promoter or σL promoter) is indicated by thick, solid lines; indirect regulation is indicated by thick, 
broken lines. Thin, blue arrows indicate weak or inconsistent regulation of a gene by a given 
regulator. Positive regulation by a given regulator is indicated by a target arrow (↓), whereas negative 
regulation by a given regulator is represented by a target stop (⊥). Navy blue arrows forming loops 
indicate auto-regulation. Large rounded rectangles indicate transcriptional regulators, small rounded 
rectangles indicate genes that regulate a transcriptional regulator. Virulence genes (including Listeria 
pathogenicity island [LIPI-1] virulence genes such as hly, plcA, plcB, mpl, and actA) are indicated by 
hexagons. A gene encoding a protein of unknown function is represented by an octagon. Stress-
response genes are indicated by squares and rectangles. Operons are indicated by genes arranged in 
vertical columns. The thick, black, broken-lined circle and arrow targeting σB indicate post-




 Studies have shown that genes regulated by σB are also expressed after the 
entry into various host cells (both: phagocytic and non-phagocytic). It is unclear 
whether this activation is solely due to σB or reflects some kind of interaction or co-
regulation with PrfA (Sleator et al., 2005, Chatterjee et al., 2006, Joseph et al., 2006, 
Raengpradub et al., 2008). It has been proposed that σB regulates specifically the 
expression of genes important for L. monocytogenes adaptation to the intestinal 
environment, whereas PrfA and the virulence gene cluster contribute to survival and 
replication in the blood (Toledo-Arana et al., 2009).  
 
 As mentioned above in section 1.3.5, σB directly contributes to the expression 
of PrfA in Listeria. This is achieved through direct regulation of the P2prfA promoter 
located upstream from prfA in the plcA-prfA intergenic region (figure 1.3). As 
P2prfA is also σA-dependent promoter, the transcription of the monocistronic prfA 
mRNA involves overlapping σA- and σB-dependent promoters (Freitag & Portnoy, 
1994, Nadon et al., 2002, Lemon et al., 2010). In contrast to P1prfA transcript 
translation (activated at temperatures higher than 30°C), translation from P2prfA 
promoter transcripts is temperature independent. Therefore, σB-dependent prfA 
expression can occur outside the mammalian host (Johansson et al., 2002, 
Chaturongakul et al., 2008). The contribution of this σB-dependent prfA gene 
activation pathway to virulence is, however, unclear since a deletion mutant in 
P2prfA promoter was similarly virulent to the wild-type after intragastric inoculation 
(Garner et al., 2006). Additionally, cell-to-cell spread of these mutants was not 
affected in several mammalian cell lines (Freitag & Portnoy, 1994, Chaturongakul et 
al., 2008). It has been suggested that the presence of σB is required to allow the 
transcription of prfA, only in undetermined, specific stages of infection. It appears 
that P2prfA directed expression of the prfA gene is growth phase-dependent and 
particularly relevant in stationary phase (Schwab et al., 2005, Abram et al., 2008a). 
 
 σB is known to influence the expression of a major virulence gene regulator 
not only in L. monocytogenes but also in other bacteria. For example, σB regulates at 
the transcriptional level the S. aureus sar gene, which in turn controls the expression 
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of the global regulatory gene, agr. The synthesis of wide range of virulence-related 
extracellular and cell-surface proteins is controlled by these two genes and, therefore, 
they are regarded as prime regulatory factors in S. aureus pathogenesis (Arvidson & 
Tegmark, 2001, Bischoff et al., 2001, Bischoff et al., 2004). 
 
 It has been also found that σB together with another alternative sigma factor, 
σL, co-regulates the expression of some genes, such as a general-stress protein, 
lmo1601, and a cold-shock protein, cspD, required for overcoming metabolic and 
physiological stresses in L. monocytogenes (Arous et al., 2004, Raengpradub et al., 
2008). σL, also called σN or RpoN, is encoded by the sigL gene of L. monocytogenes 
and belongs to the σ54 family of sigma factors (Robichon et al., 1997, Kazmierczak 
et al., 2005, Chaturongakul et al., 2008). Studies have shown that different growth 
phases and temperatures influence the expression of sigL (Liu et al., 2002, Chan et 
al., 2007a). Among the 77 σL-dependent genes described in L. monocytogenes, 
several are involved in the amino acid and carbohydrate metabolisms. Twenty-four 
of these genes showed differential expression depending on the environmental 
conditions, particularly during in vitro growth in BHI vs intracellular conditions. In 
macrophages, for example, an oligopeptide transporter gene and clpP (stress-related 
serine protease) were activated, whereas, genes involving cell division or encoding 
thioredoxin and pyruvate dehydrogenase were repressed. Other findings indicated 
that SigL facilitates survival to osmotic stress (Chatterjee et al., 2006, Okada et al., 
2006), and confirms resistance to mesentericin Y105, a bacteriocin bactericidal agent 
against L. monocytogenes (Robichon et al., 1997). Additionally, it has been shown 
that both σB and σL contribute to the L. monocytogenes response to antimicrobial 
peptides such as nisin, produced by the lactic acid bacterium Lactococcus lactis, and 
SdpC (sporulation delaying protein C), produced by some strains of B. subtilis 
(Gonzalez-Pastor et al., 2003, Butcher & Helmann, 2006, Palmer et al., 2009). 
 
 Regulation of stress response and virulence genes can be also obtained 
through controlling directly or indirectly the transcription of small RNAs (sRNAs) 
by alternative σ factors (Chaturongakul et al., 2008). In the latter case, σ factors 
regulate the expression of RNA-binding proteins and chaperones such as Hfq. It has 
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been shown that in stress conditions caused by the presence of salt or ethanol, Hfq is 
involved in the stress response and it is σB controlled in L. monocytogenes. This 
muliple stress resistance protein also plays a role in virulence in mice, however, in 
tissue culture models it has not been found to contribute to virulence. Regulation of 
sRNAs and Hfq is an example of post-transcriptional control by alternative σ factors 
(Christiansen et al., 2004, Chaturongakul et al., 2008).  
 
 
1.3.7 LISTERIAL PATHOGENIC TROPISM AND ITS 
MOLECULAR DETERMINANTS  
 
 Up to date, not much is known about the molecular basis of Listeria 
pathogenic tropism, despite evidence that strains / species of these pathogens differ 
in infectivity, host range and clinical presentation. Indeed, there is proof for 
differences in pathogenic potential of L. monocytogenes strains depending on the 
phylogenetic lineage of the bacteria. L. monocytogenes has three genetic lineages: 
lineage I contains serovars 1/2b, 3b, 4b, 4d and 4e; lineage II includes serovars 1/2a, 
1/2c, 3a and 3c; and lineage III consists of serovars 4a and 4c. The lineage status of 
serovar 7 remains unclear (Piffaretti et al., 1989, Wiedmann et al., 1997, Doumith et 
al., 2004, Liu, 2006a, Liu et al., 2006b). It has been observed that most of the human 
listeriosis cases are caused by just three serotypes (i.e. 1/2a, 1/2b and 4b). Data from 
the literature show, however, that serovar 4b Listeria are responsible for the majority 
of food-borne listeriosis outbreaks, whereas L. monocytogenes serovar 1/2a and 1/2b 
appear to be associated with sporadic cases (McLauchlin, 1987, Farber & Peterkin, 
1991, Buncic et al., 2001, Jeffers et al., 2001, Gray et al., 2004). It has been also 
shown that the majority of L. monocytogenes food isolates belong to serogroup 1, 
which include serovar 1/2a (Rocourt, 1989, Gilot et al., 1996, Ojeniyi et al., 1996, 
Autio et al., 1999). Despite that Listeria serotypes 4a and 4c (lineage III) are 
frequently isolated from animal, food or environmental sources, they are found to be 
rarely responsible for human infections (Wiedmann et al., 1997, Liu, 2006a). 
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 To date, the only well-characterized molecular mechanism involved in 
listerial pathogenic tropism is the internalization process mediated by InlA and InlB. 
Both proteins appear to differ in target cell specificities (Vazquez-Boland et al., 
2001a): whereas InlB was found to mediate entry into a wide range of cell types, 
InlA has been reported to specifically facilitate invasion of epithelial  cells bearing a 
specific isotype (human) of the E-cadherin receptor. This “InlA-susceptible” isotype 
is present in guinea pig but not in mice, explaining why the murine model is not 
satisfactory to reproduce the epithelial (intestinal) phase of infection, in contrast to 
the guinea pig model (Dramsi et al., 1995, Drevets et al., 1995, Parida et al., 1998, 
Lecuit et al., 1999). 
 
 In Listeria, the most striking difference in pathogenicity is observed between 
L. monocytogenes and L. ivanovii (see above section 1.3.3). Thanks to its differential 
pathogenic properties, L. ivanovii offers a unique comparative model to study the 
molecular mechanisms involved in bacterial host and tissue tropism. In a search for 
species-specific factors that could explain the differences in pathogenicity between 
these two bacteria, our group identified “Listeria pathogenicity island 2” (LIPI-2) 
(Dominguez-Bernal et al., 2006) (figure 1.10). LIPI-2 is a large (22 kb) 
chromosomal locus specifically present in L. ivanovii within the genus Listeria. 
LIPI-2 is the largest of the known internalin islands. Most of the inl genes in this 
island are PrfA-dependent and encode small-secreted internalins (Dominguez-Bernal 
et al., 2006). As internalin proteins have been shown to be involved in host cell 
tropism (Hamon et al., 2006), it is likely that this new large internalin island plays a 
role in the specific pathogenic properties of L. ivanovii and, possibly, its marked 
specificity for ruminants.  
 
 LIPI-2 also contains the smcL gene encoding the L. ivanovii-specific SMase. 
In contrast to the surrounding inl genes, smcL is expressed independently of PrfA 
and is transcribed in the opposite orientation (Gonzalez-Zorn et al., 1999) (figure 
1.10). The smcL product, SmcL, is responsible for the distinctive phenotype of L. 
ivanovii on sheep blood agar, characterized by a strong bizonal haemolysis and a 
typical synergistic haemolytic effect in the presence of Rhodococcus equi cholesterol 
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oxidase (the so called “CAMP-like” reaction) (figure 1.11). Our group also 
determined that SmcL is a phagosome-disrupting factor, the loss of which attenuates 
L. ivanovii virulence in the mouse and impairs intracellular proliferation in Madin-
Darby Bovine Kidney (MDBK) cells. Interestingly, SmcL is only lytic on sheep 
erythrocyte membranes, which are rich in sphingomyelin (51% of total 
phospholipids), but not in horse erythrocytes, which are poor in sphingomyelin 
(13.5% of total phospholipids), suggesting that this enzyme may play a role in host 







Figure 1.10: Genetic organization of LIPI-2 and the right flanking chromosomal region.  
LIPI-2 genes such as the smcL and inl genes are in pink and blue, respectively. Black-coloured genes 
belong to the housekeeping core genome. Small rectangles in front of the genes indicate PrfA-boxes: 
in red these with no or one mismatch respect to the perfect consensus palindrome, in yellow these 
with two mismatches and in grey these with three mismatches. Hairpins represent transcription 
terminators. LIPI-2 is inserted into a tRNA gene and, yet perfectly conserved in all L. ivanovii 
isolates, is genetically unstable in vitro, a large section of it undergoing site-specific spontaneous 
deletion together with a portion of the flanking core listerial genome at approximately 10−4 frequency. 
The spontaneously deletable fragment is boxed. Taken from Dominguez-Bernal et al. (2006).  
 
 
 SmcL is not only similar to the bacterial SMases C from S. aureus (ß-toxin), 
B. cereus or Leptospira interrogans (Gonzalez-Zorn et al., 1999, Gonzalez-Zorn et 
al., 2000) but also exhibits extensive sequence similarity with the mammalian neutral 
SMases (Openshaw et al., 2005). These endogenous membrane-associated SMases 
are thought to play a critical role in the sphingomyelin-ceramide signalling pathway. 
Ceramide is primarily generated in mammalian cells by the degradation of 
sphingomyelin by SMases and this lipid metabolite is believed to be a key second 
messenger in important eukaryotic cell processes, such as cell proliferation, 
differentiation and survival, and cell cycle arrest (Kolesnick & Kronke, 1998, Goni 

































































function in a phagosome disruption, SmcL may also play a subtler role in 
pathogenesis by directly interfering with the SM-ceramide host cell-signalling 
pathway. Studies carried out by Zhang et al. (2008), have shown that Sph2, a 
sphingomyelinase haemolysin from L. interrogans strain Lai, possibly induces 













Figure 1.11: Listeria haemolytic activity and CAMP-like reaction.  
Left panels indicate haemolytic activities of L. monocytogenes (L. mo.) and L. ivanovii (L. iv.) on 
sheep blood agar. Note the strong multizonal lytic activity of L. ivanovii due to the production of the 
SMase, SmcL. Right panels show synergistic (CAMP-like) haemolysis of L. ivanovii and S. aureus 
(S. au.) producing ß-toxin (SMase) with vertically streaked R. equi; identical shovel-shaped patches of 
synergistic haemolysis were obtained for L. ivanovii and S. aureus, showing that sphingomyelinases C 
of these two bacteria are functionally related. The SMase completely lyses the erythrocytes exposed to 
R. equi cholesterol oxidase resulting in a shovel-shaped lytic phenomenon, bizonal haemolysis (Ripio 
et al., 1995, Gonzalez-Zorn et al., 1999). As shown in the two upper right panels, the L. ivanovii 
SMase is active on sheep erythrocytes but not on horse erythrocytes. Bacteria were cultured at 37°C 
for 24 h (taken from Vazquez-Boland et al., [2001a]). 
 
 
 According to preliminary experiments carried out in collaboration with Prof. 
T. Levade, University of Toulouse, L. ivanovii induces a potent ceramide response 
during intracellular infection in MDBK cells. SmcL appears to contribute to this 
response as ceramide generation was much less intense in cells infected with an 
isogenic smcL mutant (unpublished data from our laboratory). A wealth of 
circumstantial evidence suggests that ceramide is a major regulator/mediator of the 
apoptotic response triggered by some cytokines, such as TNF-α and Fas ligand, or a 
variety of stresses including irradiation, heat shock and toxic drugs (Hannun & 
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Luberto, 2000, Andrieu-Abadie & Levade, 2002, Hannun & Obeid, 2002, Levade et 
al., 2002, Luberto et al., 2002, Pettus et al., 2002, Cossart et al., 2003, Gulbins, 
2003, Lin et al., 2006). Consistent with a possible role of SmcL in ceramide 
generation and apoptosis, data from our laboratory indicate that L. ivanovii causes 
apoptosis in MDBK cells suggesting that SmcL may contribute to this apoptotic 
response as an smcL mutant showed a reduced apoptogenic activity compared to 
wild-type bacteria (Domínguez-Bernal et al., 2006 and other unpublished 
observations).  
 
 Apoptosis induction by pathogens has been shown to contribute to limiting 
the spread of infection because of enhancing antigen presentation and the immune 
response (Gao & Abu Kwaik, 2000). Invasion of the central nervous system by L. 
monocytogenes requires a prolonged exposure of the blood-brain barrier to bacteria 
that are continually released into the bloodstream from active infectious foci in the 
primary target organs (reviewed in Vazquez-Boland et al., [2001a]). It is, therefore, 
tempting to speculate that the apoptogenic activity of L. ivanovii may account for the 
inability of this species to cause meningoencephalitis. 
 
 
1.4 APOPTOSIS IN BACTERIAL INFECTIONS 
 
 Apoptosis, or programmed cell death, is an essential and tightly regulated 
process important for development and tissue homeostasis. Apoptosis is a Greek 
word meaning “falling off “, which was first introduced in 1972 by Kerr, Wyllie and 
Currie (Kerr et al., 1972) to designate a mammalian cell death process accompanied 
by various morphological and biochemical changes, including chromatin 
aggregation, nuclear and cytoplasmic condensation resulting in cell shrinkage, 
membrane blebbing, DNA fragmentation and the emergence of “apoptotic” bodies, 
which contain ribosomes, morphologically intact mitochondria and nuclear material 
(Wyllie et al., 1981, Pallardy et al., 1997, Raffray & Cohen, 1997, Maria et al., 2000, 
 39 
Lecoeur, 2002, Weiss & Zychlinsky, 2002, Vallender & Lahn, 2006). In contrast to 
necrosis (also known as “accidental” cell death, which is due to exposure to a serious 
physical or chemical damage), apoptosis is an active process with well-organized, 
regulated biochemical events, involving cell signalling and ordered enzyme cascades 
(Bortner et al., 1995, Raffray & Cohen, 1997, Gulbins et al., 2000, Castedo et al., 
2002, Chowdhury et al., 2006). 
 
 Eukaryotic cells can undergo apoptosis dependently or independently of 
caspases, which are a group of cellular proteases. The caspase-dependent pathway 
can be either mediated by mitochondria or by surface receptors and is, then, called 
the intrinsic or extrinsic pathway, respectively. Both, the intrinsic and extrinsic 
pathways, involve a cascade of caspases ultimately leading to activation of caspase-3 
or -6, which directly results in apoptotic cell death. The extrinsic pathway begins 
with the activation of caspase-8 by receptors. The intrinsic pathway is more likely to 
involve activation of caspase-9 by cytochrome c (cyt-c) through Apaf-1 (apoptotic 
protease activating factor 1). The caspase-independent pathway involves the 
activation of calpains, which are Ca2+-dependent cysteine proteases (figure 1.12) (Li 
et al., 1997, Scorrano & Korsmeyer, 2003, Chowdhury et al., 2006, Fettucciari et al., 
2006). 
 
 Substrates involved in apoptotic cell death may interact with each other 
resulting in a variety of pathways. For example, calpains and caspases may both 
activate other caspases or proteins such as Bax and Bid. These pro-apoptotic Bcl-2 
family members may contribute to the release of proteins from mitochondria. As a 
consequence, other factors, either caspase-dependent such as cyt-c, second 
mitochondria derived activator of caspase (Smac/Diablo), or caspase-independent, 
such as apoptosis inducing factor (AIF) or endonuclease G (EndoG), may be 
activated leading to apoptotic cell death (Kohler et al., 2002, Scorrano & Korsmeyer, 
2003, Fettucciari et al., 2006). 
 
 Many pathogens modulate the death pathways of host cells in order to 
manipulate host defences to their benefit. Bacteria induce apoptosis either through: 
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(i) activation of pro-apoptotic factors such as caspases, Bim, Bax, Bad, Bid and Bak; 
(ii) inhibition of anti-apoptotic factors such as NF-κB (Nuclear Factor κB), MAP-
kinases (Mitogen Activated Protein kinases), IAPs (Inhibitors of Apoptosis Proteins) 
or Bcl-2 and Bcl-xL; (iii) interference with upstream endogenous receptor-ligand 
systems exposed to the cell surface. Bacteria often use host cell apoptosis to gain 
easier access to target organs (Chen & Zychlinsky, 1994, Behnia et al., 2000, 
Dockrell, 2001, Hasnain et al., 2003, Scorrano & Korsmeyer, 2003). The ability of 
bacteria to modulate phagocyte apoptosis has shown to be an important mechanism 
of pathogenesis. 56 bacterial strains have been found to modulate cell death in 
phagocytic leukocytes (e.g. macrophages, neutrophils, dendritic cells, monocytes) 
(DeLeo, 2004). Inducing apoptosis in macrophages is especially important for 
bacteria as these cells play a pivotal role in phagocytosis and antigen presentation. 
Induction of apoptosis in epithelial or endothelial cells may also allow bacteria to 
optimize their colonization capacity and invade deeper tissues (Grassme et al., 2001). 
 
 However, as apoptotic cells are rapidly removed by phagocytic/antigen–
presenting cells, apoptosis of infected cells may also favour the development of a 
specific immune response without inducing inflammation and tissue destruction. 
Therefore, in some instances, rather than promoting colonization, apoptosis may 
have opposite effects, limiting the virulence and the spread of the pathogen (which 
paradoxically may in turn maximize the pathogen’s within-host survival and 
transmission). This has been suggested to occur with the intracellular pathogens 
Mycobacterium tuberculosis and Coxiella burnetii (Weinrauch & Zychlinsky, 1999, 
Gao & Abu Kwaik, 2000, Danelishvili et al., 2003, Dao et al., 2004, Winau et al., 
2004).  
 
 Infection of macrophages by M. tuberculosis causes down-regulation of 
expression of the anti-apoptotic protein Bcl-2 and production of TNF-α, promoting 
apoptosis in a caspase-1 dependent manner; this proapoptotic effect is modulated by 
the secretion of soluble tumour necrosis factor receptor 2 (sTNFR2), which 
neutralizes the pro-apoptotic activity of TNF-α. It has been also reported that 
presence of high numbers of intracellular M. tuberculosis bacilli triggers a 
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macrophage caspase-independent apoptotic pathway (Gao & Abu Kwaik, 2000, Lee 














Figure 1.12: A schematic representation of the types of apoptosis. 
Based on morphological and biochemical studies (adapted from Chowdhury et al. [2006]). 
 
 
 There is strong evidence that Group B Streptococci (GBS), such as 
Streptococcus agalactiae, trigger apoptosis in macrophages and monocytes 
(Fettucciari et al., 2000, Ulett et al., 2003). GBS have been reported to induce 
macrophage apoptosis by calpain activation involving either caspase-dependent or -
independent pathways (Fettucciari et al., 2006).  
 
 Pneumolysin, a pore-forming exotoxin of Streptococcus pneumoniae, has 
been found to have a direct proapoptotic activity on macrophages and neuronal cells 
(Braun et al., 2002, Bifrare et al., 2003, Marriott et al., 2004). H2O2 is another 
exotoxin produced by this bacterium contributing to stimulation of apoptosis (Braun 
et al., 2002). Apart from macrophages and neurons, S. pneumoniae has been shown 
to cause the programmed cell death in many other cell types including dendritic cells, 
neutrophils and human alveolar and bronchial epithelial cells (Ulett & Adderson, 
2006). Interestingly, in these epithelial cells, Pneumococcus-induced apoptosis was 
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independent of pneumolysin and H2O2. The programmed cell death occurred through 
caspase-6 and non-caspase proteases but independently of caspase-3, which seemed 
to be unique in bacterial infections (Schmeck et al., 2004).  
 
 Streptococcus pyogenes produces exotoxin B, which has been found to 
induce apoptosis in epithelial cells and macrophages (Kuo et al., 1999, Tsai et al., 
1999). It has been demonstrated that this virulence factor activates eukaryotic matrix 
metalloproteinases, which contribute to the release of TNF-α and FASL, resulting in 
the induction of the programmed cell death process (Tamura et al., 2004). Other 
studies have shown that infection with S. pyogenes of epithelial cells triggers the 
intrinsic pathway of apoptosis through activation of caspase-9 (Nakagawa et al., 
2004). Helicobacter pylori induces apoptosis in macrophages through a caspase-
dependent mitochondrial pathway (Menaker et al., 2004). Upon host cell invasion, 
Legionella pneumophila activates caspase-3 in macrophages, monocytes and alveolar 
epithelial cells (Gao & Abu Kwaik, 2000, Dockrell, 2001, Abu-Zant et al., 2005). 
Salmonella, Shigella and Yersinia spp. inject directly into host macrophages type III 
secretion system effector proteins (SipB, IpaB and YopP/J, respectively) that cause 
apoptosis; Salmonella and Shigella induce caspase-1, whereas Yersinia inhibits 
survival pathways mediated by nuclear factor κB (NF-κB) and mitogen-activated 
protein kinase (MAPK) and, in parallel, appears to induce unknown caspases 
(Zychlinsky et al., 1992, Ruckdeschel et al., 1997, Navarre & Zychlinsky, 2000, 
Dockrell, 2001, Grassme et al., 2001, Hueffer & Galan, 2004, Zhang et al., 2005, 
Ogawa & Sasakawa, 2006).  
 
 Staphylococcus aureus has been found to induce apoptosis in various 
eukaryotic cells such as neutrophils, monocytes, chondrocytes, keratinocytes, 
endothelial cells, epithelial cells and osteoblasts (DeLeo, 2004, Ulett & Adderson, 
2006). S. aureus produces several exotoxigenic virulence factors, two of which are 
the superantigen enterotoxin  B and the haemolysin: α-toxin; both involved in the 
induction of apoptosis. Enterotoxin B-induced apoptosis is carried out through the 
extrinsic pathway involving TCR (T-cell receptor) engagement and FASL-CD95 
signal transduction (Ulett & Adderson, 2006). On the contrary, α-toxin induces the 
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programmed cell death through caspase activation via the intrinsic pathway, which 
involves the release of mitochondrial cyt-c and the regulation of BCL-2 (Bantel et 
al., 2001, Esen et al., 2001, Haslinger et al., 2003). Additionally, α-toxin has been 
also found to contribute to pore formation resulting in apoptosis in endothelial cells 
(Menzies & Kourteva, 2000). Furthermore, it has been shown that strongly 
haemolytic and invasive S. aureus, but not non-invasive staphylococcal strains, 
induce caspase-dependent, Fas-independent apoptosis in endothelial cells (e.g. 
HUVEC [human umbilical vein endothelial cells] or HBMEC [human brain 
microvascular endothelial cells]); heterologous expression of α-toxin in a non-
haemolytic strain partially restored apoptosis induction, suggesting a role of this 
pore-forming haemolysin as an apoptosis trigger factor (Haslinger-Loffler et al., 
2005).  
 
 The opportunistic pathogen Pseudomonas aeruginosa activates the 
endogenous Fas (CD95)/FasL (CD95 ligand) system, inducing caspases and 
mitochondrial changes. P. aeruginosa infection also triggers activation of the acid 
sphingomyelinase and the release of ceramide in sphingolipid-rich rafts in epithelial 
cells, leading to raft reorganization into larger membrane platforms which are 
required for bacterial internalization, apoptosis in infected cells and regulation of 
cytokine responses (Grassme et al., 2001, Grassme et al., 2003).  
 
 Clostridium difficile encodes virulence factors such as exotoxins A and B, 
which have been shown to cause apoptosis in several epithelial and endothelial cell 
types (reviewed in Ulett and Adderson, 2006). A common mechanism by which 
Clostridia spp. trigger apoptosis in host cells has emerged. Studies have shown that 
exotoxins produced by these bacteria contribute to the intrinsic pathway of inducing 
programmed cell death, which involves mitochondrial dysfunction and inactivation 
of Rho protein function (Fiorentini et al., 2003).  
 
 Pro-apoptotic activity has been demonstrated for a lethal toxin of Bacillius 
anthracis in murine macrophages. Studies have shown that the induction of apoptosis 
in these cell lines involved FASL binding and activation of caspases -1, -3, -4, and -8 
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(Popov et al., 2002a, Popov et al., 2002b). Additionally, it has been shown that in 
order to trigger macrophage apoptosis by the lethal toxin, the presence of the protein 
kinase PKR is essential after activation of Toll-like receptor 4 (Hsu et al., 2004).  
 
 Interestingly, it has been found that L. monocytogenes has the ability to either 
induce or inhibit apoptosis in the host cell, depending on the type of the cell infected. 
However, the information is limited and sometimes contradictory. L. monocytogenes 
develops several strategies to evade or modulate host immune responses in order to 
obtain a more favourable environment, ensuring its survival and pathogenesis. One 
of them is the ability to induce apoptosis in immune effector cells (Corr & O'Neill, 
2009). The potential benefit of this effect on immune cells is that the inflammatory 
response is limited. Thus, experiments demonstrated that the presence of apoptotic 
lymphocytes suppressed early innate immunity, allowing Listeria bacteria to grow in 
the host environment (Carrero et al., 2006, Carrero & Unanue, 2006). Lymphocyte 
apoptosis caused by L. monocytogenes is apparently mediated by LLO, which is 
released during the early growth phase of this bacterium (Carrero et al., 2004a, 
2004b, Carrero et al., 2009). LLO-induced apoptosis can occur through two 
pathways: a fast one, which is caspase-dependent and a slow one, which is caspase-
independent (Carrero et al., 2008, Cervantes et al., 2008). LLO-induced programmed 
cell death in T lymphocytes has been found to be associated with the activation of 
caspase-9 and -3 and loss of mitochondrial membrane potential, pointing to the 
intrinsic apoptotic pathway (Carrero et al., 2004a). Granzymes appear to be also 
involved in the rapid apoptosis induced by LLO on T-cells. The lack of granzymes 
results in a dramatic reduction in all apoptotic parameters, such as caspase activation, 
phosphatidylserine exposure, mitochondrial depolarization and DNA fragmentation 
(Carrero et al., 2008).  
 
 Host cell apoptosis induction by Listeria has been reported to also occur in 
murine-splenic dendritic cells (Guzman et al., 1996) and lymphocytes (Mannering et 
al., 2002, Carrero et al., 2004a), as well as in human neutrophils (Kobayashi et al., 
2003). This may result in lower levels of antigen presentation and downregulation of 
the immune response, thereby favouring the spread of the pathogen.  
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 There are also reports showing that L. monocytogenes causes apoptosis in 
murine hepatocytes (Rogers et al., 1996) and Caco-2 human colonic cells (Valenti et 
al., 1999) but these observations have not been independently confirmed. In this case 
apoptosis would have an opposite effect, inhibiting the spread of L. monocytogenes 
to neighbouring cells and making the pathogen accessible to effector cells. It has 
been also shown that Listeria induces apoptosis in murine neuroblastoma Neuro-2a 
cells (Parra et al., 2008) and this effect may contribute to listerial neuropathogenesis 
during invasion of the central nervous system (CNS).  
 
 Other studies, in contrast, show that L. monocytogenes inhibits apoptosis. 
This has been observed in infected murine bone marrow macrophages (Barsig & 
Kaufmann, 1997). In the human promyelocytic cell line THP1 this appears to be 
mediated through induction of host cell apoptosis-inhibiting products, including 
members of the Bcl-2-family. These anti-apoptotic proteins may promote host cell 
survival despite the infection, therefore, preserving the integrity of the intracellular 
replication niche and allowing bacteria to proliferate and spread to neighbouring 
cells. Due to this mechanism L. monocytogenes would remain inaccessible to 
effector cells such as neutrophils, which eliminate infected and apoptotic cells in vivo 





































 Pathogenic microorganisms are becoming increasingly resistant to current 
antimicrobial agents, posing a serious risk to public health that is continually 
increasing. In the last decade, multiresistant clones have emerged and are spreading, 
particularly in hospital wards, and people are already dying from non-tractable 
infections. New infectious diseases and pathogenic variants are also continually 
emerging, and old pathogens, such as M. tuberculosis are re-emerging, significantly 
contributing to the infectious morbidity and mortality worldwide. The development 
of new antibiotics, antimicrobial drugs and vaccines has become, therefore, a 
priority. The pharmaceutical industry has traditionally relied on empirical drug 
discovery and vaccine development, but the new threats require innovative 
approaches. Knowing in its intimate details the biology of pathogens and the 
mechanism of host-pathogen interactions, as well as an advanced understanding of 
molecular and cellular immunology, provides a rational framework to guide 
translational research for novel, better tools to combat infection. A paradigmatic 
example is provided by recent advances in vaccine and biological drug delivery 
vector development based on the exploitation of fundamental knowledge in 
intracellular pathogen biology. 
 
 Perhaps one of the most investigated and best-understood intracellular 
pathogens is L. monocytogenes. Its unique intracellular infection cycle, the 
sophisticated strategies that it deploys to subvert host cellular functions and 
signalling pathways to survive and proliferate within host cells, and its 
immunobiological characteristics, have established this pathogen as a classical 
research model in microbial pathogenesis and cell biology.  
 
 Despite the very significant advances in our understanding of the infection 
mechanisms of pathogenic Listeria, many aspects still remain obscure. Clearly, the 
pathogen-host cell interface remains an unexplored field of active interest at the 
forefront of contemporary research in microbial pathogenesis. There are also areas in 
Listeria research that, although extensively investigated, require further and 
continued work in order to be fully understood. One of these is the regulation of 
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virulence and the major role played by the transcription factor PrfA in the control of 
key steps of listerial intracellular parasitism.  
 
 Although the importance of PrfA in L. monocytogenes virulence has been 
long established, the mechanisms governing its regulatory activity, in particular those 
leading to the activation of the virulence regulon within host cells, remain poorly 
characterized or unknown. This subject has been a main focus of attention for our 
group in the last years. The currently accepted model for PrfA regulation is based on 
key findings from our laboratory. Central to this model is the ability of PrfA to 
undergo allosteric activation, presumably produced by the binding of a hypothetical 
small molecule or cofactor.  
 
 Besides being intrinsically important from a fundamental point of view, the 
investigations on the regulatory mechanism of PrfA have a clear translational 
interest. Since PrfA function is essential for pathogenicity, gaining a detailed 
molecular and structural understanding of the mechanisms underlying PrfA allostery 
may lead to the development of specific inhibitors of potential therapeutic use.  
 
 This thesis is a continuation of the work on Listeria pathogenesis being 
carried out by our laboratory, with a particular focus on PrfA.  
 
 Our primary goal was to gain a better understanding of the allosteric nature of 
the listerial regulator. We undertook a detailed structure-function analysis by site-
directed mutagenesis of the N-terminal domain of the protein. Our aim was to test 
experimentally the prediction that this domain accommodates the signalling module 
where the hypothetical allosteric effector binds, triggering the critical conformational 
changes that lead to the intracellular activation of PrfA.  
 
 This work was complemented by structure-function studies on several 




 Another important aim was to optimize the techniques used in the laboratory 
for the precise quantification of PrfA-dependent gene expression. The availability of 
such methods was capital for our work on PrfA and Listeria virulence gene 
regulation.  
 
 As secondary aims within the general theme of virulence gene regulation, we 
developed experiments to address existing gaps in specific aspects under 
investigation in the laboratory. One is the "charcoal effect", i.e. the activation of 
PrfA-dependent genes observed when the growth medium is supplemented with the 
adsorbent, activated charcoal. This effect was hypothesized to be caused by the 
sequestration by charcoal of a soluble virulence gene autorepressor released during 
exponential growth by L. monocytogenes. In this thesis, we moved to a more 
reductionist, better-defined experimental setup that would facilitate the isolation and 
characterization of the repressor molecule(s). We replaced the complex medium in 
which the previous data were obtained (Brain Heart Infusion) by a chemically-
defined medium, and the natural compound, activated charcoal, by a synthetic resin 
with similar adsorptive characteristics, AmberliteTM XAD-4. We, then, developed 
experiments aimed at validating the previous findings and the hypothesis of the 
Listeria-derived diffusible autorepressor.  
 
 The other experiments described in this thesis pertaining to virulence gene 
regulation were aimed at further exploring the role of PrfA in host cell invasion and 
the possible involvement of and/or crosstalk with the stress-related alternative sigma 
factor σB. Whilst previous findings from our laboratory indicated that L. 
monocytogenes invasiveness is strictly dependent on PrfA, other groups consider that 
σB plays a key role, particularly during entry through the intestine. Therefore, it was 
important to precisely determine the relative contributions of these two transcription 
factors in host cell invasion, the first step of Listeria intracellular pathogenesis. 
 
 In a final chapter of the thesis, our focus shifts to the cellular responses 
triggered by Listeria during intracellular infection. Our interest is centred on the 
apoptotic response, about which there are conflicting data in the literature. Upon 
 52 
examination of the apoptosis bibliography we came to the conclusion that much of 
the discrepancies among studies may be due to technical issues, particularly related 
to the way the occurrence of apoptosis in infected cell monolayers is quantified.  
 
 As a first step in our investigations on apoptosis and Listeria infection, in this 
thesis we aimed at setting up all the assays for determining this response in Listeria-
infected cells, and to establish the optimal experimental conditions for these 
determinations. It was also important to ascertain the factors that may influence the 
occurrence of apoptosis in Listeria-infected cells, and establish a mathematical 
model with a simple equation to precisely quantify the apoptogenic capacity of 





































3.1 REGULATION OF VIRULENCE 
 
3.1.1 PRFA REGULATION 
 
3.1.1.1 Optimization of RT-QPCR analysis of PrfA-
dependent gene expression 
 
 Throughout this study, we used the RT-QPCR technique to quantify gene 
expression levels. Thanks to its exquisite sensitivity, accuracy and precision this 
technique has become the method of choice for the analysis of the regulation of the 
gene expression in both eukaryotic and prokaryotic systems (Bustin, 2000, Bustin & 
Nolan, 2004). In contrast to conventional PCR, RT-QPCR permits to exactly 
quantitate the number of copies of certain target DNA sequence in a sample (Gibson 
et al., 1996, Heid et al., 1996). The quantitative determination of transcriptional 
levels of specific genes is obtained by measuring the mRNA levels. Since RNA 
cannot serve as a template for PCR, in order to quantitatively determine the amount 
of specific mRNA, the initial step of RT-QPCR involves the reverse transcription of 
the RNA template into cDNA, which is, then, exponentially amplified in a PCR 
reaction. Quantitation is achieved through the detection of the fluorescence emitted 
by a reporter dye each time a new amplicon molecule is generated during PCR. In 
this way, the number of PCR cycles needed for a target amplicon to obtain a pre-
established threshold of fluorescence is determined. This is the so-called Ct value, 
i.e. the number of PCR cycles needed to obtain this threshold, which is inversely 
proportional to the initial copy number of the target DNA sequence. This parameter 
is calculated by plotting the experimental Ct on a standard curve of known DNA 
concentrations against corresponding reference Ct values (Bustin, 2000).  
 
 Housekeeping genes are generally used as internal standards in RT-QPCR for 
normalization of expression data across experiments. Suitable reference 
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housekeeping genes should be transcribed at relatively constant levels and their 
expression be stable under the experimental conditions. Constitutively expressed 
housekeeping genes are generally involved in basic functions needed for the 
maintenance of the cells and their viability. Reference genes are amplified from the 
same cDNA samples used for target gene determinations to permit  comparison 
between RT-QPCR results (Karge et al., 1998, Bustin, 2000, Bustin & Nolan, 2004, 
Radonic et al., 2004, Huggett et al., 2005). Normalization to a reference gene serves 
as an internal control for possible technical errors in the RT-QPCR. The application 
of this type of control allows knowing the bias introduced during the transcription 
analysis process by differences in the starting material, RNA preparation, RNA 
quality and cDNA synthesis (Bustin & Nolan, 2004, Huggett et al., 2005). 
 
 The suitability of several L. monocytogenes housekeeping genes for 
incorporation as normalization controls in RT-QPCR-based analyses of PrfA-
dependent regulation was previously investigated. Two genes in particular were 
selected, rpoB encoding the β subunit of RNA polymerase, and ldh encoding lactate 
dehydrogenase, an enzyme that mediates the anaerobic energetic metabolism of 
glucose (Ripio et al., 1997b). The former gene has been extensively used as a 
housekeeping reference in many gene expression studies (Milohanic et al., 2003, Sue 
et al., 2003, Kim et al., 2004, Sue et al., 2004, Kim et al., 2005, Roberts et al., 2005, 
Schwab et al., 2005, Stritzker et al., 2005, Chaturongakul & Boor, 2006, Joseph et 
al., 2006, Kazmierczak et al., 2006, Marr et al., 2006, Tasara & Stephan, 2007); ldh, 
however, was never employed before for gene expression analysis in L. 
monocytogenes. 
 
 The stability of rpoB and ldh expression was tested in experimental 
conditions relevant to PrfA-dependent gene expression analysis such as growth in 
vitro in extracellular conditions (Brain Heart Infusion broth, BHI) and during 
intracellular infection in HeLa cells (D. Rodriguez-Lazaro et al., unpublished data). 
As part of these experiments, three different isogenic prfA backgrounds were 
assessed: wild-type (prfAWT), prfA* (prfA mutant allele encoding a PrfA* protein 
with a G145S substitution that leads to the constitutive overexpression of PrfA-
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dependent genes), and ∆prfA (an in-frame deletion mutant of the prfA* strain). The 
expression stability of the two reference genes was determined by comparing the 
absolute number of transcripts for each of them with the number of bacterial CFU in 
the sample. When grown in BHI broth, the three listerial strains showed a constant 
number of rpoB and ldh transcripts at different OD600 measurements (0.4, 0.8, 1.2 
and 2.4) (figure 3.1.1, upper panel). When grown intracellularly, the wild-type and 
the prfA* bacteria produced very similar, constant levels of rpoB and ldh transcripts 
at different time points of infection (0, 3, 6 and 12 h) (figure 3.1.1, lower panel). 
Intriguingly, the ∆prfA strain had slightly higher levels of rpoB and ldh transcript 
production in comparison with the other two strains. This difference was not 
observed when calculating the number of genome equivalents by RT-QPCR, 
indicating that a fraction of the intracellular bacterial population of the ∆prfA strain 
had either died or was present in a non-culturable state (D. Rodriguez-Lazaro et al., 
unpublished data). This observation may be explained by the fact that L. 
monocytogenes bacteria lacking prfA do not express the PrfA-dependent genes 
required for intracellular survival (hly, plcA and plcB). These bacteria remain trapped 
within the harmful environment of the phagosome, and the stressed bacteria may be 
unable to resume growth on agar plates, or be simply dead.  
 
 Building on these data, in this study, the stability of the rpoB and ldh genes 
was tested to confirm their specific suitability for use with the bacteria constructed in 
section 3.1.1.3 for the structure-function analysis of PrfA (∆prfA complemented with 
prfAWT, prfA* and the empty vector alone) (figure 3.1.2); and in sections 3.1.1.2 and 
3.1.2.2 for investigating the role of the stress tolerance mediator σB involved in L. 
monocytogenes prfA regulation and invasiveness (∆sigB mutant background in 
serotypes 4b [strain P14 background] and 1/2a [EGDe background]) (figure 3.1.3). 
The same analyses were applied to ensure that the chemically defined medium used 
in this study (IMM with different treatment conditions with the adsorbent 











Figure 3.1.1: Comparison of the two housekeeping genes ldh and rpoB, and their assessment for 
normalization of virulence gene expression during extracellular growth of L. monocytogenes in 
BHI and intracellular infection of HeLa cell line using RT-QPCR.  
Top two graphs show the ratio between transcripts and number of bacteria (CFU), both expressed as 
natural logarithm, plotted against optical densities at 600 nm (OD600) of L. monocytogenes culture in 
BHI (indicating different stages of the bacterial growth: initial exponential phase -OD 0.4-, middle 
exponential phase -OD 0.8 and 1.2- and late exponential phase -OD 2.4-) for rpoB and ldh genes, 
respectively. Bottom two graphs represent the ratio between transcripts and number of bacteria 
(CFU), both expressed as natural logarithm, plotted against different time points of intracellular 
infection in human epithelial cells (HeLa) for rpoB and ldh genes, respectively. Mean of three 
independent experiments ± standard error (SE). Source: D. Rodriguez-Lazaro et al., unpublished data. 
 
 
 For the assays in extracelullar conditions, we chose a single optical density 
(OD600 = 0.3 or 1.0, depending on the study), at which the samples of broth-grown 
bacteria were taken for analysis. Similarly for the intracellular studies, we chose a 
single time point (6 h post-infection), at which the samples were collected for 
analysis. The absolute number of transcripts for each gene was compared with the 
CFU in these conditions, as described above. The results are summarized in figures 
3.1.2 and 3.1.3.  
 
 Our data demonstrate that the reference housekeeping genes are stably 
expressed in the relevant test conditions. Again, the data obtained in HeLa cells show 
the same behaviour for the strain lacking prfA (∆prfA complemented with empty 
vector), confirming that intracellular bacterial viability is compromised in the 











Figure 3.1.2: Stability assessment of the two housekeeping genes rpoB and ldh during extracellular 
and intracellular listerial growth using RT-QPCR.  
Graphs show the ratio between transcripts and number of bacteria (CFU), both expressed as natural 
logarithm, plotted against optical density (OD600) of a L. monocytogenes culture in BHI. See text for 
















Figure 3.1.3: Stability assessment of the housekeeping reference gene, ldh, in different experimental 
conditions.  
“XAD-4” is IMM supplemented with 1% AmberliteTM XAD-4; “XAD-4 Pre-treated, Filtered” is a 
medium treated with AmberliteTM XAD-4 for 24 h at 37°C and from which the resin was then 
removed by filtration prior to bacterial growth; “Filtered” is the medium that has been filtered prior to 
bacterial growth: A. ldh stability assessment of the wild-type L. monocytogenes (P14) and the prfA* 
mutant (P14A) in the IMM alone or supplemented with AmberliteTM XAD-4. Mean of at least three 
 60 
independent experiments ± SE; B. ldh stability assessment of the P14 and its isogenic mutant 
P14∆sigB in IMM alone or supplemented with AmberliteTM XAD-4. Mean of two independent 
experiments ± SE; C. ldh stability assessment of the wild-type L. monocytogenes EGDe and its 
isogenic mutant EGDe∆sigB in IMM alone or supplemented with AmberliteTM XAD-4. Mean of three 
independent experiments ± SE; D. ldh stability assessment of the P14 and P14A and their isogenic 
mutants P14∆sigB and P14A∆sigB, respectively, extracellularly (in BHI) and intracellularly (in HeLa 




 According to the data shown in figures 3.1.1, 3.1.2 and 3.1.3, it is obvious 
that both housekeeping genes are equally valid for use as a reference gene for L. 
monocytogenes transcription analysis. However, the use of geNorm software for 
selection of control genes (http://medgen.ugent.be/~jvdesomp/genorm/) showed that, 
in the tested conditions, ldh had marginally better overall stability (data not shown). 
Therefore, we used ldh as routine reference gene for our RT-QPCR transcritption 
analyses throughout the study.  
 
 




 L. monocytogenes is capable of modulating the expression of its virulence 
genes to adapt to the specific needs of its dual saprophytic and parasitic lifestyle. To 
achieve this, Listeria bacteria recognize physical signals from the medium, like 
temperature. This physical cue is transduced down to PrfA via a thermosensor 
mechanism in the prfA mRNA that regulates its translation regulation (Kreft & 
Vazquez-Boland, 2001). Thanks to this mechanism, L. monocytogenes bacteria 
activate PrfA-dependent expression on sensing an environmental temperature of 
37ºC, which signals the entry into a warm-blooded host. Temperature, however, is 
not sufficient for full PrfA regulon activation, as demonstrates the fact that virulence 
genes are only very weakly expressed at 37°C in standard culture medium. A strong 
activation is observed at 37ºC when the bacteria are within host cells, indicating that 
additional signals, probably chemical components from the intracelullar medium, are 
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sensed by L. monocytogenes. The most clear evidence for a role of chemical signals 
in the regulation of PrfA-expression comes from the so-called "charcoal effect" 
(Moors et al., 1999, Shetron-Rama et al., 2002, Ermolaeva et al., 2004).  
 
 The "charcoal effect" refers to the observation that listerial virulence gene 
expression is significantly induced when bacteria are cultured at 37°C in a medium 
supplemented with the adsorbent, activated charcoal (Ripio et al., 1996). These 
authors showed that the supplementation of BHI with 0.2% charcoal did not affect 
the bacterial growth or change the pH of the culture medium. This indicated that the 
underlying mechanism of PrfA activation in such conditions was probably not due to 
sequestration by charcoal of essential nutrients or to charcoal-mediated changes in 
pH of the medium. Experiments were carried out in which the medium (BHI) was 
pre-treated for 24 h with 0.2% charcoal, after which the adsorbent was completely 
removed by centrifugation and filtration prior to culturing the bacteria. No activation 
of PrfA-dependent genes was observed unless the charcoal-pre-treated medium was 
supplemented again with 0.2% charcoal. It was concluded that (i) the "charcoal 
effect" was not due to the sequestration of a component from the medium 
composition acting as a PrfA-repressing signal; and that (ii) activated charcoal needs 
to be present in the culture medium while bacteria are growing. Transwell 
experiments, in which L. monocytogenes was grown, separated from activated 
charcoal particles by a microporous membrane, suggested that the effect was 
mediated by a diffusible molecule. Experiments in BHI conditioned with spent media 
indicated that a charcoal-sequestrable repressor molecule accumulated in the growth 
medium. Using a L. monocytogenes strain in which prfA was expressed only in 
monocistronic transcript form (i.e. PrfA-independently, no autoregulatory loop) 
demonstrated that charcoal induced PrfA-dependent expression without concomitant 
changes in the amounts of PrfA protein. Collectively, these data were interpreted as 
that L. monocytogenes releases into the medium an "autorepressor" molecule that 
inhibits PrfA activity. The fact that prfA* mutant bacteria, in which PrfA is locked in 
active conformation, did not exhibit the charcoal effect, seemed to indicate that the 
autorepressor somehow interferes with the allosteric activation mechanism of PrfA 
(Ermolaeva et al., 2004). It was suggested that this "negative quorum sensing" 
 62 
mechanism could be important to prevent the expression of virulence genes in L. 
monocytogenes microcolonies in the environment at elevated ambient temperature, 
or as a way to dampen down PrfA-dependent gene activation when the intracellular 
bacterial population reaches a certain threshold, to avoid damaging the host cells 
(Ermolaeva et al., 2004).  
 
 The above conclusions were reached using BHI, a complex medium of 
undetermined chemical composition, and activated vegetable charcoal, a natural 
adsorbent substance. In this chapter we explored the "charcoal effect" and sought to 
obtain confirmatory evidence of the existence of the hypothetical Listeria-derived 
autorepressor molecule. We used a chemically defined medium, Improved Minimal 
Medium (IMM; Phan-Thanh and Gormon, 1997), and a synthetic resin, AmberliteTM 
XAD-4, of similar adsorptive profile to charcoal but with defined chemical 





 Preliminary experiments in BHI supplemented with 1% AmberliteTM XAD-4 
showed that this triggered an activation of the PrfA-dependent gene plcB similar to 
that observed with charcoal (Ermolaeva et al., 2004). In these experiments, gene 
activation was monitored by measuring the activity of the plcB gene product, the 
PlcB phospholipase, in the culture medium. This natural reporter system provides an 
estimation of PrfA-dependent gene expression but does not allow to accurately 
measure the levels of gene transcriptional activation. We repeated these experiments 
in IMM to move to a more reductionist and amenable experimental system for 
investigating the nature of the charcoal-sequestrable autorepressor. Gene expression 
was measured by quantification of the specific transcripts of the actA gene by RT-
QPCR using ldh as the normalizing reference gene. The actA gene is co-transcribed 
in the same operon with the previously used plcB gene reporter system and is 
expressed from the strictly PrfA-dependent promoter PactA (Vega et al., 2004).  
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 L. monocytogenes P14 (prfAWT genotype, i.e. charcoal-activable) and P14A 
(prfA* genotype, i.e. charcoal-insensitive since PrfA system already fully activated) 
were used to test the effect of the resin in IMM. Two types of conditions were used: 
(i) medium with and without AmberliteTM XAD-4 supplementation; and (ii) medium 
that was pre-treated with the same concentration of adsorbent for 24 h at 37ºC, then 
filtered to remove the resin particles, and used with and without 1% AmberliteTM 
XAD-4 supplementation. To ensure that the experimental parameters were as similar 
as possible in all conditions, the preparation of IMM for condition (i) included 
filtration through the same type of microporous membrane. After inoculation, the 
cultures were grown until an OD600 = 0.3 and RNA was extracted for RT-QPCR 
transcription analysis. This optical density was chosen because PrfA-dependent 
expression is highest in the early exponential phase (Mengaud et al., 1991 and our 
own unpublished observations). The IMM medium contained 10 mM glucose, i.e. 
excess carbon source conditions for exponentially growing L. monocytogenes.  
 
 The data confirmed that the presence of an adsorbent in the medium 
significantly activates (26.3 times) PrfA-dependent gene expression in wild-type L. 
monocytogenes, as determined by measuring transcription from the PactA promoter 
(figure 3.1.4). As previously observed with activated charcoal, supplementation with 
AmberliteTM XAD-4 did not alter significantly the already elevated levels of PactA-
driven expression in the constitutively activated prfA* mutant background.  
 
 Similar results were obtained with the AmberliteTM XAD-4-pre-treated IMM, 
with one interesting exception: in this case, a significant induction (23.3-fold, P = 
0.002) in the expression of the actA gene was observed for wild-type L. 
monocytogenes in comparison with normal filtered IMM medium. This induction is 
of the same magnitude as that observed when the bacteria are cultured with the 
adsorbent resin present in the medium (9.3 ±1.2 vs 10.5 ±3.0, P = 0.766) (figure 
3.1.4). The addition of fresh AmberliteTM XAD-4 to the pre-treated medium 
produced a further increase in the expression levels (14.2 ±4.2 vs 9.3 ±1.2), although 
the difference was not significant (P = 0.155). Again, there were no significant 


















Figure 3.1.4: actA gene expression of wild-type L. monocytogenes (P14) and the prfA*G145S isogenic 
mutant (P14A), grown extracellularly in differently treated IMM medium and intracellularly in 
HeLa cells. 
See text for details. “XAD-4” corresponds to IMM supplemented with 1% AmberliteTM XAD-4. 
Intracellular values for both bacteria were taken from experiments carried out in section 3.1.2.2.3. 
Mean of at least three independent experiments ± SE. 
 
 
 These data are different from those observed with charcoal and clearly 
suggest that there is a repressor signal in the (IMM) medium composition that is 
removed by the resin treatment, leading to significant activation of PrfA-dependent 
expression in wild-type L. monocytogenes. 
 
 It is known that stresses enhance PrfA-dependent expression (see section 
1.3.6). It has been shown, in particular, that transfer of logarithmically growing L. 
monocytogenes bacteria to a medium that does not support growth, like cell culture 
Minimal Essential Medium (MEM), possibly creating a nutritional stress, leads to 
substantial induction of PrfA-regulated genes (Bohne et al., 1996). In order to 
exclude that the effect of AmberliteTM XAD-4 is due to the removal of a critical 
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nutrient from the medium, we monitored the growth of L. monocytogenes in IMM 
and in resin-supplemented or -pre-treated IMM. As shown in figure 3.1.5, the growth 
kinetics was the same in the three test conditions. This excludes that PrfA activation 















Figure 3.1.5: Comparison of the growth of wild-type L. monocytogenes (P14) in IMM medium pre-
treated with AmberliteTM XAD-4 (T) (see text for details) and in IMM medium in the presence 
(XAD-4) or absence of the resin.  
Mean of two independent experiments ± SE.  
 
 In order to further exclude the involvement of a stress response in the 
observed effects, we repeated the experiments using a ∆sigB mutant. As previously 
explained in section 1.3.6.2, the alternative σB, a major stress response mediator in 
Listeria, regulates the expression of prfA via P2prfA (Kazmierczak et al., 2005). 
Even if there is no apparent growth defect associated with the use of AmberliteTM 
XAD-4, there might still be a low-level nutritional stress response that passes 
unnoticed because the loss of fitness is compensated for by σB. We, therefore, tested 
the effect of σB in the prfAWT regulation context using a ∆sigB mutant in two 
different L. monocytogenes genetic backgrounds, serotypes 4b (strain P14) and 1/2a 
(strain EGDe). A precise description of these two mutants and how they were 















Figure 3.1.6: actA gene expression of L. monocytogenes P14 (wild-type) and its isogenic mutant 
P14∆sigB, grown in differently treated IMM media until OD600 = 0.3. 
See text for details. “XAD-4” is IMM supplemented with 1% AmberliteTM XAD-4. Mean of two 














Figure 3.1.7: actA gene expression of L. monocytogenes EGDe (wild-type) and its isogenic mutant 
EGDe∆sigB, grown in differently treated IMM media until OD600 = 0.3. 
See text for details. “XAD-4” is IMM supplemented with 1% AmberliteTM XAD-4. Mean of three 




 Figure 3.1.6 shows that the removal of sigB does not have a significant effect 
on PrfA-dependent gene expression in L. monocytogenes P14 both in non-treated 
IMM and in response to the treatments with the adsorbent resin (P = 0.55 to 0.75). 
Similar results were observed in L. monocytogenes EGDe, except that in IMM 
supplemented with AmberliteTM XAD-4, the ∆sigB mutant showed a significantly 
enhanced actA expression (figure 3.1.7). These data indicate that σB has no role in 
the AmberliteTM XAD-4-mediated virulence gene activation (and even may have an 





 In this section of the thesis we revisited the "charcoal effect" and carried out 
experiments using both a culture medium and adsorbent resin with defined chemical 
composition. The aim was to set up an experimental system more suitable for the 
identification of the small molecule(s) involved.  
 
 In the AmberliteTM XAD-4 pre-treated medium, the gene expression levels 
were significantly induced in wild-type L. monocytogenes, even in the absence of the 
resin. This clearly shows that AmberliteTM XAD-4 does not need to be present in the 
culture medium while the bacteria are growing, in order to exert its effect. The resin 
seems, therefore, to mediate its effect by sequestering some component of the IMM 
medium that could act as a PrfA-repressing signal. These observations, however, are 
not in agreement with the hypothesis previously formulated for the "charcoal effect" 
according to which the autorepressor substance comes from the bacteria and not the 
medium (Ermolaeva et al., 2004). 
 
 The treatment with AmberliteTM XAD-4 did not affect the bacterial growth, 
and the σB stress response regulator was not involved in the effect. Therefore, the 
resin-mediated virulence gene activation most probably reflects an interference with 
a repressor chemical signalling mechanism, rather than the outcome of a general 
physiological response to stress, indirectly affecting PrfA.  
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 L. monocytogenes bacteria with a prfA*G145S allele, expressing high levels of 
PrfA-dependent virulence factors (Ripio et al., 1997a, Vega et al., 2004), remained 
unaffected by the AmberliteTM XAD-4 treatments i.e. the high levels of PrfA-
dependent expression were not further enhanced. This is similar to what was 
previously observed with activated charcoal (Ermolaeva et al., 2004). Thus, the 
prfA*G145S mutation over-rides the repression caused by the resin-adsorbed repressor 
signal(s) from the medium, consistent with the notion that the PrfA* mutant proteins 
are locked in a constitutively hyperactive conformation.  
 
 To date, the only other known situation in which PrfA-dependent genes are 
strongly activated at a given temperature (e.g. 37ºC) is when the bacteria are growing 
intracellularly. This is also likely to involve chemical signals from the surrounding 
medium (the cytosol in this case) and is probably effected through an allosteric shift 
of the PrfA protein (Vega et al., 1998, Vega et al., 2004, Scortti et al., 2007). If the 
levels of activation achieved by wild-type L. monocytogenes in IMM with 
AmberliteTM XAD-4 and intracellularly are compared, the former remain clearly 
below (26.3-fold vs 90.5 in HeLa cells, i.e. a difference of 3.5 times). This indicates 
that the intracellular activation pathway does not only involve the removal of a 
repression on PrfA, as observed when an adsorbent is added to the culture medium, 
but some other activation pathway, most likely the allosteric activation mechanism 
suggested for PrfA, presumably mediated by the binding of a small ligand or cofactor 
(Scortti et al., 2007, Vega et al., 1998, Vega et al., 2004; see below section 3.1.1.3 
for more details).  
 
 The constitutively active PrfA* mutant protein is thought to mimic the 
conformation adopted by PrfA intracellularly (Vega et al., 1998, Vega et al., 2004, 
Scortti et al., 2007). Concordant to this, the values obtained with the prfA* bacteria 
in IMM were also significantly higher than those of wild-type L. monocytogenes 




 While our new findings indicate that the treatment with the resin removes a 
repressor component from the medium that is not bacteria-derived, they do not 
formally exclude the existence of an autorepressor molecule released by Listeria. 
Indeed, the addition of AmberliteTM XAD-4 to the resin-pretreated medium tended to 
further enhance the activation of PrfA-dependent gene expression. This was very 
evident, for example, with the EGDe∆sigB strain (figure 3.1.7). Although despite the 
extensive pre-treatment some amount of a repressor component may have remained 
in the medium, requiring the addition of more adsorbent during bacterial growth for 
complete removal, these data also support the notion that Listeria release an 
autorepressor molecule during growth.  
 
 AmberliteTM XAD-4 is a polymeric non-polar adsorbent, which has been 
used instead of activated charcoal in order to remove small organic substances from 
aqueous solutions. This synthetic resin has a small pore size, high exchange area and 
an aromatic surface. AmberliteTM XAD-4, therefore, is especially effective for the 
adsorption of low-molecular-weight hydrophobic, aromatic substances (Held et al., 
1999, Ermolaeva et al., 2004). Our future experimental work will focus on eluting 
and fractionating the adsorbed material from the resin to isolate and identify the 
PrfA-repressor molecule(s) and characterize their chemical nature. 
 
 





 PrfA is critical in Listeria pathogenesis through its role as central regulator of 
virulence. While a number of significant details concerning its general mode of 
regulation and target promoter activation have been elucidated in recent years, the 
intimate mechanism underlying PrfA activation, particularly in response to the 
cytosolic environment, remains unknown. PrfA– mutants are totally avirulent despite 
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all other listerial virulence genes being present (Vega et al., 2004), highlighting the 
key importance of this regulator in Listeria infection. Understanding in structural 
detail the mechanism of PrfA activation and the interactions with the effector 
molecules involved will be an important achievement in terms of our fundamental 
knowledge on Listeria pathogenesis, and for the development of specific inhibitory 
drugs to treat listeriosis.  
 
 As mentioned in section 1.3.4, the structure-function similarities between 
PrfA and the enterobacterial regulator Crp (Cap), a paradigm in small molecule-
mediated allostery (Popovych et al., 2009), have led to the assumption that the 
listerial regulator is allosterically activated (Ripio et al., 1997a, Vega et al., 1998, 
Vega et al., 2004, Eiting et al., 2005, Scortti et al., 2007). Besides the overall 
similarities in structural arrangement between the two proteins (Eiting et al., 2005), 
the characterization of prfA* mutants, targeting the same protein regions and even 
residues to those affected by crp* mutations, with identical functional consequences, 
is the most clear evidence that the two proteins share a similar type of mechanism for 
regulating their activity (Vega et al., 2004).  
 
 The recent crystallization and structural comparison of PrfAWT and the 
constitutively hyperactive PrfA* (G145S) mutant protein, likely mimicking the in 
vivo (activated) PrfA state, has provided some insight into the kind of structural 
rearrangements associated with the PrfA allosteric shift. The PrfA*G145S mutation 
was first described by Ripio et al. (1996) in our group. It was found in a 
hyperhaemolytic derivative of strain P14 that overexpressed all PrfA-dependent 
factors. The G145S substitution is the most commonly found among spontaneous 
prfA* mutants (Ripio et al., 1997a, Vega et al., 2004). The constitutively active 
mutant prfA*G145S is functionally analogous to crp*A144T, encoding a mutant form of 
Crp with a substitution, A144T, targeting the very same position on αD helix in the 
aligned proteins (figure 1.4). Both mutations result in a very significantly increased 
DNA-binding activity, in the case of (apo) Crp* to levels equivalent to those 
observed in the cAMP-complexed (activated) wild-type protein (Weber et al., 1987a, 
Vega et al., 2004). The crystal structure of PrfA revealed that the G145 position in 
 71 
αD establishes multiple contacts with residues from αG (A218) and αH (L221) that 
are part of the C-terminal extension of PrfA. The PrfA*G145S mutation was predicted 
to introduce steric clashes, placing a larger residue into a compact hydrophobic 
pocket, repulsing αD away from αGH, indirectly repositioning the neighbouring 
HTH motif for optimal interaction with the target DNA (Vega et al., 2004). This was 
essentially confirmed by Eiting et al. (2005), who also showed that the αE-αF loop 
was disordered in both monomers of PrfAWT in contrast to PrfA*G145S. The detailed 
structural studies by these authors revealed that while the general conformation of 
both PrfAWT and PrfA*G145S is similar, significant differences exist in the C-terminal 
(DNA-binding) domain. However, the structural differences were not only confined 
to the C-terminal domain. A lateral movement of β4-β5 from the β-barrel of the N-
terminal domain towards αE was observed, resulting in altered interactions with the 














Figure 3.1.8: Superposition of PrfAWT and PrfA*G145S. 
Taken from Eiting et al. (2005). Light grey represents PrfAWT. For clarity, structurally conserved 
regions (N-terminal domain, α-helices αG, αH, αI of the C-terminal domain) are omitted for PrfAWT. 
PrfA*G145S is shown in the following domain colours: N-terminal domain is blue, dimerization-helix 
(αC) in green and C-terminal domain in pink. Yellow asterisk indicates the position of the mutation 
G145S. Magenta colour shows the helix-turn-helix (HTH) motif in PrfA*G145S and dark grey in 
PrfAWT. The disordered loop αE-αF is indicated by a dotted magenta line. The α-helices are 
sequentially marked by letters (left-hand monomer), β-strands by numbers (right-hand monomer).  
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 These structural effects were the consequence of critical rearrangements 
between helices αD and αC, which also resulted in the straightening of the latter 
helix (that provides most of the monomer-monomer interface) by ∼11° in PrfA*G145S 
in comparison to PrfAWT (figure 3.1.9). These structural studies concluded that, 
whereas PrfAWT structurally resembles Crp in the absence of cAMP, PrfA*G145S 
adopts a conformation in which the C-terminal domains, and especially the HTH 
motif, are very similarly arranged to cAMP-Crp, further supporting the hypothesis 
that PrfA*G145S mimics the activated state of a liganded PrfA (Eiting et al., 2005).  
 
 In this section of the thesis we explored the hypothetical allosteric nature of 
PrfA by focussing on the N-terminal domain of the protein, a jelly-roll β-barrel, 
which in Crp forms the cAMP-binding site. The PrfA β-barrel is homologous to the 
cyclic nucleotide-binding (CNB) domain generally present in cAMP-regulated 
proteins. We tested the hypothesis that this structure could serve as binding site for a 
















Figure 3.1.9: Conformational changes induced by the mutation G145S. 
Taken from Eiting et al. (2005). Light grey colour represents PrfAWT and green indicates PrfA*G145S. 





 A major structural component of the CNB domain is the jelly-roll β-barrel. 
This ∼120-residue signalling module is conserved across biology in functionally 
diverse cAMP/cGMP-regulated proteins including eukaryotic regulators such as 
protein kinases A and G or guanine nucleotide exchange factor Epac, eukaryotic and 
prokaryotic ion channels, and a variety of bacterial transcription factors (Berman et 
al., 2005, Kannan et al., 2007, Rehmann et al., 2007, Kornev et al., 2008). The CNB 
domain is conserved in PrfA except for the phosphate binding cassette (PBC), a 
signature sequence located between β-sheets 6 and 7 of the β-barrel that includes key 
residues involved in the docking of the cyclic nucleotide (cNMP) via its 
phosphoribose moiety (Diller et al., 2001, Berman et al., 2005, Kannan et al., 2007, 
Rehmann et al., 2007) (figure 3.1.10A). A phylogenetic analysis of the region 
flanked by β-sheets 6 and 7 in CNB domains from proteins known to be regulated by 
cNMPs or by various unrelated effector molecules showed that the PrfA sequence 
clusters with the latter in a distinct clade characterized by the absence of conserved 
PBC features (figure 3.1.10B). These data exclude cNMPs as PrfA-activating 
ligands, consistent with the reported lack of effect of cAMP and cGMP on PrfA 
activity (Vega et al., 1998). However, they also suggest that the N-terminal domain 
of the listerial virulence regulator may contain a binding site for an unknown 
signalling molecule.  
 
3.1.1.3.2.1 Structural analysis of the N-terminal solvent-exposed pocket of PrfA  
 
 In order to determine whether an allosteric effector could be accommodated 
in the CNB domain identified in PrfA, the cAMP molecule from the cAMP-Crp 
complex (Protein Data Bank [PDB] accession no. 1G6N) (Passner et al., 2000) was 
fitted into the three-dimensional (3D) structure of the wild-type PrfA (PrfAWT) (PDB 
2BEO) (Eiting et al., 2005) through coordinate superposition. This in silico work 
was carried out in collaboration with Prof. Ben Luisi and Dr. Ricardo Núñez Miguel, 
Biochemistry Department, University of Cambridge. A fairly large void space within 
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the PrfA β-barrel at about the same position as the Crp cAMP-binding pocket was 
observed. Residues lining this internal cavity that could interact with a ligand were 
also identified (figure 3.1.10C). The same putative functional sites were 
independently recognized using the Functional Protein Sequence Pattern (FPSP) 
programme (Miguel, 2004), designed to predict solvent-accessible regions in 
proteins with a high probability of establishing functional interactions (patterns 62-
YYKGAFVI-69 and 69-IMSGFIDTETSVGYY-83, from a total of nine FPSP 
patterns).  
 
 Further in silico work, carried out in our laboratory by Dr. Caroline 
Deshayes, was aimed at mapping the β-roll pocket of PrfAWT using residues from the 
internal part of the cavity with CAVER (Petrek et al., 2006). This programme 
calculates pathways leading from buried pockets to outside solvent in protein 
structures. The Caver output of the putative cofactor-binding site of PrfAWT was 
visualized using MacPyMOL programme (figure 3.1.11). 
 
 The PrfA pocket forms an elongated, irregular channel that varies in width. It 
extends from the protein surface deep into the β-barrel. The average inner width of 
the channel is approximately 4.5Å (figures 3.1.11, 3.1.12 and 3.1.13). However, the 
pocket becomes wider in its distal part (approximately 4.5Å × 7Å × 10Å). It ends 
between the two αC helices of the PrfA dimer (αC and αC' from the opposite 
monomer), halfway their length where the αC/αC' axes cross each other (figures 
3.1.11 and 3.1.13). Both αC and αC' contribute residues to form the walls of a 
monomer's distal chamber (figure 3.1.13). These αC helices form most of the 
monomer-monomer interface and are possibly critical for dimerization. They are 
known to rotate about this point by roughly 11º in the PrfAG145S mutant (Eiting et al., 
2005). Their realignment upon cofactor binding is thought to play a key role in the 
allosteric transition (activation) of PrfA (Eiting et al., 2005). The pocket was formed 
from residues of both protomers of the dimeric PrfA. Therefore, we believe that the 
filling of the cavity with the putative ligand may directly alter the relative orientation 






Figure 3.1.10: CNB domains in cyclic nucleotide (cNMP)-regulated and non-regulated proteins and 
identification of the putative ligand-binding site in the PrfA β-barrel. 
(A) Amino-acid sequence alignment of the β6-β7 region encompassing the PBC motif in a selection 
of bacterial and eukaryotic CNB domain-containing proteins (cNMP = cNMP-regulated; No-cNMP = 
cNMP-non-regulated). Conserved blocks of sequence in red case, residues known to interact with the 
cNMP molecule in cNMP-regulated proteins are shaded green. Numbering above the sequences 
corresponds to Crp coordinates and the position of β-sheets 6 and 7 of the β-barrel is indicated by 
arrows. Alignment constructed with ClustalW2 (EMBL, http://www.ebi.ac.uk/Tools/clustalw2/) and 
visualized with ESPript (Gouet et al., 1999), (http://espript.ibcp.fr/). Protein sequences used (EMBL 
accession nos.): Crp/Cap (P0ACK0), PrkG1 (Q13976), Prkar2A (P13861), Pka (P00514), KCNH2 
(Q12809), HCN1 (Q9MZS1), CNG1 (P29973), Epac1 (O95398), Epac2 (Q9EQZ6), RpalK1 
(Q02006), MlotiK1 (Q98GN8), Vfr (P55222), MT3777 (O69644), Fnr (P0A9E5), CooA (P72322), 
Dnr (Q51441), CprK (B8FW11), NtcA (P0A4U7), PrfA (P22262). Source species: Eco, Escherichia 
coli; Hs, Homo sapiens; Bt, Bos taurus; Oc, Oryctolagus cuniculus; Mm, Mus musculus; Rpa, 
Rhodopseudomonas palustris; Rlo, Rhizobium loti; Pae, Pseudomonas aeruginosa; Mtb, 
Mycobacterium tuberculosis; Bsu, Bacillus subtilis; Rru, Rhodospirillum rubrum; Dha, 
Desulfitobacterium hafniense; Ava, Anabaena variabilis; Lmo, Listeria monocytogenes. See Figure 
1.4 for reference. 
(B) Unrooted phylogenetic tree of PBC sequences used for the alignment shown in (A). Constructed 
with Phylip 3.69 (http://evolution.genetics.washington.edu/phylip.html) and visualized using FigTree 
(http://tree.bio.ed.ac.uk/software/figtree/). Distinct evolutionary branch with cNMP-non-regulated 
CNB-containing proteins is represented in red. 
(C) Upper panel, crystal structure of holo-Crp (1G6N) showing polar contacts (black dashed line) 
between the cAMP molecule and residues in its binding pocket; lower panel, equivalent image of 
PrfAWT (2BEO) with cAMP positioned in the β-barrel according to a structural alignment with the 
Crp-cAMP complex. The superimposed cAMP molecule lodges in a cavity in PrfA's CNB domain at a 
similar position that in Crp. In the two panels, a monomer is coloured light grey and the other dark 
grey and the PBC loop (or corresponding region in PrfA) is represented in red. Residues that interact 
(Crp) or clash (PrfA) with cAMP are represented in sticks (modified from an analysis carried out by 



























Figure 3.1.11: Structure of PrfA and the cAMP-Crp complex showing the position of their surface-
exposed pockets and corresponding entrances with surface and ribbon representation. 
("side" and "top" views; top view is 90º x-axial rotation of side view with arrowhead area towards the 
foreground). In both structures, one monomer is coloured light blue with N-terminal domain in pink 
and the other monomer is in grey. The PBC loop (or corresponding region in PrfA) is represented in 
red. The additional C-terminal GHI helical bundles of PrfA are in yellow. In Crp, the cAMP molecule 
is in sphere representation with atoms coloured by element (C, yellow; O, red; N, blue). Trajectories 
of the N-terminal pocket of PrfA and the cAMP-binding pocket as determined by CAVER are shown 
in green (see also figure 3.1.15B). Figure constructed with MacPyMOL. See figure 1.4 for secondary 
structure features; the N-terminal domain, αC and the "G wedge" domain (C-terminal αGHI bundle) 























Figure 3.1.12: PrfA pocket topology and surface properties. 
(A) Stereo cutaway surface representation of the PrfA dimer (top view, see figure 3.1.11). PrfA 
pocket is framed in black. Arrows indicate the inter-domain tunnel (see figure 3.1.14). Surfaces of one 
monomer are light grey, those of the other monomer in dark grey. Cutaway plane in flat grey.  
(B) Enlargement of framed areas in (A) showing qualitative surface electrostatics of the PrfA pocket, 
as determined with the built-in vacuum electrostatics MacPyMOL function. Electronegative charge 
surfaces in red, electropositive ones in blue.  
(C) Enlargement of framed areas in (A) showing the solvent-exposed hydrophobic surface area of the 
PrfA pocket. Hydrophobic residues (Val, Ile, Leu, Met, Phe, Tyr and Trp) are shown in green.  
The three panels have been constructed with MacPyMOL. 
 
 
 The walls of the pocket have been found to be mostly non-polar except at the 
mouth and proximal section of the channel tract, where there is an electronegative 
patch, and in portions of the distal chamber where the polar constituents of the side 
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chains of Q121, Q123 and Y63 line the surface of the cavity (figures 3.1.12 and 
3.1.13). 
 
 Similar analyses of the cAMP-Crp complex using CAVER revealed 
interesting differences in topology and trajectory between the PrfA pocket and the 
Crp cAMP-binding site. While the latter traverses the β-barrel side to side, with a 
small second opening at the bottom end close to the PBC where the cAMP polar 
head lodges, that from PrfA is shorter and ends at the monomer-monomer interface. 
Moreover, the mouth of the PrfA pocket opens at the opposite side of the β-barrel, 
between the loop that forms the PBC in Crp and an adjacent loop between β-sheets 2 
and 3 (see figure 1.4 for secondary structure features of PrfA). The region that 
corresponds to the entrance of the pocket in Crp is blocked up in PrfA by the 

















Figure 3.1.13: Surface representation of the PrfA dimer (top view) with front and back planes clipped 
off to allow visualization of the internal contour of the PrfA pocket (encircled in green).  
One monomer is coloured light blue and the other in dark grey. The two αC-helices are shown in 
cartoon representation. The entrance of the pocket from each monomer is indicated by an arrow. 
Figure constructed with MacPyMOL. 
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 Interestingly, the pocket identified in the N-terminal domain using CAVER is 
different from the cavity described previously by Eiting et al. (2005) as possible 
cofactor binding site. According to our analysis, the cavity identified by Eiting et al. 
corresponds to the large inter-domain cleft, a hollow space left between the N- and 
C-terminal domains of PrfA and which in surface representation appears as a large 
tunnel or channel. The “inter-domain tunnel” has two entries and traverses the 
molecule from side to side. In contrast to the inter-domain tunnel, the putative 
binding site cavity has only one external entrance and ends deep into the PrfA 
molecule at the interface of the two monomers, between the two αC helices. The 
inter-domain tunnel and the N-terminal pocket within the β-barrel are two 
















Figure 3.1.14: PrfA (upper panels) and cAMP-Crp complex (lower panels) dimer structures from 
figure 3.1.11 appropriately rotated to expose the inter-domain tunnel.  
The N-terminal β-barrel pocket trajectories (CAVER output) are represented in green. Note that, 
whereas in Crp the entrance of the cAMP-binding pocket is through the inter-domain tunnel, in PrfA 
the pocket mouth opens at the opposite side of the β-barrel and does not coincide with the inter-
domain tunnel. See text for details. 
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3.1.1.3.2.2 Mutant design and construction 
 
 In order to explore the function of the PrfA pocket, we chose in collaboration 
with our Cambridge colleagues a number of residues lining the cavity, with solvent-
exposed side chains, for site-directed mutagenesis (figure 3.1.15). The mutations 
were selected, so that the newly introduced side chain altered internal surface 
properties with minimal secondary structure consequences. In some cases, the 
substitution was predicted to accommodate an infrequently observed rotameric state 
that would protrude into the pocket to avoid steric clashes with neighbouring 
residues.  
 
 If the function of the pocket is to accommodate an activating ligand, a 
mutation specifically interfering with this interaction is expected to confer a 
phenotype characterized by wild-type levels of basal, "intrinsic" PrfA activity but 
severely impaired intracellular activation of PrfA-dependent genes. The effect on 
phenotype was evaluated with a model infection system. To ensure that the 
mutations had little secondary effects, we explored the impact on protein stability, 
DNA binding capacity and dimerization.  
 
 Five mutations were designed to introduce changes in the topology of the 
pocket without altering the local hydrophobicity. These included substitutions 
affecting hydrophobic residues at the mouth (F29M) and the distal portion (I69W, 
V80L, and L48F) of the channel, in which the new side chains were likely to 
protrude into the cavity, and at the end of the pocket (L120V), with the mutation 
predicted to displace further inwards the wall of the cul-de-sac against αC. Two 
mutations targeted residues in the middle (S71L) and distal (Y63W) sections of the 
channel, which, in addition to altering the structure of the pocket, removed hydroxyl 
groups that could potentially be involved in the docking of a ligand via hydrogen 
bonding. Finally, two other substitutions targeted the negatively charged patch at the 






























Figure 3.1.15: Site-directed mutagenesis of the N-terminal PrfA pocket. 
(A) Close-up view of the PrfA β-barrel cavity with the CAVER-determined solvent-exposed 
trajectory in green mesh representation. In the cartoon structure, the eight residues lining the internal 
cavity that were mutated in this study are shown in orange stick representation (see also figure 
3.1.16). A monomer is coloured light grey and the other dark grey. The loop between β-sheets 6 and 
7, that corresponds to the PBC in Crp and which forms the mouth of the pocket in PrfA, is shown in 
red (see figure 3.1.11). (B) Modelling of the pocket mutations in a surface representation of PrfA. To 
illustrate the predicted local structural alterations introduced by the mutant residue, a cutaway section 
of an appropriately positioned PrfA structure exposes the relevant portion of the internal cavity when 
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necessary; the clipping plane is in flat dark grey. See figure 3.1.16 for additional spatial reference. In 
each panel, the atoms of the mutant residue/side chain are shown in space-fill representation as red 
spheres (except for Q36, shown as blue spheres, and V120 represented as red sticks with 
corresponding surface also in red); all other visible residues targeted in this study are shown as orange 
sticks. The wild-type surface of the original residue is shown in orange. The centerline of the access 
route of the pocket as determined by CAVER is represented in green. In the Y63W panel, the arrow 
indicates the position of the hydroxyl group of the Y63 side chain, which is directly exposed to the 
pocket surface (semitransparent red patch) and may establish polar interactions with a putative ligand 
(see text). The double arrow in the L120V panel illustrates the predicted inward displacement of the 















Figure 3.1.16: Same stereo cutaway surface view of the N-terminal PrfA pocket as in figure 3.1.12 
showing the mutagenized residues represented as orange sticks.  
The green volume in mesh representation is the pocket contour determined by CAVER. Note that the 
CAVER graphical output represents the solvent access path and does not fill the entire volume of the 
distal chamber cavity.  
 
 
 All nine site-directed mutations were constructed by overlap extension using 
the wild-type prfA gene as a template. The mutant alleles (with indigenous wild-type 
promoters P1prfA and P2prfA; see section 1.3.5) were inserted in monocopy into the 
chromosome of Listeria prfA deletion mutant (∆prfA*) using the integrative plasmid 
pPL2 (see Materials and Methods for details). 
 
 For each experiment performed throughout the study included in this section 
of the thesis, PrfAWT, PrfA* (G145S), vector and ∆prfA bacteria complemented with 
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a totally inactive prfA*supE173G allele (Vega et al., 2004) (designated in this section as 
E173G* for simplicity), which carries a mutation in the HTH motif that prevents 
binding to the target DNA, were used as controls.  
 
 We confirmed by western immunoblotting of bacterial whole cell extracts 
that all prfA-complemented ΔprfA bacteria produced equivalent amounts of PrfA 
protein (data not shown).  
 
3.1.1.3.2.3 Functional analysis of the PrfA pocket mutants 
 
 The behaviour of the mutant PrfA proteins was tested in the complemented 
ΔprfA bacteria grown extracellularly at 37°C in BHI, in which PrfA-dependent 
expression is weak (basal levels) (Ripio et al., 1997a, Vega et al., 2004), and 
intracellularly in infected HeLa cells, where PrfA is believed to shift to its "on" 
conformation. Samples were taken for the analysis either after reaching an OD600 = 
0.3 (early exponential phase) or after 6 h post-infection, respectively.  
 
 PrfA activity was analyzed by determining the transcription of the strictly 
PrfA-dependent genes plcA and actA (Lalic-Multhaler et al., 2001, Vega et al., 2004)  
using RT-QPCR. The plcA promoter (PplcA) has a “perfect” PrfA box and is, thus, 
very sensitive, and responds linearly, to PrfA. By contrast, the actA promoter (PactA) 
has a mismatch in the symmetrical palindrome and, therefore, it requires larger 
amounts of PrfA input for full activation, resulting in “all or nothing” response 
pattern (Sheehan et al., 1995, Williams et al., 2000, Vega et al., 2004), which has 
been described in sections 3.1.1.2.2 and 1.3.5. The number of transcripts determined 
was normalized with the number of transcripts of the constitutive housekeeping 
reference gene ldh (see section 3.1.1.1). 
 
 The mutants fell in three categories according to their intracellular 
activability (figure 3.1.17). F29M and V80L showed no significant differences with 
respect to prfAWT for the two promoters. A second group of mutants showed 
significantly reduced activability, particularly with the stringent PactA promoter. In 
 84 
three of these, E36Q, E36R and I69W, the reduction was modest to intermediate 
(PplcA 7.3 - 40.6%, mean: 23.1%; PactA: 36.2% - 51.0%, mean 43.2%); in the other 
two, S71L and L120V, intracellular gene activation was substantially impaired 
(mean reduction: PplcA 69.9%, PactA 83.7%). Finally, in mutants L48F and Y63W 
the intracellular activation of PrfA-dependent expression was virtually abolished 















Figure 3.1.17: Transcriptional analysis of the PrfA pocket mutants.  
The transcription of plcA (upper panel) and actA (bottom panel) genes has been checked by RT-
QPCR in extracellular (OD600 = 0.3 in BHI broth) and intracellular (infection of human HeLa 
epithelial cells for 6 h post-infection) conditions. The percentages of the intracellular activation 
compared to the wild-type are indicated by numbers. Error bars indicate SE of at least three 
independent experiments. Statistical analyses were performed with Student's t test. *, P ≤ 0.01. See 
text for details. 
 
 
 The negative controls behaved as expected, i.e. no detectable PrfA-dependent 
gene expression both extra- and intracellularly. The prfA*G145S-complemented 
bacteria showed in the two conditions the same high expression levels as intracellular 
prfAWT-complemented bacteria, indicating that the PrfA*G145S mutant possibly 
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mimics the hyperactive state adopted by the listerial virulence regulator within host 
cells (Ripio et al., 1996, Ripio et al., 1997a, Vega et al., 2004, Scortti et al., 2007).  
 
 Mutants F29M and I69W showed increased levels of basal (BHI) PrfA-
dependent expression (mean increment relative to prfAWT, respectively: PplcA, 
270.9% and 140.0%; PactA, 312.5% and 145.1%).  
 
 In order to characterize the phenotype of the pocket mutants, a 
semiquantitative assessment of the intrinsic activity (i.e. extracellular growth in BHI 
medium) of the mutant PrfAs was carried out. The assay tests PrfA-dependent actA 
promoter expression using the plcB gene as a reporter; plcB is expressed from the 
strictly PrfA-dependent actA promoter and encodes a phospholipase whose activity 
can be revealed very easily via an opacity reaction on egg yolk BHI agar (EYA) 
(Vazquez-Boland et al., 1992). Simultaneously, we performed another 
semiquantitative assessment of the intrinsic activity of the mutant PrfAs involving 
hly promoter expression using the hly gene as a reporter. The hly promoter, similarly 
to the plcA promoter, has a symmetrical PrfA box and is, therefore, very sensitive 
and responds linearly to PrfA (which has been also explained in sections 1.3.5). hly 
gene encodes the haemolysin LLO the activity of which can be revealed very easily 
via lysis of erythrocytes on sheep blood agar (SBA). The mutant bacteria were, 
therefore, streaked on both types of plates. After 3-day incubation at 37°C, the plates 
were examined for dark halo or lysis of erythrocytes around the streaked bacteria, 
respectively.  
 
 Consistent with RT-QPCR data, F29M and I69W displayed a PrfA* 
phenotype on EYA and SBA plates, indicating an increased intrinsic activity in the 
corresponding mutant PrfA proteins. This increase is only moderate compared to 
PrfA*G145S, as judged from the noticeably less intense precipitation halos in EYA and 
less lysis of erythrocytes around streaked bacteria in SBA, respectively, in F29M and 
I69W. Although S71L did not show detectable differences in basal PrfA-dependent 
expression compared to the wild-type as determined by RT-QPCR, it also displayed 
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a partial PrfA* phenotype on EYA and SBA plates, respectively, suggesting a more 













Figure 3.1.18: Phenotype characterization of the pocket mutants. 
Pictures taken from representative agar plates incubated at 37°C for 72 h. (A) PlcB phenotype of the 
PrfA pocket mutants grown on BHI EYA plates; note that the I69W, S71L and F29M strains show a 
partial PrfA* phenotype; (B) Hly phenotype of the PrfA pocket mutants grown on SBA plates; note 
that the I69W, S71L and F29M strains show a slight PrfA* phenotype; (see text for details).  
 
 
3.1.1.3.2.4 Virulence  
 
 We decided to investigate the effect of the mutations in virulence as PrfA is 
vital for L. monocytogenes pathogenesis. Some intracellular infection-related 
phenotypes only require some amount of PrfA activity (e.g. phagosomal 
escape/intracellular growth, which depend on “sensitive” promoters as found in front 
of the plcA and hly genes). Others, in contrast, require a high input of PrfA as 
provided by a fully activated regulator. This is the case of cell-to-cell spread, which 
primarily depends on the activity of the actin polymerizing protein ActA and the 
PlcB phospholipase, the synthesis of which is driven by the stringent PrfA-dependent 
PactA promoter (Freitag & Portnoy, 1994). Cell-to-cell spread was determined 
through the ability of the bacteria to form plaques in monolayers of L929 fibroblasts. 
L929 cells have been previously used for L. monocytogenes plaque assays and 
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reported to give better results than other cells, with more neat and wider plaques 
(Sun et al. [1990], Chatterjee et al. [2006] and our unpublished observations). The 
size of the plaques is an output variable of a complex phenotype to which several 
input variables contribute, including the efficiency of phagosome escape and 
cytosolic multiplication in addition to cell-to-cell spread and invasion of 
neighbouring cells. An isogenic deletion mutant in the actA gene, encoding the actin-
polymerizing protein essential for cell-to-cell spread (Kocks et al., 1992), was 
included as a negative control (see table 5.1 in Materials and Methods). In order to 
obtain a good distribution of individual plaques for counting purposes, the 
multiplicity of infection (MOI) was carefully adjusted (ranging from 0.005:1 to 2:1) 
according to the invasiveness of the tested strain. 
 
 The plaque assay results were completely consistent with the expression data 
(figures 3.1.19 and 3.1.20). As expected, negative controls showed a total lack of 
cell-to-cell spread capacity.  
 
 Mutants F29M and V80L, with no defect in PrfA function, and E36Q, which 
only showed a very minor intracellular activation defect (figure 3.1.17), were 
indistinguishable from the wild type (P = 0.61, 0.66 and 0.93, respectively).  
 
 Moreover, the activation-deficient E36R, I69W, S71L and L120V mutants 
showed cell-to-cell spread defects that were generally concordant to the observed 
reduction in intracellular activability.  
 
 The activation-null mutants L48F and Y63W did not form plaques, similarly 
to the spread-negative control ΔactA bacteria. Thus, the intracellular activation 
defects of the PrfA mutant proteins translated directly into commensurate 
deficiencies in infectivity. Again, despite the marked differences in extracellular 
(BHI) PrfA-depedendent expression levels between the prfAWT- and prfA*G145S-
complemented bacteria, both exhibited the same (maximal) levels of spread, further 
reinforcing the notion that the PrfA*G145S mutant protein mimics the "on" 
















Figure 3.1.20: Cell-to-cell spread of the PrfA pocket mutants in murine L929 fibroblasts after 4-day 
incubation at 37ºC, represented by plaque size in mm.  
Numbers above bars indicate the percentages of cell-to-cell spread in relation to the wild-type strain 
(which is 100%). Mean ± SE of at least two independent experiments. Statistical analyses were 




3.1.1.3.2.5 Biochemical characterization 
 
 The hypothesis that the N-terminal pocket may serve as binding site for an 
activating ligand would be supported if the intracellular activation defects caused by 
the mutations were associated with minimal structural changes, not if they caused 
major perturbations in PrfA, resulting in global loss of function. To discriminate 
between these two situations, we expressed the mutant and control prfA alleles in E. 
coli and subjected the purified recombinant PrfA proteins to biochemical 
characterization (table 3.1). These experiments were coordinated by C. Deshayes and 
performed in part using our in-house protein biochemistry facilities (protein 
expression and purification in our laboratory, DNA-binding assays in the 
Biophysical Characterization Facility, Centre for Translational and Chemical 
Biology) and in the Department of Biochemistry of the University of Cambridge.  
 
 Analytical ultracentrifugation (AUC) was used to assess the dimeric state of 
PrfA, vital for transcriptional function. This separation technique gives an accurate 
estimation of the size of a protein in solution (Lebowitz et al., 2002). The calculated 
molecular mass coincided for all proteins with the theoretical value of the PrfA 
dimer (54.56 kDa), indicating the mutations did not affect inter-protomer association 
(figure 3.1.21 and table 3.1). A PrfA mutant unable to form dimers, used here as a 
control, is described in section 3.1.1.4 (figure 3.1.29 and table 3.2).  
 
 The effect of the mutations on overall PrfA stability was assessed by a 
fluorescence-based thermal shift assay (TSA), in which the emission of the Sypro 
Orange fluorophore, quenched in aqueous solution, sharply increases in the nonpolar 
environment of the hydrophobic protein sites exposed upon thermally induced 
unfolding (Pantoliano et al., 2001, Lo et al., 2004, Ericsson et al., 2006). Shifts in the 
temperature midpoint for protein unfolding (melting temperature, Tm) reflect 
differences in stability associated with mutation-induced conformational changes. 
 
 The Tm value for PrfA*G145S was 7.2ºC lower than that of PrfAWT, indicating 
that the structural changes associated with the G145S mutation (Eiting et al., 2005) 
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make the hyperactive mutant protein slightly less stable. According to the TSA data, 
most of the mutations had no significant (P > 0.01) effect on PrfA stability (F29M, 
V80L, L120V, Y63W) or even caused a slight increase in the Tm (E36Q, E36R). 
I69W and S71L caused minor reductions in the Tm (4.25 and 7.4ºC below wild-type) 
but the values remained within the range of a functional PrfA protein (considering 
the Tm of PrfA*G145S). Only the activation-null L48F mutation and the control null 
PrfA E173G* mutation affected more substantially protein stability (Tm 10.4 and 9.7 
ºC lower than for PrfAWT, respectively), but the Tm values still approximated those of 














Figure 3.1.21: Dimerization assay by Analytical Ultracentrifugation (AUC) - targeted pocket mutants. 




 Finally, the surface plasmon resonance (SPR) technique enabled us to 
determine the specific DNA-binding activity using double-stranded DNA fragments 
containing the 14-bp PrfA boxes of PplcA and PactA. In order to assess the effect of 
the different mutations on the intrinsic ("off" or extracellular state) activity of the 
PrfA protein, the binding affinity of PrfAWT served as a reference. If the mutation 
does not introduce major structural changes in PrfA, it is expected that this activity 
remains close to wild-type levels.  
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 The calculated equilibrium dissociation constant (KD) of PrfAWT for the 
PplcA promoter, 10.95 ±0.49 × 10–7 M, was very similar to that previously 
determined by Eiting et al. by SPR using the hly promoter (9.00 ±1.00 × 10–7 M) 
(Eiting et al., 2005), which shares the same PrfA box with PplcA. The KD value was 
also similar for PactA (13.63 ±0.24 × 10–7 M). Overall, our data show a good 
correspondence between the expression levels in BHI (figure 3.1.17) and the DNA 
binding activity of the respective PrfA proteins (table 3.1). PrfAF29M and PrfAI69W, 
for example, had an intrinsic activity between three and five times greater than 
PrfAWT, consistent with the elevated levels of basal PrfA-dependent expression in 
BHI and the partial PrfA* phenotype displayed by the bacteria expressing the 
corresponding alleles. PrfAS71L, which caused partial PrfA* phenotype on agar 
plates, also showed a slightly increased DNA-binding activity for both target 
sequences. Of the two activation-null mutations, L48F associated with significantly 
reduced intrinsic DNA-binding activity (between 79 and 93%) whereas this 
parameter remained unaffected for Y63W (table 3.1).  
 
 Thus, with the possible exception of L48F, which associated with a 
significantly impaired intrinsic DNA-binding activity and somewhat reduced thermal 
stability, the PrfA pocket mutations did not seem to significantly affect basic 




3.1.1.3.2.6 Double N-terminal pocket-C-terminal α-D G145S* mutant bacteria 
 
 In order to find out whether the intracellular activation-deficient mutations 
act mainly locally in the surroundings of the β-barrel or affect more generally the 
PrfA structure, we decided to analyze their effects in a PrfA*G145S protein. The 
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     Specific DNA-binding affinity 
 Dimerization  Thermal stability  PplcA bo x   PactA bo x  
 MW (Da) 
% peak 
integration 
  Tm (ºC)   KD (nM) % PrfA
WT





 58300.18 95.49   61.75 ±1.30   1095.96 ±49.58 100   1363.18 ±24.10 100 
F29M 48971.47 96.04  59.83 ±0.29  287.51 ±4.47 381  267.15 ±15.00 510 
V80L 51961.09 92.57   62.00 ±0.00   1785.43 ±47.30 61   1404.14 ±54.05 97 
E36Q 59365.22 85.33  65.50 ±0.50  1356.25 ±11.40 81  801.02 ±6.74 170 
E36R 52037.49 86.78   66.50 ±0.50   1445.11 ±12.62 76   1078.95 ±10.31 126 
I69W 49035.53 92.85  57.50 ±0.00  346.94 ±4.28 316  392.13 ±7.65 348 
S71L 50300.96 83.30   54.33 ±0.29   695.14 ±4.24 158   740.52 ±5.93 184 
L120V 50667.43 92.28  60.17 ±0.29  3122.77 ±36.67 35  1586.28 ±16.74 86 
L48F 50440.53 90.87   51.33 ±0.29   5264.91 ±100.87 21   20841.58 ±262.12 7 
Y63W 50955.16 84.35  59.33 ±2.02  1158.36 ±8.61 95  1660.02 ±14.28 82 
S71L* 51354.84 72.88   nd   74.81 ±1.14 1465   66.87 ±11.96 2039 
L48F* 49801.70 93.27  nd  14.89 ±0.5 7362  238.79 ±6.03 571 
Y63W* 51318.86 83.03   nd   9.43 ±0.33 11617   28.68 ±0.28 4754 
PrfA*
G145S
 54352.46 83.93   54.50 ±1.00   ! 1 -   ! 1 - 
 
Table 3.1: Biochemical analysis of the PrfA pocket mutants. 
For the dimerization assay, the apparent molecular weight (MW) of the proteins has been taken from the ordinate maximum of the c(M) distribution (see figure 3.1.21). 
Thermal denaturation midpoint temperature (Tm) was determined by a thermal shift assay, monitoring the fluorescence enhancement of the hydrophobic reporter dye 
SYPRO Orange. The equilibrium dissociation constants (KD) for each purified PrfA protein was determined in a Biacore apparatus using as target the PrfA boxes of the 
PplcA and PactA promoters; relative binding affinities with respect to PrfAWT are indicated in percentage. See Materials and Methods for details. Values are mean of 
three replicates (± standard deviation [SD] where relevant). Data for the "non-binding" control PrfA*E173G mutant are in table 3.2. No precise KD values are given for 
the constitutively hyperactive PrfA*G145S mutant; likely due to the avidity for its target sequence, its dissociation rate was below the detection limit and could not be 


























G145S mutation lies in αD in the C-terminal domain and results in a constitutively 
activated PrfA form not by allostery but through local structural rearrangements that  
lead to a realignment of the adjacent DNA-binding α-helices of the HTH motif 
(figure 3.1.8; also schematized in figure 3.1.22) (Vega et al., 2004, Eiting et al., 
2005). This approach assumes that the changes introduced by the PrfA*G145S 
mutation remain mainly local, confined to the C-terminal DNA-binding domain, but 
(inevitably in such a compact molecule) there are some “retrograde” effects at the 
level of the inter-domain region and the N-terminal domain (figure 3.1.22), mainly 
realignment of a few degrees of the long inter-subunit αC (Eiting et al., 2005). 
 
 Nevertheless, such double mutant approach should allow determining 
whether it is possible to dissociate the effects of the pocket mutations in the N-
terminal domain from those of the G145S mutation in the C-terminal DNA-binding 
domain. If dissociation is possible and the pocket mutants do not abolish (or even 
better, alter significantly) the DNA-binding activity of the PrfA*G145S, it would be an 
indication that the non-activability associated with the binding site mutations is 
mainly due to local blockage of the pocket. If dissociation is not possible, we would 
not be able at this stage to say anything more definite regarding the mechanism of 
the pocket mutations.  
 
 For the analysis, three mutants were chosen: S71L, in which the point 
mutation strongly affects PrfA's intracellular activability, and L48F and Y63W, in 
which the single substitutions almost completely abolish it.  
 
 The double mutants S71L*, L48F* and Y63W* showed a strong PrfA* 
phenotype on agar plates (figure 3.1.18). They also showed elevated basal (BHI) 
PrfA-dependent expression levels (figure 3.1.17) and the same levels of cell-to-cell 
spread of prfA*G145S (figures 3.1.19 and 3.1.20). The corresponding PrfA proteins 















Figure 3.1.22: Schematic representation of the PrfA dimer with indication of the relevant structures, 
mutations and issues involved in the “pocket-PrfA*G145S double mutant strategy. 
Binding pocket mutations are represented as red dots, the PrfA*G145S mutation as a green asterisk. 
Direct effects of the mutations are represented as solid red arrows, possible indirect or “retrograde” 
effects exerted on more distant parts of the molecule as broken arrows (originating from the pocket 
mutations in red, from the G145S mutation in αD in green). See text for details. 
 
 
 These data are consistent with the intracellular activation-deficient phenotype 
caused by the pocket mutations being mainly associated with local structural changes 





3.1.1.3.3.1 Activation negative mutations L48F and Y63W 
 
 The activation of PrfA-dependent genes in infected HeLa cells was almost 
completely abolished due to the L48F and Y63W substitutions (mean intracellular 
expression < 10% of wild-type levels). This correlated with total loss of cell-to-cell 
spread capacity, a strictly PrfA-dependent virulence trait (Freitag et al., 1993, Scortti 
et al., 2007) (see figures 3.1.19 and 3.1.20). Both substitutions are predicted to 
partially occlude the entrance of the distal chamber of the pocket (figure 3.1.15), 




 In L48F, the new phenylalanine is predicted to make close hydrophobic 
contacts with Y83 (2.9Å) and F29 (3.8Å) from the same monomer, and L128 (3.3Å) 
in the other monomer, which represent steric clashes since the distances are smaller 
than the summed van der Waals radii (3.4Å in the case of two carbon atoms). This 
implies that the accommodation of the L48F substitution involves substantial 
adjustments in the PrfA structure and, likely also, in the relative position of the two 
monomers. Indeed, modelling calculations carried by our collaborator R. Núñez 
Miguel showed that, while the accessible surface area (ASA) remains unchanged, the 
gap volume at the dimer interface is increased in PrfAL48F compared to PrfAWT (data 
not shown), suggesting that the mutation moves the two monomers slightly apart. 
Consistent with this, PrfAL48F shows a significantly impaired intrinsic DNA-binding 
activity (> 80% reduction) and decreased thermal stability compared to PrfAWT (table 
3.1). Dimerization is, however, not affected and the stability, albeit reduced, is still 
comparable to that of the constitutively hyperactive PrfA* protein. Moreover, the 
double PrfAL48F*G145S mutant protein retains much of the PrfA* activity caused by 
the G145S mutation. Thus, although introducing substantial perturbations, the L48F 
mutation appears to preserve the basic structural integrity of PrfA, supporting the 
notion that the activation-negative phenotype of PrfAL48F may be related, at least in 
part, to the incapacity of an allosteric effector molecule to productively interact with 
the mutant pocket.  
 
 Residue Y63 lies in the proximal end of the distal chamber with its hydroxyl 
group directly exposed at the surface of the cavity, where it may contribute to 
stabilizing the interaction with a putative ligand via polar contacts. In addition, the 
indole ring in the rotameric state of the newly introduced tryptophan that formed less 
steric clashes with the surrounding residues is predicted to partially penetrate into the 
distal chamber (figure 3.1.15). Besides not abolishing the PrfA* phenotype of 
PrfA*G145S, Y63W, in contrast to L48F, did not affect any of the protein biochemical 
parameters analyzed (dimerization, intrinsic DNA-binding activity, thermal 
stability). This suggests that the overall structural and functional integrity of PrfA is 
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not significantly altered, consistent with Y63W being a true binding pocket mutation 
specifically affecting the intracellular activability of the listerial regulator.   
 
3.1.1.3.3.2 Activation deficient mutations I69W, S71L and L120V 
 
 Three mutations caused a significant but incomplete impairment of 
intracellular activability of PrfA-dependent genes (∼ 23 to 60%) of wild-type mRNA 
levels in average) and a similar reduction in cell-to-cell spread efficiency (37 to 
50%). None of these mutations significantly affected the structural parameters of the 
protein. In I69W and S71L the new larger side chains are predicted to partially 
obstruct the internal cavity, at the entrance of the distal chamber and access channel, 
respectively (figure 3.1.15), suggesting that a fully accessible pocket is required for 
PrfA intracellular activation. Interestingly, compared to PrfAWT, PrfAI69W shows a 
significantly increased intrinsic transcriptional activity (∼ 140%) and DNA-binding 
affinity (332%) (table 3.1) as well as partial PrfA* phenotype on EYA and SBA 
plates (figure 3.1.18). In I69W, the penetration of the bulky flat aromatic face of the 
tryptophan into the pocket and the clashes and/or new hydrophobic interactions with 
neighbouring residues (figure 3.1.15) may trigger structural changes that partially 
mimic the allosteric effects associated with the accommodation of a ligand. A similar 
interpretation can be given to the increased DNA-binding activity (∼ 171%) and 
partial PrfA* phenotype associated with the S71L mutation. In this case these effects 
are not reflected in the RT-QPCR data, possibly because weaker than with I69W. 
Transcription analyses only capture steady-state mRNA levels at a specific time 
point, and the slightly increased DNA-binding affinity of PrfAS71L may only give a 
detectable phenotype in bacterial colonies by cumulative effect.  
 
 L120 is on αC at the monomer-monomer interface and forms part of the 
hydrophobic surface of the distal chamber (figure 3.1.15). Valine has a β-branched 
side chain with restricted rotamer choice on a helix and substitution to this shorter 
residue was expected to affect the shape of the pocket without altering the position of 
the helix. Consistent with this, dimerization was not affected in PrfAL120V and can be 
excluded as the origin of the phenotype. The loss of function is not due either to 
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PrfAL120V instability, since it has the same thermal denaturation profile as PrfAWT. If 
a wild-type distal end of pocket is required for the correct positioning of a ligand, in 
the deeper L120V mutant pocket the small molecule may penetrate further inside and 
"push" the central αC helices apart (figure 3.1.15), disrupting in the liganded 
conformation the correct protomer alignment and positioning of the C-terminal HTH 
motif.  
 
3.1.1.3.3.3 Electronegative patch mutations E36Q/R 
 
 A portion of the pocket entrance is strongly electronegative (figure 3.1.12) 
and the charge may influence the delivery of a small molecule into the cavity, or 
form stabilizing interactions with a putative ligand once bound. To test this 
possibility, we substituted the negatively charged residue E36 at the mouth of the 
pocket with a neutral but polar amide (glutamine) or with a positively charged side 
chain (arginine). The E36Q substitution had little or no effect, but E36R resulted in a 
∼ 20% (PplcA) to ∼ 40% (PactA) reduction in intracellular activation respect to 
PrfAWT, similarly reflected at the level of cell-to-cell spread (∼ 34% reduction), with 
no significant effects on intrinsic DNA-binding activity or protein stability (figure 
3.1.17, 3.1.19, 3.1.20, table 3.1). We conclude that the electronegative patch at the 
entrance of the pocket may play some role in PrfA intracellular activation but is 
unlikely to be critical. Besides altering the charge, a rotameric state of the new 
arginine also introduces a bulkier side chain that partially occludes the entrance 
(figure 3.1.15).  
 
3.1.1.3.3.4 Neutral F29M and V80L mutations 
 
 F29M was anticipated to change the shape of the wall of the pocket at a 
constriction in the middle of the channel (figure 3.1.15, 3.1.16). Our data indicate 
that the flexible methionine side chain replacing the bulky and more rigid 
phenylalanine is conformationally accommodated in the active (intracellular) PrfA 
form. They also suggest that interactions with a hypothetical ligand are unlikely to be 
dominated by aromatic stacking interactions on the surface of the phenylalanine. 
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PrfAF29M bound 3.8 to 5.1 times more tightly to the PrfA box, had about three times 
the intrinsic transcriptional activity of PrfAWT and exhibited PrfA* phenotype on 
agar plates (figure 3.1.17, 3.1.19, 3.1.20, table 3.1), indicating that like for the I69W 
and S71L substitutions, the structural changes introduced by the new methionine 
may partially mimic those affiliated with PrfA activation.  
 
 V80, on the other hand, occupies a dominating part of the hydrophobic 
surface of the distal chamber. Leucine was chosen to satisfy the criteria that the 
substitution produces little perturbation of the local structure while still being 
capable of modifying the pocket topology. The absolute neutrality of the mutant 
suggests that the V80L substitution is perfectly accommodated both in the off (apo) 
and on (liganded) PrfA conformations. 
 
3.1.1.3.3.5 Concluding remarks 
 
 Two of the nine structure-guided, site-directed mutations analyzed (figures 
3.1.15 and 3.1.16), L48F and Y63W, exhibited a phenotype consistent with the PrfA 
pocket serving as binding site for an activating ligand. Y63W satisfied all the criteria 
for a bona fide allosteric activation-negative mutation, i.e. abolition of intracellular 
activability with no other detectable structure-function alterations in PrfA that could 
explain the functional loss by reasons other than local structural changes in the 
pocket. 
 
 L48F and Y63W target residues in the distal section of the pocket, which 
forms an enlarged chamber leaning against the two central C-helices that provide 
most of the monomer interface and connect the protomer's N-terminal and C-
terminal (DNA-binding) domains (figures 3.1.11, 3.1.13, 3.1.15 and 3.1.16). Another 
mutation at the distal end of the chamber, L120V on αC, and two other mutations 
near the distal chamber's entrance, S71L and I69W, also significantly impaired 
intracellular virulence gene activability without causing major overall structural 
alterations in the protein (figure 3.1.17), further suggesting a specific role for the 
inner section of the solvent-exposed pocket in PrfA allosteric activation.  
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 The distal chamber contacts the αC helices near where they tilt by 11º and 
straighten in the activated PrfA* (G145S) form. This brings the C-terminal ends of 
the C-helices towards each other, "tightening" the dimer, a movement likely to play a 
key role in the conformational readjustments of the C-terminal DNA-binding domain 
involved in PrfA activation (Eiting et al., 2005). Indeed, the αC helices at the C-
terminus of the CNB domain are critically involved in the transmission of the 
allosteric signal to the effector domains in cAMP-regulated proteins. This involves a 
movement towards the cAMP-liganded pocket in the case of the shorter αC "lid" of 
the mammalian CNB domains (Rehmann et al., 2007), or the packing of the liganded 
β-barrel against the elongated interdimeric αC helices in the enterobacterial and 
mycobacterial Crp transcription factors (Popovych et al., 2009, Reddy et al., 2009). 
Conceivably, penetration of a ligand in the distal chamber may directly affect the 
relative alignment of the monomers by altering the spatial relationships at the point 
where the two central C-helices lie closer to each other (figure 3.1.13). Attraction of 
a flap formed by the β4-β5 antiparallel hairpin of the β-barrel towards the liganded 
pocket, as observed in the cAMP-Crp complex (Popovych et al., 2009), may also 
contribute to monomer realignment via contacts between the flap and the C-terminal 
end of αC' from the opposite monomer (figure 3.1.23).  
 
 The observed elevation in the basal (extracellular) activity with the F29M, 
I69W and S71L mutations also supports a role for the N-terminal pocket in PrfA 
allostery. The activity increase is modest compared to that caused by the G145S (and 
L140F) PrfA* mutation in αD (Vega et al., 2004), which acts locally on the adjacent 
HTH motif in the C-terminal domain (Eiting et al., 2005). A weaker intrinsic activity 
compared to PrfA*G145S has been previously observed for other PrfA* mutations in 
the β-roll, such as I45S (Vega et al., 2004) or Y63C (Miner et al., 2008b). We 
interpret that the partial PrfA* phenotype of F29M, I69W and S71L may arise from 


















Figure 3.1.23: Allosteric "transmission chain" of PrfA and possible main contacts involved.  
Cartoon representation of the crystal structure of PrfA with the CAVER output represented in green 
mesh indicating the position of the pocket within the N-terminal β-barrel. One monomer is coloured 
in grey, the other monomer is coloured according to structural features: β-barrel plus αA and αB in 
dark salmon, αC in light blue, αD helix in green, HTH in magenta, C-terminal GHI α-helical bundle 
in yellow, rest of monomer in white. Residues in which PrfA* mutations have been characterized 
(including those described in this study), i.e. F29, I45, Y63, I69, S71 and L140, G145, L148, Y154 
and G155, are represented as red sticks. The β4-β5 "flap" of the β-barrel is highlighted in deep 
salmon. Residues of the flap that establish contacts with residues from αC and αC' are in sphere 
representation. The atomic volumes of the residues from the C-terminal domain in direct contact with 




 Mapping all the PrfA* mutations characterized to date in the PrfA 3D 
structure reveals a possible allosteric "transmission chain" between the pocket and 
the C-terminal domain via two key residues at the base of the β4-β5 flap, I45 and 
Y63 (figure 3.1.23). This allosteric signal path may contribute, alongside the 
repositioning of the C-helices, to the coordinated set of structural motions required 
for the correct alignment of the HTH binding helices in the active PrfA 
conformation.  
 
 Our data provide strong experimental support to the notion that PrfA is 
allosterically activated via a putative ligand-binding pocket in its N-terminal domain. 
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The shape and physicochemical characteristics of the pocket suggest that it could 
bind a relatively hydrophobic, elongated molecule with an aromatic head and 
aliphatic tail. The identification of the putative PrfA-activating ligand may lead to 









 NCTC 7973 is a well-known collection strain of serovar 1/2a, widely used in 
research laboratories worldwide and proposed as the type strain of L. monocytogenes 
in replacement of SLCC 53T (ATCC 15313) (Jones & Seeliger, 1983, Seeliger & 
Jones, 1986). The latter is non-haemolytic and displays a multiple deficiency in 
virulence-associated phenotypes. This is due to a spontaneous deletion in the prfA 
gene (Mengaud et al., 1991), therefore, it is not a good representative of the species 
(Kathariou & Pine, 1991, Ripio et al., 1996). NCTC 7973 was chosen because, in 
contrast to the official type strain, it was strongly haemolytic and virulent. Early 
work from our group established, however, that NCTC 7973 was also a spontaneous 
mutant and did not display the true wild-type phenotype of L. monocytogenes. It was 
not weakly haemolytic, as is typical for wild-type L. monocytogenes, but 
hyperhaemolytic, and also overexpressed other virulence-associated factors, such as 
PlcB, giving a wide halo of lecithinase activity on EYA (Ripio et al., 1996). The 
strain was found in fact to be a spontaneous prfA* mutant carrying the G145S 
mutation (Ripio et al., 1997a).  
 
 NCTC 7973 also carried a second mutation in prfA, C229Y, located in the 
loop between αH and αI helices of the C-terminal α-helical extension. Interestingly, 
this second mutation was always found in spontaneous prfA* mutants from serovars 
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1/2a, 3a and 1/2c, i.e. belonging to L. monocytogenes phylogenetic division II. This 
was in contrast to prfA* spontaneous mutants of phylogenetic division I, e.g. serovar 
4b, which only carried a single residue substitution, typically G145S. On trans-
complementation of a ΔprfA strain with a multicopy plasmid, both prfA* alleles, i.e. 
prfA*G145S and prfA*G145S/C229Y conferred a strong PrfA* phenotype in standard EYA 
and SBA. The intensities of the reactions tended, however, to be somewhat weaker 
with the strains carrying the natural prfA*G145S/C229Y, like NCTC 7973 (unpublished 
observations from our laboratory). The reason and functional impact of the second 
C229Y mutation in prfA*G145S mutant alleles of division II L. monocytogenes 
bacteria remains unknown. 
 
 Strain NCTC 7973 was used by Park and Kroll (1993) in the study that first 
showed that cellobiose represses PrfA-dependent expression. These authors found 
that hly and plcA gene expression was strongly downregulated when the bacteria 
were grown in the presence of this β-glucoside sugar, but not with other fermentable 
carbohydrates, such as glucose. This same effect was observed with another β-
glucoside, arbutin (Park, 1994). On the basis of these observations it was concluded 
that β-glucosides, plant derived sugars presumably abundant in soil rich in decaying 
vegetation, are used by L. monocytogenes as signalling molecules to identify its 
presence in the natural environment, i.e. outside a host where virulence factors are 
not needed (Park & Kroll, 1993). It has to be emphasized that at the time these 
experiments were carried out, it was not known that NCTC 7973 was a prfA* mutant 
nor that it carried a specific subtype of prfA* allele with a second mutation. 
 
 Later work from our laboratory, carried out using a wide collection of truly 
wild-type L. monocytogenes strains, plus the prfA* mutants P14A (single substitution 
G145S) and NCTC 7973 (double G145S/C229Y substitution), demonstrated that the 
latter in fact responded anomalously to sugars (see figure 3.1.24). Wild-type strains 
(e.g. EGD, the strain used by the European Listeria Genome Consortium for 
sequencing) were repressed not only by β-glucosides but also by glucose and all 
other fermentable sugars tested. As wild-type L. monocytogenes expresses virulence 
genes very weakly at 37ºC in vitro, to observe the repressor effect of sugars in its 
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true dimension, it was necessary to grow the bacteria in the presence of activated 
charcoal (Ripio et al., 1997b, Brehm et al., 1999). This adsorbent, as explained in 
section 3.1.1.2, activates PrfA-dependent expression (Ermolaeva et al., 2004). Strain 
P14A, producing a constitutively hyperactive PrfA* protein, was found to be 
insensitive to sugar-mediated repression, including cellobiose (Ripio et al., 1997b). 
This observation was extended to other prfA* mutants with single amino acid 
substitutions (Vega et al., 2004).  
 
 Interestingly, the repressor effect of sugars was not observed with hexose 
phosphates, which are taken up by L. monocytogenes via Hpt, a non-PTS permease 
(Ripio et al., 1997b). This supported the notion that sugar-mediated repression of L. 
monocytogenes virulence genes may represent an aspect of the global catabolite 
repression response with collateral regulatory effects on the PrfA system 
(Milenbachs et al., 1997). It was, therefore, speculated that the abnormal behaviour 
of NCTC 7973, in which only cellobiose and arbutin, not other PTS-transported 
sugars, repress L. monocytogenes virulence genes, could be due to a specific 
mutation in a specific mechanism(s) responding to β-glucosides (Behari & 
Youngman, 1998b, Brehm et al., 1999, Milenbachs Lukowiak et al., 2004).  
 
 In this study, we investigated the functional consequences of the C229Y 
mutation in PrfA. We also tested the hypothesis that the differential response to 
sugars of NCTC 7973 could be solely due to the presence of the second C229Y 
mutation in its prfA*G145S/C229Y allele, with no involvement of other unidentified 
mutations.  
 
 As part of our ongoing investigations into PrfA structure-function, in this 
chapter we also functionally and biochemically characterized two additional 
spontaneous mutations identified in our laboratory as prfA* suppressor (prfA*sup) 
mutations, A129T in the C-terminal third of αC, and E173G at the beginning of αE 


























Figure 3.1.24: Differential response of NCTC 7973 virulence genes to sugars. 
(A) L. monocytogenes strains streaked on Luria Bertani (LB) agar with 10% egg yolk and Tris 0.5 M 
(pH = 7.2) supplemented with 25 mM sugar: left panel, glucose (Glc); right panel, cellobiose (Cel). 
Strains shown: NCTC 7973 (prfA*G145S/C229Y), EGD and P14 (prfAWT), P14A (prfA*G145S), ΔprfA (prfA 
deletion mutant of P14, negative control). Unpublished data from our laboratory: plates prepared by 
Katherine Norrby. 
(B) Patterns of plcB repression in response to sugars in L. monocytogenes NCTC 7973 and EGD (Sac, 
saccharose; Glc, glucose; Fru, fructose; Man, mannose; Cel, cellobiose; Arb, arbutin, Sal, salicin; -, no 
sugar; Cel, Arb and Sal are β-glucosides). Taken from Brehm et al. (1999). 
(C) Refractory effect of prfA* mutations (G145S, I45S, L140F; indicated by red rectangles) to PrfA 
regulon repression by sugars, as determined using the plcB natural reporter system. The wild-type 
strains P14 and NCTC 10527 are strongly repressed by fermentable sugars such as glucose (Glc) and 
cellobiose (Cel), whereas the prfA* mutants (boxed in red) are not repressed. PC-PLC units indicate 
the activity of the plcB gene product used as a reporter to measure PrfA-dependent expression. Taken 
from Vega et al. (2004). 
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3.1.1.4.2 Results and Discussion 
 
3.1.1.4.2.1 General strategy 
 
 We followed here the same mutant characterization approach as used in the 
previous section for the targeted mutants in the N-terminal PrfA pocket. This 
included the construction of monocistronic prfA alleles carrying the natural mutant 
genotype in the prfA*G145S context (i.e. double mutants), or the investigated mutation 
alone (i.e. single mutants) in a prfAWT context (table 5.1). Each of the alleles was 
integrated in single copy in the chromosome of a prfA deletion mutant (ΔprfA) to 
analyze the functional consequences in vitro in culture medium and during 
intracellular infection in HeLa cells. PrfA activity was monitored by RT-QPCR 
(figure 3.1.25) and also in vitro on EYA and SBA using the plcB and hly genes as 
natural reporters (figure 3.1.26). The impact of the mutations on virulence was 
measured using a plaque assay (figures 3.1.27 and 3.1.28). Western immunoblotting 
with an anti-PrfA antibody was used to verify that the complemented strains 
produced equivalent amounts of PrfA proteins (data not shown).  
 
 All the alleles were also expressed in E. coli and the mutant proteins purified 
and functionally and biochemically characterized (DNA-binding activity, 
dimerization, structural stability; table 3.2, figure 3.1.29). 
 
 In addition, we investigated the growth kinetics of the mutants in broth 
medium (figure 3.1.30). We carried out these experiments because we noticed that a 
PrfA* genotype/phenotype associates with growth defects, which are reversed to 
wild-type growth upon deletion of the prfA* allele and its replacement by prfAWT 
(unpublished observations from our laboratory).  
 
 Finally, for C229Y, specific experiments were conducted to investigate the 
effect on sugar-mediated PrfA-dependent gene repression (figure 3.1.32). These are 
described in detail in the following section. 
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Figure 3.1.25: Transcriptional analysis of the PrfA mutants.  
The transcription of plcA (upper panel) and actA (bottom panel) genes has been quantified by RT-
QPCR in extracellular conditions (OD600 = 0.3 in BHI broth) and intracellular conditions (infection of 
human HeLa epithelial cells for 6 h post-infection). The transcription levels have been normalized by 
the number of bacteria and the level of transcription of the ldh housekeeping gene. Error bars indicate 













Figure 3.1.26: Phenotype conferred by the spontaneous PrfA mutations.  
Pictures taken from representative agar plates incubated at 37ºC for 72 h. (A) PlcB phenotype of the 




3.1.1.4.2.2 Characterization of the C229Y mutation  
 
 To dissect the role of the C229Y mutation in PrfA, we constructed mutant L. 
monocytogenes strains expressing either the prfA*G145S/C229Y allele, as present in 
NCTC 7973, or the prfAC229Y allele with no prfA*G145S mutation. To simplify, the 
mutations or strains carrying these are designated hereafter C229Y* and C229Y, 
respectively. On agar plates, the former allele conferred, as expected, a clear PrfA* 
phenotype, albeit somewhat weaker in intensity compared to prfA*G145S in both EYA 
and SBA (figure 3.1.26). Consistent with the phenotype on agar plates, the RT-
QPCR data showed that the C229Y* allele associates with high extracellular 
expression levels (BHI, i.e. spontaneous activity) from both PrfA-dependent gene 
promoters, although not as high as with prfA*G145S (respective fold-values relative to 
prfAWT: PplcA, 6.01 and 11.76; PactA, 21.22 and 58.92) (figure 3.1.25).  
 
 Therefore, the second C229Y mutation appears to partially suppress the 
PrfA* phenotype conferred by the G145S mutation.  
 
 In intracellular (PrfA-activating) conditions, PrfA-dependent gene expression 
was significantly activated in the C229Y* mutant (3.23- and 2.52-fold for PplcA and 
PactA), up to levels comparable to those seen with the strains complemented with 
 108 
prfAWT and the constitutively activated prfA*G145S allele (figure 3.1.25). Interestingly, 
the single C229Y mutant showed no intracellular activability, suggesting that when 
this mutation is present alone it results in total loss of PrfA activity. Consistent with 
these observations, the double C229Y* mutant strain formed very visible plaques in 
the cell-to-cell spread assay, similar in size to those produced by the prfAWT and the 
prfA*G145S bacteria (figures 3.1.27 and 3.1.28), whereas the single C229Y mutant did 
not.  
 
 The functional data correlated at the biochemical level with significantly 
increased (between 35.42- and 140.13-fold) and reduced (between 2.56- and 25.0-
fold) DNA-binding activity for PrfA*G145S/C229Y and PrfAC229Y compared to PrfAWT, 
respectively. These results are entirely consistent with the RT-QPCR transcriptional 
data. No significant differences were observed for the two proteins in dimerization 
and thermal stability (table 3.2 and figure 3.1.29), suggesting that the C229Y 













Figure 3.1.27: Visualization of the plaques of the PrfA mutants.  
Note that C229Y behaves like the control cell-to-cell spread-negative bacteria ΔprfA complemented 


















Figure 3.1.28: Cell-to-cell spread of the PrfA mutants in L929 fibroblasts after 5-day incubation at 
37ºC, represented by plaque size in mm. 
Numbers above bars indicate the percentages of cell-to-cell spread in relation to the wild-type strain 















Figure 3.1.29: Dimerization assay by Analytical UltraCentrifugation (AUC) - spontaneous mutants.  
Graphs for PrfAWT and PrfA* (G145S) have been extracted from the same experiment described in 














Figure 3.1.30: Growth kinetics of the spontaneous PrfA mutants in BHI broth at 37°C. 
Probably because the constitutive overexpression of all genes of the PrfA regulon causes a substantial 
burden to the L. monocytogenes economy, prfA* mutant bacteria consistently show a growth defect 
(unpublished observations from our laboratory). Note in the figure that despite the PrfA* phenotype 
being mitigated by the second C229Y mutation, the C229Y* mutant behaves similar to the reference 
prfA*G145S mutant. Mean of three experiments ± SD. Growth curves were obtained using a plate reader 




Figure 3.1.31: Localization of the spontaneous mutation sites in PrfAWT structure (PDB no. 2BEO). 
PrfAWT dimer shown in figure 3.1.23 (same colour codes for structural features) with the mutated 
residues highlighted in sphere representation: A129 in αC, marine blue; E173 in αE, hot pink; C229 
in αH, orange. The Residue K25 in the loop between β1 and β2 of the N-terminal β-roll, which 
probably establishes an electrostatic interactions with E173, is also in sphere representation (dark 




     Specific DNA-binding affinity 
 Dimerization  
Thermal 
stability 
 PplcA box   PactA box  
 MW (Da) 
% peak 
integration 
 Tm (ºC)  KD (nM)  % PrfA
WT  KD (nM)  % PrfA
WT 
PrfAWT 58300.18 95.49   61.75 ±1.30   1095.96 ±49.58 100   1363.18 ±24.10 100 
A129T 47814.09 71.92  nd  27162.75 ±419.36 4  37687.52816 ±744.77 4 
32257.30 47.87     
A129T* 
53499.40 18.16   
nd 
  
32028.10 ±630.35 3   19039.13421 ±271.30 7 
E173G 52763.20 81.93  58.17 ±0.29  1347.42 ±0.44  81  1695.308541 ±16.12 80 
E173G* 53298.30 81.32   52.00 ±0.50   10518.48 ±317.49 10   32021.79 ±5274.58 4 
C229Y 49111.50 99.99  62.50 ±0.00  28498.83 ±2665.95 4  3513.511196 ±67.54 39 
C229Y* 53365.67 81.85   57.00 ±0.00   7.82 ±0.24   14013   38.48791547 ±0.420 3542 
PrfA*G145S 54352.46 83.93  54.50 ±1.00  ! 1 -  ! 1 - 
 
Table 3.2: Biochemical analysis of the spontaneous PrfA mutants. 
No dimerization defects were observed except for the PrfA*A129T mutant protein, 47.9% of which was detected in monomeric form; the single-substituted PrfAA129T 
was, however, a dimer. The E173G and C229Y mutant PrfA proteins, carrying also a G145S substitution, showed all a reduction in the thermal stability similar to that 
observed for PrfA*G145S when compared to PrfAWT. The least stable protein was the totally inactive PrfA*E173G protein. For an unknown reason, the thermal stability of 
the A129T proteins could not be determined (indicated "nd"). Binding to the PrfA box was severely impaired in PrfAA129T, PrfA*A129T, and PrfAC229Y; PrfA*E173G 












We conclude that the C229Y mutation introduces minor structural changes 
that render the PrfA protein transcriptionally inactive, probably through local 
alterations in the C-terminal domain impacting on the stability of the DNA-binding 
HTH motif (figure 3.1.31). These alterations are overridden or compensated for by 
the PrfA* G145S mutation, through its direct effects on the conformation of the HTH 
motif (Eiting et al., 2005). 
 
 
3.1.1.4.2.3 Role of the C229Y mutation in the sugar-mediated repression 
phenotype of NCTC 7973 
 
 We next explored the impact of a second C229Y mutation in PrfA*G145S on 
the response of the L. monocytogenes PrfA system to fermentable sugars. We 
investigated in particular whether this mutation had any role in the differential 
response to cellobiose and glucose displayed by the prfA*G145S/C229Y strain NCTC 
7973 (Park & Kroll, 1993, Behari & Youngman, 1998b, Brehm et al., 1999). In 
addition to these two sugars, we checked gene expression upon growth on glucose-1-
phosphate (G-1-P), which is taken up through the non-PTS permease Hpt and has 
been previously reported not to repress L. monocytogenes virulence genes (Ripio et 
al., 1997b). For these analyses, we aimed to use experimental conditions maximizing 
the isolation of the potential effects of the test variable (presence of second C229Y in 
PrfA*G145S) from other possible interfering factors.  
 
 First, we moved away from the genetic context of the L. monocytogenes 
phylogenetic division II, in which the C229Y substitution is naturally linked to the 
PrfA*G145S mutation. This was also important because the anomalous response 
pattern of NCTC 7973 to cellobiose and glucose had been linked to unknown genetic 
defects in regulatory loci related to general catabolite repression and/or cellobiose-
specific regulation (Behari & Youngman, 1998b, Brehm et al., 1999, Milenbachs 
Lukowiak et al., 2004). We achieved this by expressing the C229Y* allele in a 
serovar 4b (i.e. phylogenetic division I) ΔprfA mutant, after integration in single 
copy in the chromosome.  
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 Second, as the culture medium composition may have a substantial effect on 
virulence gene expression (Ripio et al., 1996, Behari & Youngman, 1998b), we used 
the chemically defined IMM (see section 3.1.1.2) for growing the bacteria. The IMM 
medium was modified by lowering the concentration of phosphates from 1,642 mM 
(used for pH buffering) to 25 mM and adding 3-(N-morpholino)propanesulfonic acid 
(MOPS) (see Materials and Methods). This was necessary to allow L. 
monocytogenes to grow on G-1-P via uptake by the Hpt hexose phosphate permease 
(growth of L. monocytogenes is strictly dependent on the presence of a utilizable 
sugar as a carbon source). Hpt is an organic:inorganic phosphate antiporter, i.e. the 
translocation of the sugar phosphate into the bacterial cell involves the simultaneous 
expulsion of an inorganic phosphate molecule to the extracellular medium (Kadner et 
al., 1993, Huang et al., 2003, Lemieux et al., 2004). We noticed that the presence in 
the culture medium of a high concentration of phosphate buffer, as in IMM, prevents 
the uptake of hexose phosphates by L. monocytogenes, probably because the 
inorganic phosphate antiporting cannot proceed against gradient (our unpublished 
observations).  
 
 Third, instead of the natural adsorbent activated charcoal, we used the 
chemically defined synthetic resin AmberliteTM XAD-4 to induce PrfA-dependent 
gene expression in the modified IMM (see section 3.1.1.2). Activation of PrfA 
regulation is necessary in these sugar repression experiments for two reasons. (i) 
Wild-type L. monocytogenes expresses very weak to undetectable levels of PrfA-
regulated virulence genes in vitro, and it is questionable whether repressor effects 
observed in an already almost totally downregulated expression background are 
biologically relevant (Ripio et al., 1997b). (ii) In addition, since the hpt gene is 
strictly PrfA-dependent, activation of the PrfA system is indispensable for prfAWT 
bacteria to grow on G-1-P (Ripio et al., 1997b, Chico-Calero et al., 2002).  
 
 Finally, we used the highly sensitive and accurate RT-QPCR technique to 
quantify the effects of sugars on virulence gene expression. In previous studies from 
our laboratory PrfA-dependent expression was measured with the plcB natural 
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reporter system (Ripio et al., 1997b, Brehm et al., 1999, Vega et al., 2004), which, 
although working well, is not sufficiently sensitive and has a restricted linear 
dynamic range (saturation of output units above a relatively low PrfA activation 
threshold; our unpublished observations).  
 
 The results obtained are summarized in figure 3.1.32.  
 
 The RT-QPCR transcription values obtained for PplcA and PactA in bacteria 
grown on G-1-P as the sole carbon source were significantly more elevated than 
those observed with glucose. This is consistent with the notion that this non-PTS 
sugar does not significantly repress PrfA-dependent expression (Ripio et al., 1997b). 
If the transcription values obtained with G-1-P are taken as reference for non-
repressed PrfA-dependent expression, the data in figure 3.1.32 show that glucose 
downregulates virulence genes in both the prfAWT and prfA*G145S genetic contexts, 
albeit more intensely in the former. Thus, contrary to what was initially thought 
(Vega et al., 2004), the constitutively hyperactive PrfA*G145S mutant form is not 
totally "immune" to sugar-mediated repression.  
 
 This is particularly evident with cellobiose, which strongly repressed, in all 
conditions, PrfA-dependent expression. The reasons for these marked differences in 
the intensity of the repression in response to glucose and cellobiose are unknown. If 
this repression results from an interconnection between PrfA regulation and the 
carbon catabolite repression network (as suggested by the fact that only PTS-
transported sugars seem to trigger the effect), the differential effect of the two sugars 
could be related to the relative number of PTS permeases involved in the transport of 
β-glucosides and glucose in L. monocytogenes. The former are much more abundant 
in the L. monocytogenes genome (n = 17 vs only ptsG for glucose; in addition, there 
is evidence that glucose can be transported through non-PTS permeases or 
membrane facilitators) (Glaser et al., 2001) and can potentially generate a stronger 





Figure 3.1.32: Transcriptional analysis of the C229Y mutants in the presence of different sugar 
sources. 
The transcription of plcA (upper panel) and actA (bottom panel) genes has been determined by RT-
QPCR in extracellular conditions at 37ºC in IMM (early exponential phase, OD600 = 0.2). IMM was 
supplemented with 20 mM of the indicated carbon source (excess conditions for exponentially 
growing bacteria). “XAD-4” means IMM supplemented with 1% AmberliteTM XAD-4. For these 
experiments, normalization of transcription was carried out with ldh and a second reference gene, 
rpoB, since for an unknown reason, expression of ldh was on occasions slightly affected in bacteria 
grown on G-1-P. The red line represents a theoretical signal saturation threshold above which gene 
expression values are considered maximal. We set this threshold to the expression levels determined 
for prfA*G145S in cellobiose, as in these conditions there is no detectable effect on PrfA-dependent 
expression using the plcB gene as reporter system (see figure 3.1.24). No expression values are 
detected for prfAWT in normal medium (no AmberliteTM XAD-4) with G-1-P because L. 
monocytogenes does not grow in these conditions (PrfA-dependent gene hpt not active; see text for 
details). The same applies to prfAC229Y in IMM with or without AmberliteTM XAD-4 supplementation, 




 The above observations are important because they provide a simple 
explanation to the different response of NCTC 7973 to glucose and cellobiose. We 
suggest that the response of NCTC 7973 to sugars is no different from that exhibited 
by other L. monocytogenes strains, and that the difference seen between cellobiose 
and glucose are artifactual rather than biological. Our characterization work has 
shown that the second C229Y mutation partially suppresses the PrfA* phenotype 
conferred by the G145S mutation in vitro. This lower basal activity of 
PrfA*G145S/C229Y results in lower expression values (either with or without 
supplementation with AmberliteTM XAD-4) in response to sugars than with 
PrfA*G145S (figure 3.1.32). Reporter-based techniques, as those previously used for 
the analysis of NCTC 7973, have a narrower linear dynamic range than RT-QPCR. 
In these conditions, values below the signal saturation threshold are interpreted as 
repression whereas those slightly above are interpreted as maximal expression levels. 
This is illustrated in figure 3.1.32, in which a signal saturation threshold has been set 
to coincide with the expression levels of the prfA*G145S with cellobiose. According to 
figure 3.1.24 and previous data from Brehm et al. (1999) (figure 3.1.24B) and Vega 
et al. (2004) (3.1.24C), these levels correspond to (or are above) the signal saturation 
threshold of the plcB reporter and, thus, no apparent repression is observed. 
Expression levels below this threshold, as observed with C229Y* grown on 
cellobiose but not on glucose (figure 3.1.32), are interpreted as repression.  
 
 
3.1.1.4.2.4 Characterization of two PrfA*G145S suppressor mutations 
 
 Two PrfA− mutations were identified as prfA*G145S suppressor mutations 
(prfA*sup) while manipulating in our laboratory prfA* mutant strains. The mutants are 
Hly and PlcB negative in SBA and EYA plates, do not utilize hexose phosphates, 
and are not charcoal or AmberliteTM XAD-4-activable. To characterize these 
mutations, we used the same methodology as above, i.e. we expressed the prfA*sup 
(double mutant) alleles plus the single mutated prfAWT allele in a ΔprfA background, 
and analyzed the PrfA phenotype on plates and by RT-QPCR in broth-grown and 
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intracellular bacteria. We also recombinantly expressed the two (single and double 





 The prfA*sup mutation A129T was accidentally identified during the 
construction of a ΔsigB mutant (section 3.1.2.2.1) by double crossover in our 
prototype prfA*G145S strain P14A. This procedure involves a selection step at 42ºC 
(for thermosensitive vector counterselection; see Materials and Methods), a high 
temperature that is dysgenesic to L. monocytogenes and favours the appearance of 
mutations (Vega et al., 2004). The spontaneous prfA*G145S/A129T mutant displayed all 
the phenotypic characteristics of a PrfA null mutant (i.e. no spontaneous PrfA-
dependent gene expression and lack of activability by charcoal; see figure 3.1.2.2), as 
did the ΔprfA bacteria complemented with the corresponding allele (short name, 
A129T*) (figure 3.1.26). Neither the single A129T nor double A129T* mutated 
alleles showed any activity, even in intracellular conditions, i.e. they were non-
activable, indicating that the PrfA was totally non-functional (figures 3.1.25, 3.1.27 
and 3.1.28).  
 
 This spontaneous mutation appears to have a dramatic effect on PrfA 
following the reasoning used in section 3.1.1.3.2.6, since it was not overridden by the 
PrfA*G145S mutation in the C-terminal domain. This is consistent with the major role 
of αC in the structure-function of the members of the Crp family of transcriptional 
regulators. αC is the "dorsal spine" that connects the N-and C-terminal domains of 
the regulator's monomer, establishes most of the protomer-protomer contacts 
important for dimerization, and is critically involved in the transmission of the 
allosteric activation signal, as recently demonstrated for Crp (Popovych et al., 2009) 
and inferred from the comparison of the crystal structures of PrfAWT and PrfA*G145S 
(Eiting et al., 2005) (see section 3.1.1.3 for additional details). Residue A129 is near 
the point where the αC helices tilt by 11º and straighten in the activated PrfA*G145S 
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mutant form (figures 3.1.8 and 3.1.9), a movement that brings the C-terminal ends of 
these helices together, "tightening" the dimer (Eiting et al., 2005).  
 
 Interestingly, the A129T mutation causes a significant defect in the 
dimerization of the PrfA*G145S/A129T double mutant protein, but not in the PrfAA129T 
single mutant (figure 3.1.29, table 3.2), suggesting that this residue plays a key role 
in the monomer-monomer realignment and associated conformational readjustments 
of the C-terminal DNA-binding domain involved in PrfA activation.  
 
 Mutations at a similar position in Crp have been described, which also have a 
dramatic effect in protein function. Mutations in residues T127 and S128 (which 
align with S127 and L128 of PrfA; figure 1.4) of this region have been reported to 
alter Crp/cAMP interaction and interfere with cAMP-mediated changes in Crp 
structure (Lee et al., 1994, Cheng et al., 1995, Leu et al., 1999). It has been also 
shown that amino acid substitutions that introduce hydrophobic amino acid side 
chain constituents at either position 127 or 128 decrease Crp discrimination of cAMP 
and cGMP (Lee et al., 1994). In the Crp structure, S128 interacts with cAMP through 
hydrogen bonding. Additionally, it has been shown that amino acid substitutions at 
Crp positions 124 and 128 residues, which are one C-helix turn away from each 
other, affect both cAMP binding affinity and binding cooperativity (Tomlinson et al., 
2003). For example, Crp mutants including S128A and S128P showed inactive Crp 
phenotypes (Crp−). Our PrfAA129T mutant showed similar phenotype, as it was 
incapable of activating virulence gene expression intracellularly.  
 
 From the position of residue A129 in the PrfA structure, with the side chain 
facing the interior of the monomer towards αH of the C-terminal extension in both 
PrfAWT (figure 3.1.31) and PrfA*G145S (not shown), it is not totally clear how the 
A129T mutation may disrupt dimerization. It is probable that a larger side chain at 
PrfA position 129 introduces, primarily, major structural constraints in the normal 
interactions of the GHI α-helical bundle that "wedges" between the N- and C-
terminal domains, which is critical for PrfA function (see below), leading to a totally 
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afunctional protein. In the PrfA*G145S conformation, the changes obviously lead in 
addition to loss of critical monomer-monomer contacts involved in dimerization.  
 
 A similarly located substitution, D133Y only one helix turn away from 
A129T in αC, was identified by Herler et al. (2001) using a positive selection system 
for PrfA−. In the PrfA three-dimensional structure, the Tyrosine 133 side chain also 
faces and pushes away αH of the C-terminal extension, suggesting a similar 
mechanism of mutational inactivation, through structural alteration of the αGHI 
interdomain wedge interactions and concomitant secondary destabilization of the C-




 This mutation was identified some time ago in the laboratory by Dr. Yolanda 
Vega (Vega et al., 2004) as a spontaneous suppressor mutation in the prfA* strain 
NCTC 7973. The PrfA protein of this mutant strain, designated prfA*supE173G, carries 
in total three mutations, E173G, G145S and C229Y. Here we isolated the E173G 
mutation and investigated its effect in the PrfAWT (E173G mutant) and PrfA*G145S 
(E173G* mutant) contexts.  
 
 As the data shown in figures 3.1.25, 3.1.26, 3.1.27 and 3.1.28 indicate, the 
E173G and E173G* PrfA proteins are totally inactive even intracellularly. This is 
easily explained by the fact that residue E173 forms part of αE, the first α-helix of 
the DNA-binding motif, suggesting that the functional defect specifically affects the 
binding to the target promoter sequence. This was confirmed by our biochemical 
characterization analyses, which show that the E173G mutation does not alter the 
general structural parameters of PrfA (dimerization, thermal stability). It does, 
however, results in an almost total loss of DNA-binding activity. Interestingly, this is 
only observable in PrfA*E173G, not in PrfAE173G. The explanation appears simple: in 
PrfA*G145S the HTH motif is exposed and in the correct conformation for productive, 
specific interaction with the PrfA-box sequence, so that the effect of the mutation is 
readily observable; in PrfAWT, by contrast, the HTH motif is inadequately arranged 
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and the mutation does not have a significant impact on specific DNA binding (the 
PrfA protein being in the "off", weakly active state).  
 
 Interestingly, the E173G mutation is identical to, and aligns to the very same 
protein position, as another mutation in Crp, CrpE171G, identified in a suppressor 
mutant of a Crp*A144T strain (Garges & Adhya, 1988), in turn homologous to our 
PrfA*G145S. This coincidence highlights the significant structure-function similarities 




 Our observations show that the second C229Y mutation naturally present in 
all spontaneous prfA*G145S mutants of L. monocytogenes phylogenetic division II 
(1/2a and related serovars) attenuates the PrfA* phenotype. The reason why this 
mutation is always associated with the G145S substitution is unknown. Clearly the 
two mutations are co-selected, and the attenuation in PrfA activity may provide a 
selective advantage because the bacteria do not express levels of PrfA-regulated 
genes and products as high as those associated with a prfA*G145S genotype, thus, 
reducing the draw on vital resources. Clearly, this apparently does not entail any type 
of constraint in the phylogenetic division I genetic context, since the G145S mutation 
is found alone in these strains. The nature of the physiological constraints associated 
with a prfA*G145S mutation in division II strains remains a mystery, since the C229Y 
mutation does not mitigate the effect on bacterial fitness exerted by the PrfA*G145S 
mutation on L. monocytogenes, as shown in figure 3.1.30.  
 
 Our data help to clarify several key aspects of carbon source regulation of L. 
monocytogenes virulence genes: (i) we confirm that hexose phosphates do not appear 
to repress PrfA-dependent gene expression, this only occurs with PTS-transported 
sugars; (ii) a PrfA* mutation does not render L. monocytogenes insensitive to sugar-
mediated virulence gene regulation, as repression is still observable but with higher 
final output levels that are proportional to the intrinsic activity of the PrfA protein; 
(iii) the intensity of the repression varies depending on the sugar and may depend on 
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the number of potential PTS permeases involved in the uptake. Collectively, these 
observations suggest that there is a clear interconnection between the PrfA regulation 
and carbon catabolite repression systems in L. monocytogenes. Since the G145S 
mutation does not bypass the repressor effect of sugars, the carbon catabolite 
repression is probably exerted by a mechanism that is independent from, (or does not 
interfere with, i.e. it is superimposed to) the allosteric activation mechanism of PrfA.  
 
 Our data also provide a parsimonious explanation to the anomalous behaviour 
of strain NCTC 7973 in response to sugars. Earlier studies suggested that the 
differential response to glucose and cellobiose exhibited by this strain reflects the 
existence of at least two separate, semi-independent pathways of sugar-mediated 
repression, one related to general catabolite repression, which manifests when L. 
monocytogenes grows in the presence of glucose or fructose, and another responding 
specifically to β-glucosides. We demonstrate here that the point mutation C229Y is 
sufficient to confer differential response to glucose and cellobiose in quantitative 
terms, which depending on the gene expression analysis technique used and its 
corresponding signal saturation threshold, may lead to the conclusion that one sugar 
represses (cellobiose), whereas the other (glucose) not.  
 
 In essence, while it is certainly possible that independent sensing pathways 
exist for cellobiose or other sugars upstream of PrfA, we suggest that the underlying 
mechanism of PrfA repression is essentially the same but that it manifests with 
different intensities depending on the sugar transported. These different intensities 
may lead to artifactual interpretations related to the signal saturation threshold of the 
reporter systems used to measure gene expression. 
 
 Finally, our data also highlight the critical importance of the C-terminal 
αGHI extension, unique to PrfA among Crp-related transcription factors (Scortti et 
al., 2007), for activity. Apart from C229Y in the loop between αH and αI, which 
entirely disables PrfA (no expression detected in PrfA-activating conditions, i.e. 
intracellularly or with AmberliteTM XAD-4) if not accompanied by a second 
PrfA*G145S substitution, there is another naturally occurring mutation in this region 
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that causes PrfA− phenotype. This is the L220T substitution identified by Roche et 
al. (2005) in avirulent food isolates of L. monocytogenes. Like C229Y, the L220T 
mutation (also in αH) results in total loss of PrfA-dependent gene expression and 
cell-to-cell spread capacity. The two mutations differ, however, in that L220T 
abolishes DNA-binding in native (non-active, apo-form) PrfA whereas C229Y, 
according to our data, apparently does not. However, it is difficult to judge whether 
this difference is biologically significant, given the low levels of intrinsic DNA 
binding activity of the non-activated PrfA form. Moreover, Roche et al. (2005) used 
an electrophoretic mobility shift assay (EMSA), much less sensitive than our Biacore 
assays, to measure DNA binding. In fact, previous data from our laboratory using 
EMSA show that PrfAWT is unable to form detectable protein-DNA complexes.  
 
 A previous study, based on positive selection of PrfA− mutations using 
conditional lethality in B. subtilis, identified a number of mutations in the αGHI 
extension. The selection system involved co-transformation with a plasmid carrying 
the L. monocytogenes iap gene (encoding the P60 murein hydrolase, lethal for B. 
subtilis) under the control of the PrfA-dependent hly promoter, and a second plasmid 
encoding PrfA. Survival of B. subtilis was only possible if PrfA was inactivated by 
spontaneous mutations. The PrfA− mutations identified in this way mapped to the N-
terminal β-barrel (n = 3), αC-hinge-αD (n = 2), the HTH motif (n = 1) and the αGHI 
extension (n = 3), highlighting the functional importance of these regions (table 1.1). 
The C-terminal extension mutants were unable to bind to the DNA (Herler et al., 
2001), consistent with the notion that the GHI α-helices are important for the 
stability of the HTH motif.  
 
 The GHI α-helical bundle packs against the inter-domain cleft, forming a 
wedge that is likely critical for the C-terminal domain to maintain some structural 
rigidity. This may explain why native (unliganded) PrfA is capable of specific 
binding to the target DNA sequence, albeit with low affinity, in contrast to Crp, 
which lacks this extension and only shows unspecific binding to the DNA (Harman, 
2001). Indeed, the recently determined structure of (apo) Crp shows that the lower 
part of the αC helix is disordered in the absence of the allosteric activator cAMP, 
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resulting in inadequate intersubunit alignment and positioning of the HTH motif 
(Popovych et al., 2009). Two other mutations in αC, A129T described in this thesis, 
and D133Y identified by Herler et al. (2001), affect residues that face αH in the PrfA 
structure (figure 3.1.31), further suggesting that any alteration in the conformation 








 Some years ago it was observed in our laboratory that L. monocytogenes 
prfA* mutants were hyperinvasive (Suarez et al., 2001), suggesting an involvement 
of PrfA in the internalization process. Further work by Dr. Héctor Monzó et al. in 
our laboratory investigated in detail the role of PrfA in L. monocytogenes 
invasiveness. It was found that prfA* mutants, which constitutively overexpress 
PrfA-regulated genes at high (∼ intracellular) levels (see section 3.1.1.3), were up to 
165 times more invasive than broth-grown wild-type L. monocytogenes. Deletion of 
the prfA* allele reduced entry several orders of magnitude to the same levels 
observed with the non-invasive species L. innocua (typically 0.004 - 0.01% 
internalization vs 3% for prfA* in HeLa cells). Re-complementation with prfA*, but 
not prfAWT, restored the hyperinvasive phenotype (figure 3.1.2.1). Using inlAB 
mutants, it was demonstrated that the internalins InlA and InlB were responsible for 
the PrfA-dependent invasiveness in HeLa cells and other non-phagocytic cells. 
Moreover, inlAB expression followed the typical pattern of PrfA-regulated loci: 
negligible in a ΔprfA mutant, weak during extracellular growth, and strong in prfA* 
bacteria and within host cells (H. J. Monzó, M. K. Bielecka et al., manuscript in 
preparation). These observations were paradoxical as they showed that virulence 
determinants involved in cell invasion were induced after the bacteria had become 
internalized into host cells. They also were leaving unexplained how invasion of host 
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cells by extracellularly grown L. monocytogenes bacteria (i.e. PrfA regulon down, 
weakly invasive) can take place at the portal of entry during the epithelial phase of 
infection. In naturally susceptible hosts, this has been shown to involve the direct 
invasion of enterocytes via specific interactions of internalin proteins and host cell 
receptors, rather than the internalin-independent translocation of the intestinal barrier 
through the Peyer's patches (Racz et al., 1972, Jensen et al., 1998, Lecuit et al., 











Figure 3.1.2.1: PrfA-dependence of L. monocytogenes invasiveness in HeLa cells. 
Gene complementation experiments demonstrated that PrfA activity is essential for entry into host 
cells. Numbers above the bars are the mean % bacteria internalized. Trans-complementation of L. 
monocytogenes ∆prfA with multicopy plasmid constructs encoding PrfA proteins with different levels 
of intrinsic activity. prfAWT = weakly active wild-type PrfA protein; prfA* = constitutively 
hyperactive PrfA*G145S mutant protein; prfA*PSUP = PrfA*G145S/C229Y, a PrfA* protein with a second 
mutation C229Y that partially suppresses ("PSUP") the PrfA-activating effect of the G145S mutation 
(see section 3.1.1.4); vector = mock strain transformed with the trans-complementation shuttle vector 
(pHPS9) without insert. prfA*REV is a wild-type revertant of a natural prfA*G145S strain (P14A) 
obtained by replacing the prfA* allele by a prfAWT allele by double recombination. Taken from H. J. 
Monzó doctoral thesis, University of Bristol 2007.  
 
 
 Other groups maintain that the stress response mediator σB plays a major role 
in the invasion of the intestinal barrier by L. monocytogenes (Kim et al., 2005, 
Garner et al., 2006, Gray et al., 2006). The rationale behind this notion is that the 
transit of L. monocytogenes through the intestine involves the exposure to 
environmental stresses, particularly to the acidic conditions of the stomach, the 
resistance against which has been shown to be σB mediated (Wiedmann et al., 1998, 
Gahan & Hill, 2005, Freitag et al., 2009). Indeed, the inlAB operon appears to be 
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subject to complex regulation involving both PrfA, through one of the six promoters 
identified in the locus, P3inlA controlled by an unconventional PrfA-box with two 
mistmatches, and σB through two other promoters, P4inlA and P2inlB (Lingnau et 
al., 1995, Kazmierczak et al., 2003). 
 
 Some studies suggest that inlAB is also controlled post-transcriptionally 
(Stritzker et al., 2005), and others even report that the locus is poorly expressed 
within cells but substantially induced in broth medium (Bubert et al., 1999), a pattern 
opposite to that expected for PrfA-regulated genes. Therefore, the inlAB locus is 
largely considered to be only partially regulated by PrfA and to have an expression 
pattern that does not conform to the PrfA regulon archetype. The fact that one of the 
monocistronic prfA promoters (P2prfA) is apparently controlled by σB (Nadon et al., 
2002, Rauch et al., 2005, Schwab et al., 2005) adds complexity to the situation. This 
raises questions about whether the reported effect of σB in L. monocytogenes 
invasiveness (Kim et al., 2005, Garner et al., 2006) is due to a direct (PrfA-
independent) activation of inlAB expression, or is exerted indirectly via PrfA.  
 
 In this chapter of the thesis we have investigated, using isogenic deletion 
mutants, the relative importance of PrfA and σB in L. monocytogenes invasiveness, 
with the aim of clarifying the predominant regulatory pathway that controls this key 





3.1.2.2.1 Construction and characterization of ∆sigB mutants in L. 
monocytogenes serovar 4b  
 
 We constructed in-frame deletion mutants of the sigB gene in the genetic 
context of our model 4b strain to test the role of the σB stress mediator in L. 
monocytogenes invasiveness. Mutant bacteria were obtained in two prfA 
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backgrounds: the weakly invasive prfAWT (strain P14), and the hyperinvasive 
prfA*G145S (isogenic derivative P14A). The P14ΔsigB and P14AΔsigB mutants were 
produced by a homologous recombination technique as described in detail in 
Materials and Methods.  
 
 In order to characterize the phenotype of the ∆sigB mutants, we streaked 
them on EYA plates with or without 0.5% activated charcoal supplementation. This 
was important for ruling out any defect in PrfA activity, as according to our data, 
PrfA plays a critical role in the invasive phenotype of L. monocytogenes. A strong 
opacity reaction on EYA was observed for P14A∆sigB, identical to that of P14A, 
indicating that both strains have similar PrfA-dependent gene expression. As 
expected, no opacity reaction was observed around the wild-type P14 strain, since in 
this regulation context the PrfA-dependent genes, including the phospholipase gene 
plcB, are weakly expressed in vitro. By contrast, in the presence of activated 
charcoal, which upregulates PrfA (Ermolaeva et al., 2004), an opacity halo 
developed around the wild-type strain P14 and its ∆sigB derivative (figure 3.1.2.2).  
 
 The intensity of the PrfA-dependent plcB reporter activity in the two ∆sigB 
mutants was identical to that of their respective parental strains, indicating that σB 
does not seem to play a role in prfA expression, at least in the experimental 
conditions tested.  
 
 As controls, we carried out similar phenotypic analyses with a previously 
described ∆sigB mutant in the serovar 1/2a context of L. monocytogenes strain EGDe 
(Stritzker et al., 2005). The behaviour of EGDe and EGDe∆sigB was again similar, 
with no differences in the plcB reporter activity in charcoal-supplemented EYA.  
 
 In conclusion, no differences in terms of PrfA activity were observed 
between the serovar 4b and 1/2a strains and their counterpart strains lacking sigB, 


















Figure 3.1.2.2: PrfA phenotype of the ΔsigB mutants.  
Plates were incubated at 37°C for 48 h. (A and C) EYA medium; (B and D) EYA supplemented with 
0.5% activated charcoal. (A and B) ΔsigB in L. monocytogenes serovar 4b. The plates also show the 
spontaneous PrfA− mutant derivative of P14A, prfA*G145S/A129T described in 3.1.1.4.2.4, which arose 
while selecting at 42ºC during ΔsigB mutant construction. (C and D) corresponding plates for ΔsigB 
in L. monocytogenes serovar 1/2a. 
 
 
3.1.2.2.2 Effect of sigB on L. monocytogenes invasiveness 
 
 We next tested the ∆sigB mutants and corresponding parental bacteria in 
infection assays in HeLa cell monolayers, to determine the role of L. monocytogenes 
σB in host cell invasion. Inocula were initially prepared in BHI in standard conditions 
(pH = 7.4).  
 
 L. monocytogenes bacteria carrying a prfA*G145S allele showed a 
hyperinvasive phenotype compared to in vitro-grown wild-type bacteria (∼ 10 times 
increment). Removal of PrfA in this background led to total loss of the ability to 
invade host cells (> 700-fold reduction in invasiveness). These assays, therefore, 
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confirmed previous observations from our laboratory that L. monocytogenes 
invasiveness is strictly dependent on PrfA. 
 
 In the prfAWT background, in which basal PrfA-dependent expression levels 
are very low, the ∆sigB mutation associated with a detectable reduction in L. 
monocytogenes internalization (∼ 6 times). This is consistent with previous 
observations by other groups (Kim et al., 2005, Garner et al., 2006, Gray et al., 
2006), which reported that σB plays a role in L. monocytogenes invasiveness.  
 
 However, we observed no effect of σB in L. monocytogenes with prfA* 
background, which mimics the fully activated state that PrfA adopts in vivo during 
















Figure 3.1.2.3: Effect of σB and acidic growth conditions on L. monocytogenes invasiveness. 
“5.5” next to the name of the strain indicates the inoculum used was grown in acidic conditions (BHI, 
pH = 5.5), otherwise bacteria were grown in BHI with neutral pH (pH = 7.4). MOI used, 20:1. Mean 
of 4 independent duplicate experiments ± SE. Numbers above the bars are the mean percentage of 
bacteria internalized. * denotes statistically significant difference at P ≤ 0.05 in the indicated 
comparisons (red). L. monocytogenes P14 serotype 4b has an intrinsically low invasion capacity 
because its PrfA system is not switched on in extracellular conditions. 
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 In view of the apparent lack of effect of σB in bacteria cultured in standard, 
optimal growth conditions (rich medium at neutral pH), we repeated the experiments 
using bacterial inocula grown at pH = 5.5. This was to imitate the mildly acidic 
environment found by L. monocytogenes in the intestine, where the stress response is 
thought to be relevant for host colonization (Gahan & Hill, 2005, Kazmierczak et al., 
2005, Freitag et al., 2009, Toledo-Arana et al., 2009). No significant difference was 
observed in the internalization of the tested bacteria when grown in acidic conditions 
compared to neutral pH-grown inocula. Moreover, the acidic conditions did not 
affect the internalization rate of L. monocytogenes (figure 3.1.2.3). 
 
 Our results indicate (i) that σB does not seem to play a major role in the 
ability of L. monocytogenes to invade host cells in conditions relevant to infection, 
i.e. when the PrfA system is activated; and (ii) that mild acid conditions do not seem 
to trigger a stress response that activates L. monocytogenes invasiveness.     
 
 
3.1.2.2.3 Effect of σB and PrfA activation status on inlAB 
expression 
 
 Given the above data, we sought to investigate in detail the effect of σB on 
the expression of the inlAB locus encoding the major listerial invasins, InlA and InlB 
(Hamon et al., 2006). Since our invasion data suggested possible differential effects 
of σB on invasion depending on the activation status of PrfA (figure 3.1.2.3), we 
performed the expression analysis with the PrfA system downregulated (prfAWT 
bacteria grown extracellularly in BHI) and activated (prfA*G145S bacteria, and 
intracellular conditions). For the RT-QPCR analyses we used specific probes for inlA 
and inlB as well as actA, which we used as strictly PrfA-dependent gene control.  
 
 The results of the transcription analyses are shown in figure 3.1.2.4. Overall, 
the expression patterns of inlA and inlB were similar to those of the strictly PrfA-
dependent gene actA, except that the absolute transcription levels were about 10 






Figure 3.1.2.4: Transcription analysis of the inlAB locus: PrfA dependence and effect of a ΔsigB 
mutation in L. monocytogenes serovar 4b.  
The transcription profiles were determined by RT-QPCR in wild-type L. monocytogenes (P14), the 
isogenic prfA* strain (P14A), and isogenic sigB deletion mutants of strain P14 (P14∆sigB) and P14A 
(P14A∆sigB). As a control, transcription of the strictly PrfA-dependent actA gene was also 
determined in the same RNA samples. Expression analyses were carried out on bacteria grown until 
OD600 = 1 (mid-exponential phase in the conditions of the experiment, i.e. a BHI culture at 37ºC in a 
100 ml flask with constant shaking at 200 rpm). Mean of at least two independent experiments ± SE. 
Note that inlA/B expression is undetectable for ∆prfA in HeLa  cells. Confirming previous 
observations, there was no significant further activation of inlAB expression in prfA*G145S bacteria in 
intracellular vs extracellular (BHI) conditions. These findings are consistent with previous data 
indicating induction of the inlAB locus in conditions of PrfA activation (prfA* background) (Ripio et 
al., 1997a), and with recent genome-wide transcriptomic studies showing that PrfA stringently 
controls inlA and inlB (Milohanic et al., 2003, Marr et al., 2006) and is induced intracellularly 






 (i) Similar to the control PrfA-regulated gene actA, inlAB expression is 
activated intracellularly (between ∼ 3 and 5 times) and is insignificant in a ΔprfA 
mutant, extra or intracellularly. This is in perfect agreement with the observed loss of 
invasiveness upon removal of the prfA gene (figure 3.1.2.3), indicating that inlAB 
expression is strictly dependent on PrfA. 
 (ii) The ΔsigB mutations had no obvious influence on inlAB expression, 
except for a statistically insignificant decrease of ∼ 3 to 6 times in transcript levels 
(for inlB and inlA, P = 0.28 and 0.13, respectively) in the prfAWT background in in 
vitro conditions (BHI). This effect is consistent with the reported presence of 
putative σB-regulated promoters in front of inlA (P4inlA) (Lingnau et al., 1995) and 
inlB (Kazmierczak et al., 2003) and the observed decrease in invasiveness associated 
with the ∆sigB mutant in the (weakly invasive) prfAWT background (figure 3.1.2.3).  
 (iii) There are no significant differences in inlAB expression associated with 
the presence/absence of σB in PrfA-activating conditions (prfAWT background 
intracellular; prfA*G145S background, extracellular and intracellular).  
 
  We conclude that σB does not play a major role in the control of inlA and 
inlB expression, and that these genes are tightly controlled by PrfA. Like other 
members of the PrfA regulon, inlA and inlB are expressed only weakly in 
extracellular conditions whilst they are strongly induced during intracellular 
infection, to levels similar to those observed in prfA* bacteria. 
 
3.1.2.2.4 Differential role of σB in L. monocytogenes serovars  
 
 Working with serovar 1/2a strains, other groups reported that a σB-mediated 
stress response does play a role in L. monocytogenes invasion. Our data with a 4b 
strain, however, do not support that σB is significantly involved in L. monocytogenes 
invasiveness. The only detectable effect was seen in broth-grown prfAWT bacteria, in 
which the internalization levels are intrinsically low, raising questions about the 
biological significance of the observation. Moreover, this effect was detectable 
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regardless of whether the bacteria were cultured at neutral pH, in which σB is not 
expected to play any significant role, or at an acidic pH, normally associated with the 
activation of a σB stress response in L. monocytogenes (Kazmierczak et al., 2003, 
Wemekamp-Kamphuis et al., 2004, Raengpradub et al., 2008, Abram et al., 2008a) 
(figure 3.1.2.3).  
 
 We, therefore, asked whether our conflicting findings could be explained by 
strain-specific differences in the role and function of σB in L. monocytogenes stress-
related phenotypes. To address this, we compared the response of our serovar 4b 
bacteria and the serovar 1/2a EGDe strain, with and without the sigB gene, upon 
exposure to elevated temperature (42ºC) and oxidative stress. The effect on bacterial 
fitness was determined by monitoring the growth kinetics with an automated plate 
reader. The results are shown in figures 3.1.2.5 and 3.1.2.6.  
 
 Our data show a differential effect associated with the lack of sigB in our 4b 
bacteria and EGDe grown at 42ºC. The elevated temperature had a very clear effect 
on EGDeΔsigB gene at the post-exponential phase, resulting in lower bacterial 
numbers in the stationary phase plateau than with wild-type EGDe. The effect of the 
lack of sigB was also observable at 37ºC, but less pronounced (figure 3.1.2.5A). By 
contrast, the serovar 4b ΔsigB mutant showed no fitness impairment with respect to 
its isogenic sigB-proficient parental strain. The elevated temperature had, in the wild-
type 4b bacteria, a similar effect to that observed with EGDe. Thus, while sigB does 
not seem to play a role in protection against thermal stress in our serovar 4b strain, 
these bacteria seem to possess a mechanism to counteract the effects of high 
temperature.  
 
 Similar results were observed when testing, in the serovar 4b context, the 
effect of σB on thermal stress resistance in the prfA*G145S and ΔprfA backgrounds 
(a ΔsigB was constructed in P14AΔprfA; see table 5.1). Thus, the PrfA activation 








Figure 3.1.2.5: Growth kinetics of 4b and 1/2a mutant strains under thermal stress.  
Bacteria were grown in BHI for 24 h at 37°C and 42°C. Comparisons of σB-proficient and isogenic 
ΔsigB bacteria: (A) EGDe and EGDe∆sigB mutant; (B) P14 and isogenic P14∆sigB mutant; (C) P14A 
and P14A∆sigB mutant; (D) P14A∆prfA and P14A∆prfA∆sigB double mutant. Mean of three 
experiments ± SD. Growth curves of each strain were obtained using an automated plate reader; note 
that the OD values differ from those obtained in standard flask cultures. 
 
 
 The same growth kinetics studies were also carried out under oxidative stress 
conditions (growth in the presence of 15 mM H2O2). A total lack of protective effect 
of σB was also observed here for the serovar 4b bacteria. In the prfAWT background, 
even a marginal improvement in fitness was associated with the ΔsigB mutation. 
This was also observed by other authors with a ∆sigB mutant of a serovar 4c strain 
(L99) (Moorhead & Dykes, 2003). In our study, P14∆sigB mutant (serotype 4b) 
seemed to behave similarly. In the experiments with EGDe, the same protective 
effect of σB was again observed at 37ºC (0 mM H2O2), combined with an extension 




 The above results indicate that there are strain-specific differences regarding 





Figure 3.1.2.6: Growth kinetics of 4b and 1/2a mutant strains under oxidative stress. 
Bacteria were grown in BHI for 24 h in the presence and absence of 15 mM H2O2 and OD600 values 
were taken every 30 min. with an automated plate reader. Similar strain comparisons as in figure 
3.1.2.5. Note that EGDe responds differently to oxidative stress than to thermal stress, with a growth 
delay during the exponential phase. The differences seen in stationary phase are the same seen in 





 Contradicting previous reports by other groups, the data presented in this 
chapter do not support that the stress mediator σB plays a major role in host cell 
invasion by L. monocytogenes. We showed using in-frame deletion mutants that σB 
does not affect internalization when the PrfA system is activated, i.e. in a virulence 
gene regulatory context, in which the key L. monocytogenes invasion factors, InlA 
and InlB, are fully expressed and the bacteria are fully invasive. An effect of σB was 
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only observed when the PrfA system was downregulated, with extracellularly (BHI 
broth) grown bacteria of wild-type prfA genotype. This observation is in line with 
previous findings reported by others (who used L. monocytogenes with wild-type 
prfA genotype) that σB plays a role in L. monocytogenes invasion (Kim et al., 2005, 
Garner et al., 2006). However, in these conditions there is no significant expression 
of the inlAB operon and the bacteria are weakly invasive (figures 3.1.2.1, 3.1.2.3 and 
3.1.2.4). We, therefore, question the biological significance of an effect that is only 
causing a reduction in internalization in an already much reduced invasive 
phenotype, and which corresponds to a PrfA activation status only seen in vitro and 
not in vivo during infection. It has been reported that the P4inlA and P2inlB 
promoters are σB-dependent (Lingnau et al., 1995, Kazmierczak et al., 2003) and this 
may explain the observed effect of the ∆sigB mutation in the absence of PrfA-
mediated activation of inlA/B expression.  
 
 There is evidence suggesting that L. monocytogenes responds differently to 
various stress conditions in a serotype-dependent manner. Some studies found that 
food isolates of serotype 1/2a were less pathogenic and exhibited longer lag phases at 
37ºC in comparison to clinical isolates of serovar 4b after being exposed to cold 
storage/starvation conditions (Avery & Buncic, 1997). Buncic et al. (2001) also 
observed some group differences between 1/2a and 4b strains in their response to 
stress factors associated with foods (such as mild heat treatment and bacteriocins 
from Lactobacillus sake) and in pathogenicity for chick embryos, although the data 
obtained were not entirely consistent. The authors did not investigate, however, the 
differences between the two serovars in respect to mutant strains lacking sigB. Other 
studies showed more specifically that the role of the sigB gene in the general stress 
response of L. monocytogenes differs between phylogenetic lineage II and III strains 
(Moorhead & Dykes, 2003, 2004). Thus, a serotype 1/2a strain, of food origin, was 
found to be more dependent on sigB for survival in stress conditions in comparison 
to a serotype 4c, of clinical origin. Also, in the L. monocytogenes serovar 1/2a strain, 
σB contributed to respond to osmotic stress (3% NaCl), lethal acid concentrations 
(pH = 2.5) and exposure to high temperatures (50ºC), whereas in the serovar 4c 
strain it did not.  
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 Our data indicate that there are strain-dependent differences in the role of σB 
as stress response mediator in L. monocytogenes. In our serovar 4b bacteria, it does 
not seem to be important, whereas in the serovar 1/2a strain EGDe, a clear protective 
effect was observed against two stress-related conditions (growth at elevated 
temperature and exposure to hydrogen peroxide). This was surprising, because it is 
largely assumed that σB plays a major role in maintaining homeostasis during the L. 
monocytogenes stress response (Kazmierczak et al., 2005, Gandhi & Chikindas, 
2007, Freitag et al., 2009). A possible explanation to the apparent lack of phenotype 
(both invasion- or stress tolerance-related) of the ΔsigB mutations in our model 
serovar 4b strain is that the gene could be non-functional due to non-expression or 
the presence of mutations in the coding sequence. Additionally, there could be 
alterations in the promoter sequences recognized by σB in the prfA and/or inlAB loci. 
We did not find any significant changes in the nucleotide sequence of the relevant 
promoters, but found a single amino acid substitution Y→F at position 216 of the 
protein. However, this mutation is conservative and is also present in all serovar 4b 
strains sequenced to date (figure 3.1.2.7), as well as in the phylogenetic division III 
serovar 4c (not shown), so it is unlikely to affect σB functionality. The rsbV and 
rsbW genes from the sigB operon, encoding proteins that regulate σB activity 
(Kazmierczak et al., 2005), were also 100% conserved. Further research is needed to 
understand the reasons behind the apparent lack of functionality of σB in the stress 
response of our 4b strain.  
 
 Our results are in accordance with those of Moorhead and Dykes (2003), who 
also observed a clear involvement of the sigB gene in thermal stress tolerance in a 
serotype 1/2a strain, unlike a serotype 4c strain, in which it had no effect. However, 
other authors reported that heat stress responses were at least partially σB-
independent in serotype 1/2a bacteria (Ferreira et al., 2003), indicating that strain-






Figure 3.1.2.7: CLUSTAL W (1.83) multiple protein sequence alignment of σB from 1/2a (F6854 
through EGDe) and 4b (H7858 through P14) serotype L. monocytogenes. 
All 1/2a serotype strains checked contained tyrosine (Y) and all 4b strains a phenylalanine (F) at 
position 216 (indicated in colour). Genbank accession numbers of SigB sequence of strains F6854, 
10403S, EGDe, H7858 and F2365 are as follows: AADQ00000000.1, AF032445.1, AL591824.1, 
AADR00000000.1 and AE017262.2, respectively, except for P14, which was sequenced in house 
(nucleotide sequence not yet deposited in public database). 
 
 
 Despite the lack of effect of the ∆sigB mutation in the serovar 4b strain, the 
two sigB-proficient 1/2a and 4b bacteria appeared to be equally resistant to the same 
stress conditions. This suggests that L. monocytogenes 4b possesses additional, σB-

































 Others have reported that σB contributes to survival of stationary-phase L. 
monocytogenes 1/2a under oxidizing conditions (strain 10403S; Ferreira et al. 
[2003]). However, with EGDe under oxidative stress, we did not see any specific 
effect in stationary phase, only a significant delay of the ∆sigB mutant during 
exponential growth (figure 3.1.2.6). Thus, there seem also to exist strain-related 
qualitative differences in the σB-mediated response to stress.  
 
 There appear also to be qualitative differences in the protective role of σB 
within a same strain depending on the type of stress. This is shown by our EGDe 
data, in which the ΔsigB-related fitness defects associated with thermal and oxidative 
stress manifest, respectively, during the exponential phase, causing a growth delay, 
and the post-exponential phase, leading to a reduction of the stationary-phase 
bacterial population (figures 3.1.2.5 and 3.1.2.6).  
 
 Due to lack of time we could not prepare all necessary constructs needed to 
conduct comparative experiments in the EGDe context (particularly, prfA*G145S 
genotype bacteria). Therefore, we could not test whether the observed role of σB in 
stress tolerance in EGDe associated with visible effects in invasion. Even if further 
work demonstrated that σB plays a significant role in the stress-induced modulation 
of EGDe invasiveness, we again question the biological significance of an 
observation that would be restricted to only one of the major serotypes involved in 
natural cases of listeriosis. Moreover, 1/2a strains are much less frequently isolated 
than 4b strains from human and animal clinical cases, and are not associated with 
major foodborne listeriosis outbreaks (Buncic et al., 2001, Jeffers et al., 2001, 
Vazquez-Boland et al., 2001a, Gray et al., 2004). 
 
 Although one of the monocistronic prfA gene promoters (P2prfA) has been 
reported to be regulated by σB (Nadon et al., 2002, Rauch et al., 2005, Schwab et al., 
2005), according to our data, σB does not appear to exert a major control on prfA 
gene expression (figure 3.1.2.2). This is consistent with the lack of any significant 
effect of the ΔsigB mutations on the transcription of the strictly PrfA-dependent gene 
actA (figure 3.1.2.4). It would be interesting to conduct additional experiments in 
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PrfA-downregulating and -activating conditions under different environmental 
stresses to determine the real importance of the σB-PrfA crosstalk in the fine 
regulation of L. monocytogenes virulence genes.  
 
 Finally, our data confirmed previous observations from our laboratory that L. 
monocytogenes invasiveness is strictly dependent on PrfA. We showed that PrfA is 
essential for the expression of the L. monocytogenes invasion locus inlAB and the 
ability of L. monocytogenes to invade host cells. Moreover, inlAB expression was 
activated intracellularly and in a prfA*G145S context, in which PrfA is constitutively 
activated. This is consistent with recent genome-wide transcriptomic studies showing 
that inlA and inlB are stringently regulated by PrfA (Milohanic et al., 2003, Marr et 
al., 2006) and selectively induced intracellularly (Chatterjee et al., 2006, Joseph et 
al., 2006).  
 
 Interestingly, in contrast to what is normally seen with other PrfA-regulated 
genes, the intracellular activation of inlAB in the prfAWT background did not reach 
the same high levels seen with prfA*G145S (figure 3.1.2.4). The reason for this is 
unclear and may be related to the multiple promoters controlling inlAB expression 
(Lingnau et al., 1995, Kazmierczak et al., 2003). However, the low transcription 
levels of inlAB compared to actA, and the fact that only a single time point was 
sampled, makes it difficult to judge the biological significance of the differences 
observed. Since the deletion of the sigB gene did not affect the internalization of 
prfA*G145S bacteria, which mimic the virulence gene regulatory context of L. 
monocytogenes during intracellular infection, we can rule out any significant 
intervention of σB during the invasion process in vivo. 
 
 The strict PrfA-dependent invasiveness suggests an infection model in which 
exposure to extracellular defences is minimized by the intracellular induction of 
invasins, facilitating bacterial re-entry into host cells and, eventually, efficient cell-
to-cell spread. This model does not explain how the invasion occurs at the portal of 
entry, as this involves extracellularly grown bacteria that are likely to be weakly 
invasive as a consequence of the low PrfA-dependent expression levels.  
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 It has been proposed that the exposure of L. monocytogenes to the 
gastrointestinal environment may result in the stress-mediated induction of inlAB via 
σB-dependent activation, directly or through σB-regulated expression of the prfA 
gene (Kim et al., 2005, Gray et al., 2006). As above explained, our data do not lend 
support to this hypothesis. A possibility is that the ability to attach to intestinal 
epithelial cells (via non-internalin adhesion proteins) may contribute to some level of 
PrfA activation (Renzoni et al., 1999). Intestinal epithelial cells also tend to be more 
susceptible to InlA/B-mediated invasion, resulting in substantially more elevated 
levels of internalization compared to other cellular lineages (unpublished 
observations from our laboratory). The weak extracellular expression levels of the 
inlAB genes, eventually reinforced by the observed σB-dependent expression 
enhancement in these conditions, may trigger the uptake of sufficient numbers of L. 
monocytogenes bacteria to initiate a productive infection. Other initial mode of entry 
could be through the Peyer’s patches, which have been confirmed to be involved in 
listerial crossing of the intestinal barrier (Jensen et al., 1998). Indeed, it has been 
reported that transcytosis through microfold cells (M cells) does not require the 
presence of PrfA-dependent internalins or haemolysin (Pron et al., 2001, Corr et al., 
2006). Further research is needed to clarify the impact and mechanisms involved in 
the traversal of the epithelial barrier at the portal of entry via the strictly PrfA-




3.2 INVESTIGATION INTO LISTERIA-





 There is increasing evidence that intracellular pathogens systematically 
subvert physiological pathways of the eukaryotic cell to survive and to proliferate 
within host cells. This subversion is quite often achieved via mimicry of host cell 
functions by the microbial virulence factors. Analysis of the Listeria model provides 
clear examples of how microbial adaptation to the intracellular habitat involves 
mimicry of eukaryotic structures and functions. The ActA protein, for example, 
induces actin polymerization by activating the Arp2/3 complex via mimicry of the 
natural function of the Cdc42 downstream effector WASP, to which sections of the 
N-terminal domain of ActA are structurally related (Cossart, 2000a, Zalevsky et al., 
2001, Vazquez-Boland et al., 2001a, Cossart et al., 2003). The Hpt transporter is 
another striking example. Hpt is a bacterial homologue of a key element of glucose 
homeostasis in mammals (Chico-Calero et al., 2002), the G-6-P translocase (G-6-PT) 
that transports G-6-P from the cytosol into the endoplasmic reticulum in the final 
step of gluconeogenesis and glycogenolysis (Nordlie et al., 1999). Via Hpt, Listeria 
adopt the same function as an eukaryotic organelle and eventually compete with it 
for capturing the central metabolite, G-6-P (Chico-Calero et al., 2002).  
 
 In the general introduction we mentioned that L. ivanovii produces a neutral 
sphingomyelinase (nSMase), SmcL that shares sequence similarity with mammalian 
enzymes with the same function (see section 1.3.2). A major research interest in our 
group is to investigate the “mimicry” aspects of listerial intracellular parasitism, and 
our hypothesis is that SmcL may indeed act as a mimic of the mammalian nSMases. 
These enzymes are thought to play a key role in the sphingomyelin-ceramide 
 142 
signalling pathway. Degradation of sphingomyelin by SMases generates ceramide, a 
lipid metabolite increasingly recognized as an important pro-apoptotic mediator 
(Hannun & Luberto, 2000, Birbes et al., 2001, Andrieu-Abadie & Levade, 2002, 
Hannun & Obeid, 2002, Levade et al., 2002, Luberto et al., 2002, Pettus et al., 2002, 
Lin et al., 2006, Carpinteiro et al., 2008). Despite intensive research in the past 15 
years, the exact role of ceramide in apoptosis remains unclear, and aspects such as 
the source sphingomyelin pool attacked by the endogenous SMases, or whether a 
membrane-associated nSMase or a lysosomal acid SMase is primarily involved, 
remains to be established. Consequently, investigating the role of SmcL in ceramide 
generation and apoptosis may not only shed light onto the role of bacterial SMases in 
virulence; it may also provide key novel insight into the role played by ceramide in 
host cell physiology, with particular emphasis on the apoptotic response. 
 
 The work described in this chapter of the thesis is a first step in a broader 
project aimed at understanding the impact of the listerial SmcL enzyme in L. ivanovii 
virulence and pathogenic tropism, and in general on the role of SMases in the 
signalling of apoptosis. The first logical step in this research programme is to study 
in detail the phenomenon of apoptosis caused by L. ivanovii during intracellular 
infection, which we hypothesize may be linked to the intracellular release of the 





3.2.2.1 Optimization of methodologies to monitor 
Listeria-induced apoptosis 
 
3.2.2.1.1 Apoptosis detection by flow cytofluorometry 
 
 According to the literature, Listeria spp. either induce or inhibit apoptosis in 
different cell lines to promote their survival within the host environment (Rogers et 
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al., 1996, Barsig & Kaufmann, 1997, Carrero et al., 2004a, Parra et al., 2008). 
However, the exact mechanisms responsible for these contradictory behaviours 
remain unknown. In order to explore in detail the occurrence of apoptosis during 
Listeria infection, we first focussed on the experimental setup necessary for detection 
of the cell response in our model cell line for L. ivanovii, the bovine kidney epithelial 
cells MDBK. This cell line was chosen because we previously found that detectable 
apoptosis is induced in response to L. ivanovii infection (Dominguez-Bernal et al., 
2006). 
 
 For an objective and precise quantification of apoptotic cells, we used a flow 
cytofluorimetrical technique using infected cell in suspension (see Materials and 
Methods). The use of Annexin V-FITC staining allowed us to detect early apoptotic 
cells due to the ability of Annexin V to bind to phosphatidylserine. This phospholipid 
is translocated to the outer leaflet of the plasma membrane when the cells lose the 
symmetry of their membrane during the early stage of apoptosis (Koopman et al., 
1994, van Engeland et al., 1998, Vermes et al., 2000). This technique made also 
possible to discriminate those cells that were necrotic. This is achieved by using a 
second fluorescent dye, propidium iodide, which binds to double-stranded DNA after 
permeating through damaged cell membranes, indicative of cell death by necrosis 
(Nicoletti et al., 1991, Vitale et al., 1993, Vermes et al., 2000). 
 
 We used MDBK cells grown in 6-well plates for 10 to 12 h until ~ 80% 
confluence. It was necessary to very carefully keep always the same conditions in 
order to obtain reproducible results, and also to ensure that cells were Mycoplasma-
free with regular checks. In each set of experiments, we included non-infected cells 
as a negative control, to quantify the background spontaneous apoptosis during the 
experimental time. As a positive control, we used cell monolayers treated for 3 to 4 h 
with staurosporine (STS), a cell-permeable inhibitor of protein kinases that induces 






 We carried out intracellular proliferation assays using L. ivanovii ATCC 
19119 and the wild-type L. monocytogenes serovar 4b strain P14. To infect the cells 
we used a multiplicity of infection (MOI) of 25:1 for L. ivanovii and 100:1 for L. 
monocytogenes P14.  
 
 After 12 h of intracellular proliferation we observed 14% more apoptosis in 
the cells infected with L. ivanovii compared to those infected with L. monocytogenes 














Figure 3.2.1: Percentage of internalization of L. ivanovii and L. monocytogenes (prfAWT and prfA*G145S 
genotypes) in MDBK cells. 
Mean ± SE of at least two independent experiments performed in duplicate. 
 
 
 We noticed that invasion of MDBK cells was substantially higher for L. 
ivanovii than L. monocytogenes P14 (8.3% vs 0.2%) (figure 3.2.1). We tried to adjust 
the MOI by either increasing it for L. monocytogenes or decreasing it for L. ivanovii. 
However, the changes of MOI did not markedly modify the percentage of invasion 
(data not shown). The two bacteria also exhibited marked differences in PrfA-
dependent expression in vitro. Contrary to L. monocytogenes P14, L. ivanovii 
overexpresses constitutively all the virulence factors of the PrfA regulon (Mauder et 
al., 2006). As the expression level of PrfA-dependent genes directly influences 
 145 
 
invasiveness (section 3.1.2), we decided to carry out additional experiments using 
P14A, the isogenic prfA*G145S derivative of P14 (Ripio et al., 1997a, Vega et al., 
1998). This mutant strain overexpresses in vitro all the PrfA-dependent genes to 
levels similar to L. ivanovii (our unpublished observations). 
 
 We observed that L. monocytogenes prfA*G145S was ~ 17 times more invasive 
than L. monocytogenes prfAWT, reaching levels that were close to those of L. ivanovii 
(figure 3.2.1).  
 
 These data led us to perform new comparative apoptosis experiments 
between L. ivanovii and L. monocytogenes using P14A, readjusting the MOI for the 
latter to 50:1 to achieve, according to the observed internalization, similar initial 
intracellular numbers for both bacteria. In these experiments, we determined 
apoptosis at different time points and, in parallel, we carefully measured the amount 














Figure 3.2.2: Percentage of apoptosis in Listeria-infected cells.  
Data represent values in infected cells after the subtracting the background (spontaneous) apoptosis 
detected in the non-infected control cells. Data for controls: uninfected cells, 4.4 ±0.5; and STS-
treated cells, 35.4 ±2.9. Mean ± SE of two independent experiments.  
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 The percentage of apoptosis in infected cells is shown in figure 3.2.2. After 3 
h of intracellular proliferation, the percentage of apoptosis was alike for both strains 
and similar to the one in untreated cells. At later time points, the level of apoptosis 
increased slightly, reaching the maximum at 12 h. At this time point the data were 
17.1 ±1.2% for L. ivanovii and 8.5 ±1.0% for P14A; this difference was statistically 
significant (P = 0.02). At 20 h post-infection, we observed a similar percentage of 
apoptotic cells to that for P14A at 12 h, and a decrease in the percentage of apoptosis 
in the case of L. ivanovii (figure 3.2.2). There was substantial variability in the 
apoptosis data at this time point, which we attributed to the occurrence of cell 
damage and detachment of the monolayer from the bottom of the well in some of the 
samples.  
 
 The number of intracellular bacteria determined at each time point is 
presented in figure 3.2.3. There were only slight differences between the two strains 
at 3 and 7 h post-infection, but their amounts increased at later time points. At 12 h, 
L. ivanovii proliferated 3.3 times more than L. monocytogenes P14A (7.5 ±0.65 ×107 
and 2.3 ±0.61×107 CFU/well, respectively). At t = 20 h post-infection, however, the 
bacterial population declined in both cases. On microscopic examination of the 
infected cells, this effect coincided with very obvious cell destruction as indicated by 
the appearance of patches of monolayer detachment. Therefore, the observed 
reduction in the intracellular population at this late time-point was probably only 
paradoxical, likely due to the killing of the bacteria from the damaged cells by the 
gentamicin present in the extracellular medium (used to kill extracellular bacteria 
and prevent extracellular growth; see Materials and Methods). 
 
 We repeated the experiments using lower MOIs for L. ivanovii, in order to try 
to obtain similar numbers of intracellular bacteria for both strains during the 
proliferation phase. However, in these conditions we could not observe significant 
levels of apoptosis in the L. ivanovii-infected cells. We also tried to increase the MOI 





Figure 3.2.3: Intracellular proliferation of L. ivanovii and L. monocytogenes P14A in MDBK cells. 
The bacterial numbers were determined in the same samples as those used for apoptosis determination 
(figure 3.2.2). Mean ± SE of two independent experiments.  
 
 
 Thus, according to our results the optimum time to measure apoptosis in 
MDBK cells infected with Listeria spp. was around 12 h post-infection using MOIs 
ranging from 25:1 and 50:1 for L. ivanovii and L. monocytogenes P14A, respectively. 
At this time point, we observed the highest levels of apoptosis and maximum number 
of intracellular bacteria. 
 
 
3.2.2.1.2 Normalization of apoptosis determinations 
 
 The above observations suggested that L. ivanovii was more apoptogenic than 
L. monocytogenes. However, if the bacteria are responsible for the increased 
apoptosis detected in an infected monolayer (over background levels), the values 
observed would be dependent on the number of intracellular bacteria present in the 
well. In cell-based infection assays it is difficult and impractical to try to adjust the 
conditions so that the exact number of the two bacteria that are being compared is 
always obtained at a given time point. One way of resolving this problem is to try to 
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normalize the apoptosis values by the total number of bacteria in the monolayer. We 








n   
 
where NA is the normalized apoptosis, a is the percentage of infection-associated 
apoptotic cells (percentage of apoptotic cells in the sample minus the percentage of 
spontaneous apoptotic cells in the uninfected control), b is the total number of 
intracellular bacteria in the well, and n is a correction factor (common decimal 
exponent of the number of bacteria being compared).  
 
 When applying the NA formula to the values obtained in the above described 
experiments, the conclusion was that, despite the percentage of apoptosis being 
greater in L. ivanovii-infected monolayers, L. monocytogenes P14A bacteria would 
in fact be paradoxically more apoptogenic (37.04 ±2.8 and 22.8 ±1.2, respectively; P 
= 0.001) (figure 3.2.4). 
 
 However, the above calculations do not take into account another key factor 
with a direct influence on the outcome variable. Assuming there is a direct 
correlation between the presence of bacteria in the cell and the occurrence of 
apoptosis, it is obvious that the larger the percentage of infected cells in the 
monolayer, the greater the percentage of apoptosis is expected to be detected. Since 
the bacteria under comparison may differ in their capacity to invade and/or spread in 
the monolayer, it became apparent that it was also necessary to incorporate in the 
data normalization the number of infected cells. In summary, the number (or 
percentage) of apoptotic cells observed at a given time point t depends on how many 




















Figure 3.2.4: Normalized apoptosis in MDBK cells infected with L. monocytogenes P14A and L. 
ivanovii at t = 12 h post-infection.  
Values were calculated with the formula NA = a / b × 10n from data shown in figures 3.2.2 and 3.2.3 
as indicated in the text. Mean ± SE of two independent experiments. 
 
 
 With the help of Dr. Nick Savill, an expert in mathematical modelling from 
the Centre for Infectious Diseases of the University of Edinburgh, an Apoptosis 















where a is the net percentage of apoptotic cells (after subtraction of spontaneous 
apoptosis), b is the total number of intracellular bacteria, c is the percentage of 
infected cells, t is the time point, and β is a variable that determines how the number 
of bacteria in an infected cell (B) affects the apoptosis rate (a detailed description of 
the mathematical basis used in the derivation of the AI formula can be found in 




3.2.2.1.3 Setting up and validation of microscopic apoptosis 
determination  
 
 To apply the above formula, we needed to determine accurately the 
percentage of infected cells. This had ideally to be in the very same cell monolayer in 
which we were determining apoptosis. To achieve this, we needed to use a 
microscopic technique, with visualization of intracellular bacteria by phase contrast 
and fluorescence microscopy for apoptosis. For the latter, we needed first to ensure 
that the apoptosis quantitative readouts were comparable to those obtained by the 





Figure 3.2.5: MDBK cells infected with L. ivanovii ATCC 19119 and stained with Hoechst 33258. 
Left top panel, phase contrast; right top panel, blue fluorescence with DAPI filter; right bottom panel, 
merge; left bottom panel, digital magnification of bright blue colour denoting chromatin condensation 
indicates apoptotic cells. Note the abundance of intracellular bacteria in the L. ivanovii-infected cells, 





 For the microscopic determinations, we used MDBK cell monolayers grown 
in glass-coverslips (see Materials and Methods). We compared two fluorescent 
stains, Annexin V-FITC used in the flow cytometry-based determinations, and a 
Hoechst dye, reported to provide a more simple and accurate method for visual 
apoptosis detection (Weiss & Zychlinsky, 2002). Hoechst dyes are cell permeable 
nuclear stains that emit blue fluorescence when bound to double-stranded DNA. 
They allow striking visualization of chromatin condensation, a hallmark in apoptotic 
cells (Vermes et al., 2000, Chowdhury et al., 2006). 
 
Figure 3.2.5 shows MDBK cells infected with L. ivanovii ATCC 19119 and 
stained with Hoechst 33258, in which characteristic changes in chromatin are 
evident.  
 
 To compare the flow cytofluorometrical and visual detection of apoptosis 
using the above mentioned stains, we performed in parallel both techniques, 
incorporating cells treated/untreated with STS as controls. MDBK cells treated with 
STS showed 23.84% of apoptotic cells with flow cytofluorometry, and 28.04% and 
27.31% of apoptotic cells in case of fluorescent microscopy when stained with 
Annexin V-FITC and Hoechst, respectively. The percentages of apoptosis in 
untreated cells were 7.23%, 2.44% and 7.77%, respectively (figures 3.2.6 and 3.2.7).  
 
We concluded that the flow cytometrical and microscopic techniques gave 
essentially equivalent results. For the latter, we decided to use the Hoechst 
fluorophore because this reagent is less expensive than Annexin V-FITC and 
additionally it gives less background noise to the stained cell images. Moreover, the 












Figure 3.2.6: MDBK cells treated with STS and labelled with Annexin V-FITC (left panels) and 
Hoechst 33258 (right panels).  
Same fields are shown for comparison. White arrows indicate some representative strongly positive 
cells. Note the surface decoration of Annexin V-FITC-positive cells, based on detection of surface 
translocation of phosphatidylserine. There was generally good correlation between Annexin V-FITC-
positive signal and the presence of pyknotic, fragmented nuclei as observed with Hoechst 33258. 
Some Annexin V-FITC-positive cells did not show as apoptotic with the DNA stain, possibly because 
they were early apoptotic cells (the membrane translocation of phosphatidylserine is an early event 
during apoptosis that precedes nuclear condensation and fragmentation). However, overall, the two 




















Figure 3.2.7: Apoptotic cells detected using flow cytofluorometry (FC) or fluorescent microscopy 
(FM) at 4 h after exposure to the pro-apoptotic drug, staurosporine (STS).  
White bars represent percentage of apoptotic MDBK cells in samples treated with STS, black bars 
correspond to untreated control samples (CC). Mean ± SE of at least two independent experiments.  
 
 
3.2.2.2 Comparative analysis of L. ivanovii and L. 
monocytogenes using the microscopic technique and 
Apoptosis Index (AI) 
 
 Once we set up the microscopical technique, we carried out infection assays 
with L. ivanovii and L. monocytogenes P14A in MDBK monolayers on coverslips 
and monitored for the presence of infected and apoptotic cells at t = 14 h. The fixed 
coverslips were stained with Hoechst 33258 and the number of infected and 
apoptotic cells was determined upon examination of a minimum population of 500 
randomly selected cells, from random microscopical fields and at least two 
experiments. The results are shown in table 3.3 together with the corresponding AI 
calculations.  
 
 If we assume that there is a linear correlation between the number of bacteria 
and the apoptosis rate (β = 1), in the AI formula btβ becomes bt1 and ct1-β becomes ct0 
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 % apoptosis CFU x 106 % infected cells 
L. ivanovii 18.21 ±1.65 9.13 ±1.83 98.40 ±1.61 
P14A   8.46 ±1.58 4.60 ±1.01 94.48 ±4.98 
!actA    2.99 ±0.10 1.56 ±1.19 51.77 ±14.98 
 
 AI =0 AI =1 
L. ivanovii 0.013 ±0.001 0.142 ±0.013 
P14A 0.006 ±0.001 0.154 ±0.039 
∆actA  0.004 ±0.001 0.340 ±0.264 
= 1, meaning that the apoptosis rate depends only on the number of bacteria. In this 
case, L. ivanovii and L. monocytogenes P14A would not significantly differ in 
apoptogenic activity (P = 0.78) (table 3.3B). 
 
 
Table 3.3: Relevant data from Listeria-infected MDBK cells.  
MOIs used: L. ivanovii 20:1, L. monocytogenes P14A 50:1, P14AΔactA 75:1. Time point t = 14 h.  
(A) Mean percentage of apoptosis and corresponding intracellular bacterial numbers per well and 
percentage of infected cells.  
(B) Mean apoptosis index. This index was calculated independently for each experiment replicate. β is 
the variable that determines how the rate of apoptosis depends on the number of bacteria in an 
infected cell B. This parameter is not known and there are several possible scenarios, for example that 
the apoptosis rate (Bβ) is independent on the number of bacteria, is linearly, quadratically, 
exponentially correlated, or even show a threshold, etc. For AI calculations, in this study we made the 
simpler assumptions that β was either independent (β = 0) or linearly correlated (β = 1) with bacterial 













 However, if we assume that the apoptosis rate is independent from the 
number of intracellular bacteria (β = 0), then in the AI formula btβ becomes bt0 = 1 
and ct1-β becomes ct1, i.e. the apoptosis rate only depends on the percentage of 
infected cells. Here, L. ivanovii would be significantly more apoptogenic than L. 
monocytogenes P14A (P = 0.008) (table 3.3B).  
 
 Therefore, we clearly see that it is not really possible to estimate the relative 
apoptogenic potential of two different bacteria unless we know how the apoptosis 
rate of infected cells depends on the number of bacteria within these cells.  
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3.2.2.2.1 Relationship between apoptosis and presence of bacteria 
in MDBK cells 
 
 In order to approximate the above question, we applied the microscopic 
technique to investigate the relationship between the presence of bacteria and 
apoptosis in the MDBK monolayers infected with L. ivanovii and L. monocytogenes 
P14A. Two different time points were analyzed to monitor changes during the 
infection dynamics, early after inoculation (t = 4 h), and after the infection was well 
established in the monolayer (t = 14 h). To determine the percentage of infected 
cells, we inspected random microscopical fields under phase contrast and observed a 
minimum of 200 eukaryotic cells, again randomly. To provide a quantitative 
measure, these cells were classified in five different categories according to the 
number of associated bacteria: "0", "1-15", "16-30", "31-50" and " ≥ 51". 
 
 At t = 4 h, the percentage of infected cells was 62.7% for L. monocytogenes 
P14A and 95.2% for L. ivanovii, whereas at t = 14 h these percentages equalized 
(92.6% and 98.3%, respectively). Consistent with our previous observations at 
monolayer population level, the number of bacteria per infected cell was higher for 
L. ivanovii compared to L. monocytogenes P14A at both time points. At 4 h post-
infection, most of the cells (50.5%) infected with P14A contained less than 16 
bacteria, whereas most L. ivanovii-infected cells (52.2%) contained more than 16 
bacteria and a significant percentage (30.4%) harboured  between 16 and 30 bacteria. 
At 14 h, nearly half (46.6%) of L. ivanovii-infected cells were packed with bacteria 
(≥ 51 per cell), whereas only a few (7.8%) of P14A-infected cells contained more 
than 30 bacteria, and no cells contained ≥ 51 bacteria (figure 3.2.8). Thus, the 
bacterial load increased for both strains during the course of the infection, but the 
extent to which this happened was greater with L. ivanovii than L. monocytogenes 
P14A. 
 
 We next investigated the correlation between the presence of bacteria and the 
occurrence of apoptosis. To approach this, we compared the numbers of bacteria in 



















Figure 3.2.8: Percentage of infected cells and corresponding load of L. ivanovii and L. monocytogenes 
P14A bacteria per cell at 4 and 14 h of intracellular infection.  
Mean ± SE of at least two independent experiments. 
 
 
 At 4 h post-infection, 42.7% of the apoptotic cells in the L. ivanovii-infected 
monolayer contained over 30 bacteria, whereas most apoptotic cells in the L. 
monocytogenes P14A-infected wells contained only few bacteria (≤ 15, 54.3%) or 
were not infected at all (35.3%). However, whilst at this time-point a significant 
number of positive cells (n = 150) could be identified in the L. ivanovii-infected 
monolayers, too few apoptotic cells were found with P14A (only 14), so the 
percentages with the latter should be interpreted with caution. Many of these few 
apoptotic cells, thus, clearly belonged to the spontaneously occurring population. At t 
= 14 h, the apoptotic cells were clearly more abundant and all were associated with 
intracellular bacteria. Most of the L. ivanovii-infected cells (64.2%) were packed 
with bacteria (≥ 51 per cell), whereas only 10.9% of P14A-infected cells contained 
more than 30 bacteria per cell; cells with ≥ 51 bacteria were not found with L. 
















Figure 3.2.9: Distribution in percentage of the intracellular loads of L. ivanovii and L. monocytogenes 
P14A bacteria in apoptotic (Hoechst 33258-positive) cells at 4 and 14 h post-infection. 
Mean ± SE of at least two independent experiments. 
 
 
 By contrast, in the non-apoptotic cells the number of bacteria found was 
generally lower at both time points for the two strains. In L. ivanovii-infected cells, 
for example, 1.8% and 35.1% contained ≥ 51 bacteria at t = 4 h and 14 h among the 
non-apoptotic population, whereas the corresponding percentages were 23.1 and 64.2 
among the apoptotic cells. In addition, a number of non-apoptotic cells were 
bacteria-free (21.9 and 55.1% at t = 4 and 3.4 and 5.1% at t = 14 for L. ivanovii and 
P14A, respectively), whereas virtually all apoptotic cells contained bacteria (figures 




















Figure 3.2.10: Distribution in percentage of the intracellular loads of L. ivanovii and L. 
monocytogenes P14A bacteria in non-apoptotic (Hoechst 33258 - negative) cells at 4 and 14 h 
post-infection. 
Mean ± SE of at least two independent experiments. 
 
 
 Thus, (i) when an infection is established in the monolayer and there has been 
substantial bacterial proliferation, apoptotic cells are always associated with bacteria. 
This indicates that the apoptotic response is linked to listerial intracellular infection. 
In addition, (ii) a significant number of infected cells do not undergo apoptosis, 
although the number of bacteria within them tends to be lower than in apoptotic 
cells. This may indicate that the host cells belong to different subpopulations 
differing in their susceptibility to Listeria-induced apoptosis. It may also reflect that 
a minimum exposure time above a certain bacterial threshold could be also required 
to trigger host cell apoptosis.  
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 In practical terms regarding our AI equation, our data exclude that there is a 
strict linear correlation between the number of bacteria in the monolayer and the 
percentage of apoptosis detected. Without further work clarifying the nature of the 
relationship between the presence of bacteria and the dynamics of appearance of the 
apoptotic response, we have, thus, to assume that β = 0, i.e. the apoptosis rate is not 
dependent on the total number of intracellular bacteria in the well but rather on the 
percentage of infected cells.  
 
 In these conditions, according to the data in table 3.3B, L. ivanovii would be 
at least twice as much apoptogenic as L. monocytogenes P14A. 
 
 
3.2.2.2.2 Cell-to-cell spread and apoptosis 
 
 An element related to Listeria infection dynamics with a possible impact on 
apoptosis is the cell-to-cell spread phenomenon. Cell-to-cell spread may influence 
the apoptotic response by promoting the colonization of the cell monolayer as the 
infection progresses, leading to higher numbers of infected cells that may potentially 
undergo apoptosis. Also, if after internalization the bacteria do not move to 
neighbouring cells via actin-based motility, as in a ΔactA mutant, they accumulate in 
the infected cell as they replicate, forming compact micro-colonies near the nucleus 
(Domann et al., 1992, Kocks et al., 1992). This overcrowding and ensuing 
intracellular accumulation of secreted toxic PrfA-regulated virulence factors, such as 
the pro-apoptotic LLO toxin (Carrero et al., 2008), may cause premature host cell 
death. The importance of bacterial overcrowding of the cytosol as an apoptosis 
trigger is suggested by our data, in which there seems to be an association between 
the more elevated percentage of apoptotic cells in L. ivanovii vs L. monocytogenes 
P14A and the greater numbers of bacteria found in the cells infected with the former 
species. In this scenario, the spreading of bacteria to adjacent cells after 
multiplication in the cytosol may be important to reduce the bacterial burden in the 
infected cell, favouring its survival, at least at short term. Incidentally, we observed 
that L. ivanovii spreads ~ 40% less efficiently than L. monocytogenes P14A in a 
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plaque assay (figures: 3.2.11 and 3.2.12), and this may contribute to explain the 
higher apoptosis levels seen in the cells infected with these bacteria. The reason for 
this cell-to-cell spread defect is unknown, although it may be related to the 
particularly divergent sequence of the ActA protein of L. ivanovii (the most 
dissimilar among all the listerial PrfA-regulated factors).  
 
 To examine the impact of cell-to-cell spread in apoptosis, we used the ΔactA 
mutant derivative of P14A (section 3.1.1.3) and compared its apoptogenic activity to 
that of its intercellular motility-proficient parent strain. Before carrying out the 
apoptosis assays, as ActA was previously shown to contribute to L. monocytogenes 
internalization (Suarez et al., 2001), we carefully determined the invasiveness of the 














Figure 3.2.11: Plaque assay of L. ivanovii ATCC 19119, L. monocytogenes P14A and isogenic ∆actA 
derivative of P14A.  
Infected monolayers were incubated at 37ºC for 72 h. Note the smaller size of the plaques formed by 



















Figure 3.2.12: Quantification of cell-to-cell spread of L. ivanovii and L. monocytogenes P14A in L929 
cells. 
The diameter of the plaques shown in figure 3.2.11 was measured as in figure 3.1.20 but the data are 
presented in relative values (% of P14A). Mean ± SE of three experiments.  
 
 
 The actA gene deletion associated with a significant reduction in 
internalization into MDBK cells, from ~ 4% for P14A to 0.67%. We also found that 
the ∆actA mutant proliferated less efficiently than its parent strain (figure 3.2.13). 
Therefore, to obtain similar intracellular population numbers at the time point chosen 
for apoptosis determination, t = 14 h, we had to use a larger MOI for the ΔactA 
mutant (75:1 vs 50:1 for P14A). 
 
 The apoptosis experiments for the ΔactA mutant were carried out 
concomitantly with those for P14A and L. ivanovii, as described in section 3.2.2.2. 
The corresponding data are shown in table 3.3.  
 
 After 14 h of infection, the percentage of apoptotic cells in the monolayer 
was significantly lower for the ΔactA mutant than for P14A (2.99 ±0.1% and 8.5 
±1.6%, respectively, P = 0.03). The intracellular numbers and percentage of infected 







Figure 3.2.13: Intracellular proliferation of L. monocytogenes P14A and its isogenic ∆actA derivative 
in MDBK cells. 
On the right panel the intracellular proliferation data were normalized to the initial bacteria counts at t 
= 0 using an intracellular growth coefficient (IGC = [bt = n – bt = 0] / bt = 0, where bt = n and bt = 0 are the 
intracellular bacterial numbers at a specific time point, t = n, and t = 0, respectively). Positive IGC 
indicates proliferation, negative values reflect decrease in the intracellular bacterial population. Mean 
± SE of at least two independent experiments. 
 
 
 When these data were applied to the AI formula, considering β = 0 (apoptosis 
rate assumed to be independent from the number of intracellular bacteria), no 
significantly different index values were obtained (0.004 ±0.001 and 0.006 ±0.001 
for ΔactA and P14A, respectively; P = 0.39). The same conclusion was reached if 
taking β = 1 (apoptosis assumed to increase linearly with the number of bacteria; AI 
= 0.34 ±0.26 and 0.15 ±0.04, respectively, P = 0.34).  
 
 We also investigated the distribution of the ΔactA bacteria in infected cells, 
apoptotic cells and non-apoptotic cells. The data are shown in figures 3.2.14, 3.2.15, 
and 3.1.16. Whilst there were less infected cells in the monolayers, these contained 
more ΔactA bacteria. In addition, all apoptotic cells contained bacteria and were very 
heavily infected in comparison to apoptotic cells in the P14A-infected monolayers, 
whereas most non-apoptotic cells did not contain bacteria (~ 57.0%) or contained 
only a few bacteria (≤ 15, ~ 28.1%).  
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 Thus, despite the significant differences in the numbers of intracellular 
bacteria in the infected cells, there seems not to be intrinsic differences in 
apoptogenic activity between L. monocytogenes P14A and its cell-to-cell spread-
deficient ΔactA derivative. We also conclude that the presence of L. monocytogenes 












Figure 3.2.14: Distribution in percentage of L. monocytogenes P14AΔactA bacteria and those of its 
parent strain in infected MDBK cells.  













Figure 3.2.15: Distribution in percentage of L. monocytogenes P14AΔactA bacteria and those of its 
parent strain in apoptotic (Hoechst 33258-positive) cells at 14 h post-infection.  














Figure 3.2.16: Distribution in percentage of L. monocytogenes P14AΔactA bacteria and those of its 
parent strain in non-apoptotic (Hoechst 33258-negative) cells at 14 h post-infection.  




3.2.2.3 Investigating the role of L. ivanovii SMase 
(SmcL) in apoptosis – stable heterologous expression 
of smcL in ∆plcAB L. monocytogenes 
 
 In previous studies carried out in our laboratory, it was demonstrated that an 
smcL mutation in L. ivanovii has effects comparable to those reported for plcA and 
plcB mutations (Marquis et al., 1995, Smith et al., 1995). The smcL knock-out 
mutant showed moderate attenuation of virulence in mice and intracellular growth 
capacity in epithelial cells (e.g. MDBK cell line). Heterologous expression of the 
smcL gene in a L. monocytogenes background lacking all known phagosome-
disrupting virulence factors, such as Hly, PlcA and PlcB, although with limited 
efficiency, enabled the release of the mutant bacteria to the cytosol and their 
intracellular proliferation. It was concluded that SmcL plays a role in virulence 
similar to that of PlcA and PlcB, as an accessory membrane-damaging factor acting 
alongside LLO and the other two phospholipases to faciliate bacterial escape from 
the phagocytic vacuole (Gonzalez-Zorn et al., 1999). 
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 The presence in L. ivanovii of an additional membrane-disrupting 
phospholipase, with redundant functions to PlcA and PlcB and partially overlapping 
substrate range with the PlcB enzyme, is intriguing.  Since SmcL is encoded in the 
species-specific LIPI-2 pathogenicity island, we hypothesized that this SMase could 
play a role in the specific pathogenic properties of L. ivanovii (Dominguez-Bernal et 
al., 2006) (see Introduction section 1.1.2). 
 
 Initial attempts were made in our laboratory to try to establish whether SmcL, 
in addition to its “mechanic” role in phagosome membrane disruption, could also 
modulate host cell responses via ceramide, the degradation product of sphingomyelin 
by a SMase. Preliminary experiments showed that infection of MDBK cells by L. 
ivanovii is accompanied by a strong ceramide generation response (6-fold relative to 
non-infected cells). The ceramide levels were very significantly reduced in cells 
infected with an isogenic smcL mutant (unpublished data). Using the same smcL 
bacteria, it was shown that the lack of SMase activity associates with significantly 
reduced apoptosis in MDBK cells (Dominguez-Bernal et al., 2006), suggesting a 
connection between ceramide generation and cell death in L. ivanovii-infected cells.  
 
 It is known that ceramide can be generated also by the broad-substrate range 
phospholipase C, PlcB, which is active against many phospholipids, including 
sphingomyelin (Geoffroy et al., 1991, Goldfine et al., 1993). PlcB generates in 
addition diacylglycerol (DAG), a lipid second messenger that acts as a signalling 
molecule by binding directly to many different proteins. Depending on the target, 
DAG-induced cellular responses can be proliferative or apoptotic (Griner & 
Kazanietz, 2007). Moreover, the phosphatidyl-specific PlcA phospholipase can 
generate signalling phosphoinositides with important regulatory roles in eukaryotic 
cells. Therefore, to investigate the impact of SmcL in ceramide generation, 
apoptosis, and eventually other cell responses, it is essential to isolate its effects from 




 To achieve this, the smcL gene was expressed in a deletion mutant of L. 
monocytogenes EGD lacking the plcA and plcB genes. This mutant did express 
normally Hly, necessary for phagosomal escape (and ceramide generation by the 
SmcL nSMase; unpublished data). The heterologous expression in a different host 
bacterium had the additional advantage that the smcL gene was expressed outside L. 
ivanovii, thus, isolating SmcL from other bacterial products potentially involved in 
the apoptotic response caused by this species.  
 
 Previous attempts in our laboratory to express smcL in the EGDΔplcAB 
mutant used the bifunctional Bacillus - E. coli shuttle vector pHPS9, that replicates 
in L. monocytogenes and, which we routinely use for trans-complementation 
experiments. We tested the pHPS9smcL-complemented ΔplcAB mutant in infection 
assays in MDBK cells but found that the vector carrying the smcL gene was lost at a 
high frequency (80 to 90% of plated colonies after 12 h of intracellular infection).  
 
 To overcome this problem, we used the pPL2 vector (Lauer et al., 2002) to 
stably express smcL in L. monocytogenes bacteria. This vector integrates in single 
copy into the host chromosome and was successfully used for expressing our prfA 
mutant alleles in the work described in section 3.1.1.3. As a control, we constructed a 
mock-complemented ΔplcAB strain with the empty pPL2 vector integrated in the 
chromosome (figure 3.2.17). 
 
 We previously showed that in vitro-grown L. monocytogenes bacteria with 
prfAWT genotype, like EGD, are very weakly invasive due to down-regulation of the 
PrfA regulon (see section 3.1.2). In addition, we also earlier demonstrated that L. 
monocytogenes internalizes into MDBK cells much less efficiently than L. ivanovii 
(see figure 3.2.1 and Guillet et al., 2010). Indeed, both the smcL and mock-vector 
EGD integrants showed very low invasivity in MDBK cells: 0.009% ±0.004 and 














Figure 3.2.17: Stable expression of the L. ivanovii SMase gene smcL in single copy from the 
chromosome of a L. monocytogenes ΔplcAB mutant.  
Blood agar plate in which the activity of the smcL product is detected through a CAMP-like 
(synergistic haemolytic reaction) with the R. equi cholesterol oxidase (Gonzalez-Zorn et al., 1999, 
Navas et al., 2001).  
 
 As a consequence, it was not possible to determine apoptosis, even using 
flow cytofluorometry, because there were too few bacteria inside the host cells to 
observe any detectable cell death response (only 104 CFU / well after 66 h post-
infection). According to our data, to obtain workable levels of apoptosis with 
Listeria-infected cells it is necessary to reach an intracellular bacterial population in 
the monolayer between 106 and 107 CFU / well at 12-14 h post-infection (see figures 
3.2.3 and 3.2.13). 
 
 To try to increase the invasion rate of the EGDΔplcAB bacteria, we cultured 
them in BHI supplemented with 1% AmberliteTM XAD-4 at 37ºC to activate the PrfA 
system (section 3.1.1.2) and the PrfA-regulated inlAB invasion locus (section 
3.1.2.2.2). However, for an unknown reason, this approach did not result in any 
substantial increase in internalization. Prolonging the incubation time (from 40 min. 
to up to 2 h) after infection also did not result in significantly greater internalization. 
Due to these difficulties and time limitation for the completion of the PhD thesis 
work, it was not possible to try other possible strategies to increase the invasiveness 
of the strains. We plan, for example, to try in a first instance replacing the prfAWT 
allele in EGD∆plcAB(pPL2smcL) for the constitutively hyperactive prfA*G145S allele 
to ensure that a sustained high PrfA input drives the full activation of inlAB 
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expression. Alternatively, we may move to a macrophage infection model in which 
internalization is inlAB-independent and is significant (∼ 5 - 10%), but we would 
need to explore first whether apoptosis is relevant to Listeria-infected macrophages. 
This work will be undertaken as part of the SmcL-ceramide-apoptosis research 





 In this final chapter of the thesis we describe our initial approaches to the 
study of the apoptotic response caused in host cell by Listeria bacteria. This 
investigation was prompted by the observation that L. ivanovii causes significant 
levels of apoptosis in MDBK epithelial cells, in contrast to L. monocytogenes, which 
does not (Dominguez-Bernal et al., 2006; other unpublished observations from our 
laboratory). The information available about the apoptogenic activity of pathogenic 
Listeria is conflicting, so further research is clearly needed to clarify the role of this 
host cell response in listerial pathogenesis.  
 
 When researching the scientific literature about bacterial infections and 
apoptosis, we were surprised to see that on most occasions researchers just report 
crude percentage of apoptotic cells. When comparing two strains potentially 
differing in apoptotic activity, e.g. a mutant and its wild-type, usually the only 
normalization applied was based on the use of "similar" numbers of input bacteria in 
the system, with no consideration to possible differences in invasion, proliferation, 
survival, or even the actual numbers present at the time point where apoptosis is 
determined (Ojcius et al., 1998, Menzies & Kourteva, 2000, Abul-Milh et al., 2001, 
Bantel et al., 2001, Esen et al., 2001, Mannering et al., 2002, Popov et al., 2002a, 
Haslinger et al., 2003, Schmeck et al., 2004, Carrero et al., 2004b, Jain et al., 2007, 
Cervantes et al., 2008, Parra et al., 2008, Tattoli et al., 2008). Since the apoptosis 
output clearly depends on the aforementioned parameters, and the investigated 
mutations may affect these primarily, we think that most scientific literature on the 
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role of specific bacterial factors in apoptosis is marred by serious experimental flaws 
and should be interpreted with caution.  
 
 We, therefore, decided, as a first step in our work on Listeria and apoptosis, 
to very carefully establish the experimental conditions to monitor and accurately 
measure apoptosis in cells infected by an intracellularly proliferating pathogen. With 
the aid of a mathematician, we developed an apoptosis index AI that incorporates two 
key variables with a clear potential impact on the apoptosis output, i.e. the total 
number of bacteria present in the monolayer and the percentage of infected cells.  
 
 A limitation to the application of the AI is that it is not really possible to 
estimate the relative apoptogenic potential of two species unless we know how the 
apoptosis rate of infected cells depends on the number of bacteria in the cells. This is 
referred to as β, a variable that describes how the number of bacteria affects the 
apoptosis rate and which has a profound impact on the AI value (see equation on p. 
145). β can be = 0 (apoptosis rate assumed to be independent from the number of 
intracellular bacteria), = 1 (apoptosis increases linearly with the number of bacteria), 
= 2 (apoptosis increases quadratically), etc. To decide what assumption is closer to 
the real situation, we carried out experiments in which we semi-quantitatively 
assessed the number of bacteria present in apoptotic and non-apoptotic cells. We 
observed that while apoptotic cells were always associated with bacteria, a 
significant number of non-apoptotic cells were also infected, albeit with lower 
bacterial numbers. From our data we concluded that, whilst bacteria need to be 
present for apoptosis, a strict correlation does not exist between the total number of 
bacteria in the monolayer and the percentage of apoptosis. In other words, most 
likely β = 0 and, therefore, the AI depends mainly on the percentage of infected cells. 
 
 Another conclusion is that since β (how the rate of apoptosis Bβ depends on 
the number of bacteria B; see p. 145 and Appendix II) has a strong influence on the 
AI calculations (see table 3.3), it is, therefore, also important to try to estimate the 
rate of change of the percentage of apoptotic cells. This can only be achieved with at 
least two measurements of the net (above background) percentage of apoptotic cells 
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a. Therefore, a more accurate method for determining the AI would be to incorporate 























 Our data indicate that at early time points, like t = 4, the percentage of net 
apoptotic cells does not differ significantly from background values due to the 
presence of insufficient no. of bacteria in the monolayer. Based on our experience, 
the ideal dual time points for AI calculation would be between 10 and 12 h for t1 and 
18 to 20 h for t2. Future work will address this question and will establish the optimal 
working protocol for accurately determining the apoptosis potential of pathogenic 
Listeria using the two-time point AI equation. 
 
 When applying the AI equation with β = 0 to our data, it appears that L. 
ivanovii would be at least twice more apoptogenic than L. monocytogenes. A 
possible reason is that L. ivanovii-infected cells contain significantly more bacteria 
than those infected by L. monocytogenes. Thus, the presence of excess pathogenic 
Listeria (and corresponding secreted products) in the host cell cytosol seems to 
promote programmed cell death. This could be linked to the reduced cell-to-cell 
spread capacity observed for L. ivanovii (60% that of L. monocytogenes; figure 
3.2.12), which may lead to overcrowding of the cytosol due to the incapacity of the 
bacteria to move to neighbouring cells after replication.  
 
 We tested whether host cell bacterial overcrowding determines an increase in 
the apoptosis rate by carrying out infection experiments with a ΔactA mutant and its 
parent L. monocytogenes strain. Bacteria lacking ActA do not spread to neighbouring 
cells and accumulate in the initially invaded cell, forming large perinuclear 
microcolonies after multiplication in the cytosol (Domann et al., 1992, Kocks et al., 
1992). Indeed, our data confirmed that the cells infected with ΔactA tend to contain 
more bacteria (figure 3.2.14). Apoptotic cells in the ΔactA-infected monolayers also 
contained significantly more bacteria than the apoptotic cells infected with the cell-
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to-cell-proficient bacteria. However, according to the AI calculations, the ΔactA 
mutant did not differ from the parent strain in apoptogenic activity. Thus, 
overcrowding in itself does not seem to explain the greater apoptogenic activity of L. 
ivanovii compared to L. monocytogenes, implying that other species-specific 
differences or factors are possibly involved.  
 
 The methods and approaches developed in this chapter should be helpful in 
determining whether such pro-apoptotic factors indeed do exist in L. ivanovii, and in 
examining the possible role of SmcL in ceramide signalling and apoptosis in L. 








































The experimental work described in this thesis has led to the following conclusions:  
 
(i) We developed a robust methodology to measure PrfA-dependent gene expression 
by RT-QPCR that provides accurate and reproducible transcription data in L. 
monocytogenes. The technique uses the lactate dehydrogenase gene ldh as 
housekeeping reference gene for normalization. We found that this gene is 
constitutively expressed in most conditions relevant to analysis of PrfA regulation, 
including intracellular conditions. The rpoB gene, encoding the β subunit of the 
RNA polymerase, also shows a stable and constitutive pattern of expression suitable 
for PrfA-dependent gene regulation analysis; this gene can be used alternatively to -
or in conjunction with- ldh as housekeeping reference gene for transcription data 
normalization. 
 
(ii) The synthetic adsorbent resin AmberliteTM XAD-4 leads to an activation of PrfA-
dependent genes comparable to that observed with activated charcoal. However, in 
contrast to charcoal, the presence of the resin in the culture is not required. Pre-
treatment of the medium, with subsequent removal of AmberliteTM XAD-4, leads to 
virulence gene activation levels similar to those observed when the medium 
incorporates the resin during bacterial growth. AmberliteTM XAD-4 did not affect 
bacterial growth and a σB stress response was not involved in the virulence gene 
activation, indicating that the effect is most likely related to chemical signalling 
rather than to a stress response indirectly affecting PrfA. Thus, the resin seems to 
exert its effect by adsorbing a chemical component of the medium with PrfA 
repressor activity. This conclusion does not support the notion that the gene 
activation effect is due to the sequestration of a Listeria-derived quorum-sensing 
PrfA autorepressor substance.  
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(iii) The levels of PrfA-dependent gene activation in wild-type L. monocytogenes 
with AmberliteTM XAD-4 were clearly below those observed in HeLa cells, 
suggesting that the intracellular activation of the PrfA system does not only involve 
de-repression but an additional positive regulation pathway. A prfA* mutation lifts 
the medium-associated repression, indicating that the constitutively activated PrfA* 
protein is not sensitive to the medium-derived chemical repressor signal.  
 
(iv) We identified in the PrfA N-terminal domain a solvent-exposed cavity at an 
equivalent position to that of the cAMP-binding site of the structurally related 
enterobacterial Crp regulator. We examined the function of this pocket by structure-
based site-directed mutagenesis.  Our results provide strong experimental support to 
the notion that PrfA is allosterically activated within host cells via a putative ligand-
binding pocket in the jelly-roll β-barrel that forms the N-terminal domain of the 
protein monomer.  
 
(v) We described and characterized three new spontaneous loss-of-function 
mutations in PrfA, A129T in the αC helix and E173G in the HTH motif, identified as 
PrfA*G145S-supressor mutations, and C229Y in the C-terminal extension, which is 
always present together with the G145S substitution in L. monocytogenes 
phylogenetic division II spontaneous prfA* mutants. A129T and E173G caused total 
loss of activity in PrfA, even when in "on" (PrfA*) conformation, by directly 
affecting dimerization and DNA-binding, respectively; C229Y alone totally 
inactivated PrfA but only partially suppressed the PrfA* phenotype conferred by the 
G145S mutation. Our data highlight the critical importance for PrfA function of the 
central inter-subunit αC helix, the HTH motif, and the C-terminal wedge unique to 
the listerial regulator among the Crp family of bacterial transcription factors.  
 
(vi) We clarified several key aspects of carbon source regulation of L. 
monocytogenes virulence genes. (a) Hexose phosphates do not repress PrfA-
dependent expression, this only occurs with PTS-transported sugars. (b) A PrfA* 
protein ("on" conformation) does not render L. monocytogenes insensitive to sugar-
mediated virulence gene regulation; repression is still observable but with higher 
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final output levels that are proportional to the intrinsic activity of the PrfA protein. 
(c) The intensity of the repression varies depending on the sugar utilized and may 
depend on the number of potential PTS permeases involved in sugar uptake. Our 
observations suggest a clear interconnection between the PrfA and carbon catabolite 
repression systems in L. monocytogenes. 
 
(vii) We demonstrate that the unusual phenotype reported for L. monocytogenes 
strain NCTC 7973 in response to sugars, with a differential response to glucose and 
cellobiose, previously assumed to reflect the existence of independent repression 
mechanisms for the two carbohydrates, is due to the attenuation effect of the double 
C229Y mutation on PrfA*G145S. Depending on the gene expression analysis 
technique used and its corresponding signal saturation threshold, the attenuated 
activity of the double PrfA*G145S/C229Y may lead to the wrong interpretation that one 
sugar represses (cellobiose), whereas the other (glucose) not. 
 
(viii) Contrary to what was initially thought, the constitutively hyperactive 
PrfA*G145S mutant form is sensitive to PTS sugar-mediated repression. Although 
final expression levels remained still high, sugars clearly repressed the transcription 
of PrfA-dependent genes in prfA* bacteria. This suggests that the carbon source-
mediated repression pathway represents a level of regulation that is superimposed to 
that of the PrfA allosteric activation pathway. 
 
(ix) Contradicting previous reports by other groups, our data do not support that the 
stress mediator σB plays a major role in host cell invasion by L. monocytogenes. The 
ΔsigB mutation had no obvious influence on invasion or inlAB expression, except for 
a small decrease only observable in the prfAWT background in in vitro conditions, not 
in the prfA*G145S background mimicking the in vivo PrfA regulation status. We 
question the biological significance of these effects, as they are observed in an 
already much reduced invasive phenotype that corresponds to a PrfA activation 
status only seen in vitro and not in vivo during infection. 
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(x) Consistent with the lack of effect of σB on L. monocytogenes invasiveness and 
inlAB expression, growth in acidic conditions did not seem to trigger a stress 
response leading to an enhancement in the internalization rate. 
 
(xi) We confirm previous observations from our laboratory that L. monocytogenes 
invasiveness is strictly dependent on the central virulence gene regulator, PrfA. We 
showed that PrfA is essential for the expression of the L. monocytogenes invasion 
locus inlAB and the ability of L. monocytogenes to invade host cells. Like other 
members of the PrfA regulon, the inlAB locus was expressed only weakly in 
extracellular conditions, whereas it was strongly induced during intracellular 
infection, to levels similar to those observed in prfA* bacteria.  
 
(xii) Our work with ΔsigB mutants in two L. monocytogenes serotypes, 1/2a and 4b, 
indicate that there are strain-specific differences regarding the protective role of σB 
against environmental stresses. Our data are consistent with previous observations by 
other groups suggesting that σB does not play a significant role in the stress response 
of L. monocytogenes strains belonging to phylogenetic division I. There appear also 
to be qualitative differences in the protective role of σB within a same strain 
depending on the type of stress. 
 
(xiii) We have identified that the quantitative data published in the scientific 
literature about apoptosis in bacterial infections are frequently flawed by 
methodological errors. They do not take into account that the percentage of apoptotic 
cells in an infected population may be affected by the invasiveness, intracellular 
proliferation and spread capacities of the bacteria. Key variables, such as the actual 
total number of bacteria in the monolayer, or the percentage of infected cells, are not 
taken into account when quantifying apoptosis. As a first step in our work 
programme on Listeria-induced apoptosis, we addressed these problems and 
developed, with the aid of a mathematician, an Apoptosis Index (AI) equation that 
incorporates the major parameters that may influence the outcome variable. The 
application of this AI in pilot experiments conducted with the ruminant pathogen L. 
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ivanovii showed that this species is more apoptogenic than L. monocytogenes for 
MDBK bovine epithelial cells.   
 
(xiv) Detailed microscopical examinations of infected MDBK monolayers led us to 
conclude that the presence of pathogenic Listeria within host cells is associated with 
the occurrence of apoptosis. However, a strict correlation did not exist between the 
total number of bacteria in the monolayer and the percentage of apoptotic cells, 
indicating that both variables are not linearly correlated. A significant number of 
infected cells did not undergo apoptosis, reflecting the possible existence of host cell 
subpopulations differing in susceptibility to Listeria-induced apoptosis, or a time-
bacterial load exposure threshold effect.  
 
(xv) Despite the significant differences in number of intracellular bacteria within 
infected cells between a ΔactA mutant (unable to spread to neighbouring cells and 
which, therefore, accumulates in the invaded cell after replication) and its wild-type 
parental L. monocytogenes, the application of the AI indicated that the two strains did 
not differ in apoptogenic activity. Thus, overcrowding in itself does not seem to 
result in increased levels of apoptosis, possibly reflecting the existence of a bacterial 
input threshold for triggering cell death in an infected cell.   
 
 
4.2 FUTURE DIRECTIONS  
 
Future directions of the research based on the findings and work reported in this 
thesis are:  
 
(a) Continuation of the search for the presence of the medium-derived PrfA repressor 
signal will be greatly facilitated by the use of the chemically defined medium IMM 
and the synthetic resin AmberliteTM XAD-4. The chemical signal adsorbed by the 
resin can be selectively eluted through monitoring of its repressor activity, and its 
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nature determined using standard analytical chemistry procedures. Once the identity 
of the repressor is determined, biochemical and structural studies of its mode of 
action can be undertaken.  
 
(b) The identification of the N-terminal putative binding pocket is a major 
breakthrough for understanding the allosteric nature of PrfA and how the activity of 
the central regulator of listerial virulence is modulated. The shape and 
physicochemical characteristics of the pocket suggest that it could bind a relatively 
hydrophobic, elongated molecule with an aromatic head and aliphatic tail. Future 
work will aim at the identification of the putative PrfA-activating ligand and use this 
knowledge in the development of inactive analogues that could serve as potent 
Listeria anti-infectives.  
 
(c) Future work will also focus on the detailed structural characterization of the 
spontaneous PrfA− mutations identified in this thesis, which will allow us to gain a 
better understanding of the structure-function of the listerial virulence regulator. 
Understanding the reason for the selective advantage conferred by the second C229Y 
mutation in the phylogenetic division II spontaneous prfA*G145S mutants will provide 
insight into basic aspects of listerial physiology and the impact of the PrfA 
regulatory network on L. monocytogenes fitness and evolution.   
 
(d) It will also be interesting to investigate the differential role of σB in the stress 
response of L. monocytogenes serotypes, in particular the apparent lack of impact of 
this alternative sigma factor on stress tolerance and virulence in serotype 4b.  
 
(e) The methods and approaches developed in this thesis for the determination of 
apoptosis will be very helpful in the research programme on SmcL, ceramide and 
programmed cell death. Future work will focus on the refinement and further testing 
of the AI equation for determination of the apoptogenic activity of Listeria strains 
(and eventually other bacterial pathogens). The role of SmcL in the modulation of 




































5.1 MICROBIOLOGICAL TECHNIQUES 
 
5.1.1 BACTERIAL STRAINS, CULTURE CONDITIONS AND 
CHEMICALS 
 
 Bacterial strains used in this study are listed in table 5.1. Listeria spp. and 
E.coli strains were routinely cultured in Brain Heart Infusion (BHI) (BD, 
Laboratories–Beckton, Dickinson and Co.) and Luria–Bertani (LB) (Pronadisa S.A., 
Spain) media, respectively. Bacteria were grown in aerobic conditions at 37ºC, 
(Memmert UM-800/400 Universal Incubators; Shwabach, Germany) with or without 
continuous shaking at 200 rpm (Inmersa 4230 Refrigerated Incubators. New 
Brusnwick Scientific; New Jersey, USA). To obtain solid media, 1.6% of 
bacteriological agar (Oxoid, Nº1; Hampshire, England) was added to the broth 
media. The base medium was supplemented with appropriate antibiotics when 
required. Chemicals and antibiotics were purchased from Sigma-Aldrich Co. (Dorset, 
UK) unless otherwise stated.  
 
5.1.2 PREPARATION OF BACTERIAL INOCULA  
 
 Bacterial cultures grown overnight were inoculated 1:100 in 200 ml BHI 
broth (or BHI broth acidified with HCl to pH = 5.5 for ∆sigB mutant experimental 
purposes; see section 3.1.2), incubated at 37°C with shaking (200 rpm) until mid-
exponential phase (OD600 = 1.0 - 1.2). Bacteria were collected by centrifugation 
(5,836 x g for 10 min. at 4˚C using 6K15 Sigma Lab Centrifuge), washed three times 
in ice-cold PBS (phosphate-buffered saline, pH = 7.4), resuspended in 4 ml of ice-
cold 20% glycerol PBS v/v solution, aliquoted into vials (100 µl portions) and stored 
at -80°C until use. The number of bacteria present in the frozen stocks was 
determined by thawing three aliquots and calculating the average CFU / ml by plate 
counting on BHI agar. For inoculation purposes, aliquots were thawed, washed twice 
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in PBS and resuspended in 900 µl of PBS. Inocula of Listeria with a pPL2 plasmid 
integrated into the chromosome were prepared as described above, but cultured in 
BHI broth supplemented with 7.5 µg / ml chloramphenicol. 
 
5.1.3 PREPARATION OF IMM BROTH 
 
 IMM (Improved Minimal Medium) is a chemically defined medium, which 
was prepared according to the formulation described by Phan-Thanh and Gormon, 
(1997) (table 5.2). Different components of this medium were either stored at 4oC or 
frozen at -20oC when appropriate. Ready IMM was stored at 4oC for a period no 
longer than 2 weeks and protected from light. Sugar source such as glucose, glucose-
1-phosphate (G-1-P) or cellobiose (Sigma) was added at an appropriate final 
concentration. For experimental purposes described in section 3.1.1.4.2.3, the 
concentration of phosphates was decreased (from 1,642 mM to 25 mM) and the IMM 
medium was buffered with 100 ml of 1 M 3-(N-morpholino)propanesulfonic acid 
(MOPS) (pH = 7.03) (Sigma). 
 
5.1.4 BACTERIAL GROWTH MEASUREMENTS AND 
GROWTH CURVES 
 
 An overnight culture of Listeria spp. was inoculated (1:100) into BHI or 
IMM broth and incubated at 37˚C, with shaking (200 rpm). For manual growth 
curves (figure 3.1.5), flasks with 30 ml broth were used. The OD600 was determined 
using a spectrophotometer (model mentioned above) after inoculation (t = 0) and at 
one-hour intervals. Uninoculated BHI or IMM was used as blank. Growth data of 
figures 3.1.30, 3.1.2.5 and 3.1.2.6 were obtained using an automated microplate 
reader machine (FluoStar OPTIMA, BMG Labtech) at the same optical density 




5.1.5  BACTERIAL CULTURES FOR RT-QPCR 
EXPRESSION ANALYSES 
 
 Stationary phase overnight bacterial cultures were diluted 1:100 in 30 ml of 
BHI medium or IMM (Improved Minimal Medium) (Phan-Thanh & Gormon, 1997), 
supplemented with appropriate concentration of antibiotics if necessary, or with 1% 
Amberlite™ XAD-4 (Sigma) before sterilizing of the media, to achieve PrfA 
activation in vitro.  For some experiments (see section 3.1.1.2), a pre-treated IMM 
medium was obtained by incubating IMM with 1% Amberlite™ XAD-4 at 37°C for 
24 h, and, then, the amberlite particles were removed by filtration through 0.2 µm 
pore size membrane. Bacteria were grown in 100 ml flasks with shaking at 200 rpm 
at 37°C. The OD600 was measured for each culture using the Ultrospec 3300 pro 
UV/Visible spectrophotometer (Amersham Biosciences). At the initial and middle 
exponential phase (OD600 ~ 0.3 and OD600 ~ 1, respectively), 0.5 ml of medium 
containing L. monocytogenes cells were transferred into 1.5 ml microcentrifuge tube 
and chilled on ice immediately. Collected samples were kept for further expression 
analysis by RT-QPCR. In parallel, aliquots of bacterial cultures were diluted and 
plated on BHI agar plates to determine the number of bacteria (CFU).  
 
5.1.6 MEASUREMENT OF HAEMOLYSIN AND 
PHOSPHOLIPASE ACTIVITY 
 
Strains were regularly checked for PrfA activity using as reporters the strictly 
PrfA-dependent genes hly and plcB, encoding the LLO cytolysin, and the broad 
substrate-range phospholipase/lecithinase, respectively (Vazquez-Boland et al., 
1992). Semi-quantitative determination of Hly and PlcB activity was carried out by 
streaking L. monocytogenes onto 5% sheep-blood agar (SBA) plates (BioMerieux; 
Marcy l'Etoile, France) or egg yolk agar (EYA) BHI plates, respectively.  EYA 
plates were prepared by adding 5% v/v of egg yolk suspension (a fresh egg yolk in 
100 ml of sterile saline solution) to BHI agar. The egg yolk agar plates, either with or 
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without the supplementation of activated charcoal (0.5% v/w, Merck), were 
incubated at 37°C for 48 - 72 h. Determination of the activity was based on the 
diameter of the halos developed around colonies.  
 
5.1.7 PREPARATION OF ELECTROCOMPETENT E. COLI  
 
 An overnight culture of E. coli was inoculated in LB-broth (1:100) and grown 
until OD600 = 0.6. Then, the culture was centrifuged at 5,836 x g for 10 min. at 4˚C 
(6K15 Sigma Lab Centrifuge). The pellet was resuspended in 100 ml ice-cold 
destilled water and centrifuged as previously. After a second wash with the same 
conditions, bacterial cells were resuspended in 20 ml of 10% glycerol and Milli-Q 
water, and centrifuged as previously. Finally, the pellet was resuspended in 400 µl of 
ice-cold, 10% glycerol solution and 20 µl aliquots in microtubes were stored at -80˚C 
(U410 Ultra Low Temperature Freezer; New Brunswick Scientific, Hertfordshire, 
UK).  
 
5.1.8 ELECTROCOMPETENT LISTERIA CELLS 
 
 Listeria were grown overnight in 5 ml BHI supplemented with 0.5 M sucrose. 
The culture was diluted 1:100 in BHI broth containing 0.5 M sucrose and incubated 
at 37˚C with vigorous shaking (200 rpm) until reaching OD600 value of 0.2. Then, 
penicillin G (10 µg / ml) was added and the culture was incubated for further 2 h in 
the same conditions. After this time, bacteria were transferred to sterile, ice-cold 
centrifuge tubes and spun at 5,836 x g for 10 min. at 4°C (6K15 Sigma Lab 
Centrifuge). Cells were washed three times with ice-cold transformation buffer 
prepared by mixing 0.5 M sucrose, 1 mM HEPES in Milli-Q water  (pH = 7.0) and 
the pellet was resuspended in 500 µl of ice-cold transformation buffer containing 
10% v/v glycerol. Aliquots of 50 µl were quickly dispensed into chilled, sterile 
microfuge tubes and immediately stored at -80˚C (U410 Ultra Low Temperature 
Freezer; New Brunswick Scientific, Hertfordshire, UK) until use. 
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5.1.9 LYSIS OF LISTERIA CELLS FOR STANDARD PCR 
 
 Bacteria were resusupended in 50 µl of buffer for PCR 1x (prepared by 
mixing 5 µl of Biotools buffer 10x and 45 µl of sterile Milli-Q water). After 
vortexing the sample, 5 µl of lysozime (100 mg / ml) was added. After mixing 
thoroughly, the sample was incubated at 37˚C for 1 h. Then, 1.2 µl of Proteinase K 
(20 mg / ml) was added. The sample was vortexed and incubated for 1 h at 55˚C and 
later for 15 min. at 100˚C. 3 µl of the suspension was taken to prepare the PCR 
reaction (final volume 50 µl).  
 
5.2 MOLECULAR BIOLOGY TECHNIQUES 
 
5.2.1 DNA TECHNIQUES AND SEQUENCE ANALYSES 
 
 Extraction of genomic DNA from bacteria was carried according to Ausubel 
et al. (2002) with modifications (Ausubel et al., 2002). A 10 ml overnight culture of 
Listeria spp. was centrifuged at 3,864 x g for 10 min. (3K30C Lab Centrifuge, 
Sigma; Harz, Germany). The pellet was re-suspended in 576 µl of TE buffer (10 mM 
Tris-HCl, 1 mM EDTA pH = 8), and 3 µl of 100 mg / ml lysozyme was added. The 
mixture was incubated at 37°C for 1 h and stirred every 10 min.. After this time, 3 µl 
of 20 mg / ml proteinase K and 30 µl of 10% SDS (sodium dodecyl sulphate) were 
added and the suspension was incubated for another hour at 37°C with stirring every 
10 min.. Then, 170 µl of 5 M NaCl were added and the suspension was mixed 
thoroughly (to resuspend the salt added). Afterwards, 5 µl of 0.5 mg / ml RNAse 
(Qiagen, Crawley, West Sussex, UK) and 80 µl of CTAB/NaCl solution (10% CTAB 
- hexadecyltrimethyl ammonium bromide in 0.7 M NaCl) were added and the 
suspension was incubated for 30 min. at 65 °C. After cooling to room temperature, 
750 µl of phenol/chloroform/isoamyl alcohol was added, the suspension mixed and 
spun for 10 min. at maximum speed on a benchtop centrifuge (MiniSpin Plus bench 
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Centrifuge, Eppendorf; Cambridge, UK). The aqueous phase (~ 600 µl) was 
transferred to a fresh tube and an equal volume of chloroform was added. After 
mixing thoroughly, the suspension was centrifuged for 10 min. at maximum speed, at 
room temperature. The aqueous phase (~ 450 µl) was transferred to a new tube and 
mixed with 0.6 volume of isopropanol to precipitate the nucleic acids. The tube was 
shaken back and forth until DNA became visible. After centrifugation (5 min. at 
6,000 × g, at room temperature), the supernatant of the suspension was carefully 
removed. The remaining pellet of DNA was washed with 70% ethanol to eliminate 
residual CTAB and centrifuged again (5 min., 6,000 × g, room temperature). The 
supernatant was discarded and the pellet was air-dried and re-suspended in 100 µl of 
sterile Milli-Q water (double-distilled).  
 
 The oligonucleotides used during this study are listed in table 5.3 and were 
purchased from Metabion (Martinsried, Germany) or Sigma (UK). The genome 
sequence of L. monocytogenes strain P14 (sequenced by our laboratory using the 
facility in the School of Biological Sciences, University of Edinburgh) or the genome 
sequence of L. monocytogenes F2365 (Nelson et al., 2004), served as the basis for 
designing the primers.  
 
 Taq DNA polymerase (Biotools; Madrid, Spain) was used to carry out 
polymerase chain reaction (PCR), PfuTurbo® DNA polymerase and the PfuUltra II 
fusion HS DNA polymerase (both from Stratagene [CA, United States]) were used 
when high-fidelity PCR was required. Restriction enzymes were obtained from 
Promega (Southampton, UK) and New England Biolabs (Herts, UK). All enzymes 
were used according to the manufacturer’s instructions. 
 
 PCRs were carried out using Minicycler (M.J. Research, Inc; Massachusetts, 
USA) and MasterCycler Gradient (Eppendorf; Hamburg, Germany) thermal cyclers. 
General parameters used were as follows: 1) 5 min. of initial denaturation at 95˚C, 2) 
30 cycles of amplification involving i) 30-60 sec. of denaturation at 94˚C, ii) 30-60 
sec. of oligonucleotide hybridization at the appropriate temperature (calculated 
according to the general formula T=[2˚(A+T)+4˚(G+C)]) and iii) elongation at 72˚C 
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for 1 min. per 1 Kb amplified, and 3) 10 min. of final elongation at 72˚C. A volume 
of 50 µl per reaction was used to carry out the PCR with 10 to 100 ng of template, 10 
mM dNTPs (Biotools; Madrid, Spain), 10 µM of each oligonucleotide, an 
appropriate amount of reaction buffer and DNA polymerase enzyme.   
 
 For routine analysis, the PCR products were visualized on 1% agarose gels 
(Pronadisa; Madrid, Spain) by running a gel electrophoresis in a Mini-Sub® Cell GT, 
with a PowerPac Basic Power Supply Kit (Bio-Rad Laboratories, Ltd., UK). For 
cloning purposes, the PCR products were used directly, or after purification from 
0.7% megabase certified agarose gel (Bio-Rad Laboratories, Ltd., UK) with 
QIAquick Gel Extraction Kit (Qiagen, Crawley, West Sussex, UK), as recommended 
by the manufacturer. 
 
 Quantity and purity of the DNA extracted was assessed either by using 
Nanodrop® Spectrophotometer ND-1000 (ThermoScientific, USA) or by measuring 
the absorbance of the solution at 260 and 280 nm wavelengths (Ultrospec 3300 pro 
UV/Visible spectrophotometer; Amersham Biosciences). In order to increase the 
purity of the DNA, samples were purified with the QIAquick PCR Purification Kit 
(Qiagen, Crawley, West Sussex, UK). DNA samples with an A260/A280 absorbance 
ratio lower than 1.75 - 1.80 were discarded. DNA samples were sent to Agowa 
genomics services (Gesellschaft für molekularbiologische Technologie mbH, Berlin, 
Germany) or submitted to the GenePool (University of Edinburgh, UK) for 
sequencing. Sequences and chromatograms were analyzed using FinchTV 
(Geospiza) and DNA strider 1.2 softwares. Alignment of nucleotides and protein 
sequences was carried out using the multiple sequence alignment programmes 
ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/index.html) and the Basic Local 
Alignment Search Tool (Blast) (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Chemicals 





5.2.2 RNA ISOLATION FOR RT-QPCR 
 
 An aliquot of 0.5 ml BHI containing exponentially growing Listeria cells or 
0.5 ml of PBS containing Listeria infected mammalian cells were added to 1 ml of 
RNAprotect bacteria reagent (Qiagen, Crawley, West Sussex, UK) and mixed 
immediately by vortexing for 5 sec.. The mixture was incubated for 5 min. at room 
temperature and subsequently centrifuged at 5,000 × g for 10 min. at 4 °C (3K30C 
Lab Centrifuge) and stored at -80˚C until use. The pellet was thawed on ice and 
resuspended in the Buffer RA1 (Macherey-Nagel, Düren, Germany) containing 
1:100 β-mercaptoethanol (Sigma) and transferred to a blue-cap tube containing 
Lysing Matrix B (Q-Biogen). Samples were processed in the FastPrep® Instrument 
(Q-Biogen) at a setting of 6.0 during 40 sec. and centrifuged at 12,000 × g for 5 min. 
at 4ºC (3K30C Lab Centrifuge). The supernatant was transferred to a new 
microcentrifuge tube and an equal volume of 70% ethanol (Sigma; prepared in 
autoclaved 0.01% diethylpyrocarbonate [DEPC] water) was added and mixed well 
by pipetting. The nucleic acid solution was purified using the Nucleospin RNA II kit 
(Macherey-Nagel). The resulting 50 µl elute was treated with 10 U of DNase I (RQ1 
RNase-free DNase I, Promega, UK) for 30 min. at 37ºC. Subsequently, the total 
RNA solution was purified in a second round using the kit Nucleospin RNA II 
(Macherey-Nagel) and finally eluted in 50 µl of RNase- and DNase-free water. 
 
5.2.3 CDNA SYNTHESIS 
 
 RNA was reverse transcribed using the Improm-II reverse system (Promega, 
UK) in a 20 µl reaction mix including 1× Improm II reaction buffer, 1.5 mM Mg2+, 
0.5 mM dNTPs, 100 µM random hexamers (Eurogentec, Belgium), 5 µl of RNA 
template and 1 µl Improm-II reverse transcriptase. Before reverse transcription, RNA 
was denatured for 5 min. at 65ºC followed by cooling on ice. The reverse 
transcription conditions were: 25ºC for 5 min., 42ºC for 1 h, and inactivation by 
heating for 15 min. at 70ºC. All cDNAs were diluted 1:10 in nuclease-free water 
before being used as a PCR template for RT-QPCR. 
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5.2.4 EXPRESSION ANALYSES BY RT-QPCR 
 
 The assays were performed in a 20 µl reaction volume containing 1× PCR 
TaqMan® buffer II (Applied Biosystems, UK), 6 mM MgCl2, 200 µM dNTP 
(Promega and Biotools), 300 nM primers (Metabion, see table 5.3), specified 
concentration of the probe (100 nM or 150 nM, Applied Biosystems, see table 5.3), 1 
U of AmpliTaq Gold® DNA polymerase (Applied Biosystems, UK) and 5 µl of the 
target solution. Reactions were run on an iCycler 2.0 (BioRad, UK) and 
StepOnePlus™ Real-Time PCR System (Applied Biosystems, UK) using the 
following program: 10 min. at 95ºC and 40 cycles of 15 sec. at 95ºC and 1 min. at 
60ºC. Assays were analyzed using the iCycler IQ Optical System Software v3.0a 
(BioRad, UK) and StepOne Software v2.0 (Applied Biosystems, UK), respectively.  
 
 To determine the absolute starting number of each specific cDNA molecules 
present in the samples, standard curves were created using Listeria genomic DNA. 
Genomic DNA isolated from overnight culture of wild-type Listeria were serially 
diluted to final concentrations equivalent to approximately 3×105, 3×104, 3×103 and 
3×102 genomic-equivalent per reaction, and used in triplicate for building the 
standard regression curve, which was used in each RT-QPCR run. 
 
 The number of transcripts was calculated from threshold cycle (CT) values of 
cDNA preparations after extrapolation from a standard regression curve of cycle CT 
values plotted against L. monocytogenes P14 genomic DNA standards of known 
concentration (a comparative threshold method). Negative amplification results were 
considered for those reactions with CT value of 40 or above. All reactions were 
performed by duplicate. 
 
 Expression data were normalized by dividing the number of transcripts for 
the target gene by the number of transcripts for the L. monocytogenes housekeeping 
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gene ldh (encoding lactate dehydrogenase) and/or rpoB (encoding the β subunit of 
RNA polymerase).  
 
5.2.5 PLASMID EXTRACTION AND TRANSFORMATION 
BY HIGH-VOLTAGE ELECTROPORATION 
 
 Plasmids used in this thesis are listed in table 5.4. Extraction of plasmids 
from E. coli was carried out using the BIO 101® Systems RPM® SPIN MIDI, 
(QBiogene; La Jolla, USA) or QIAprep® Spin Miniprep Kit (Qiagen, Crawley, West 
Sussex, UK), according to manufacturer’s instructions. The electrocompetent 
bacteria were thawn on ice and mixed with 10 ng / µl of plasmid (2-4 µl). The mix 
was transferred into a previously chilled, 2 mm electroporation cuvettes (Biorad, 
UK) and kept on ice for 3-4 minutes. After electroporation (with following settings: 
voltage = 2500 V, capacitance = 25 µF, resistance = 200 Ω for E.coli or 2900 V, 25 
µF, 100 Ω for Listeria spp.) using GenePulserXcell electroporator (Biorad, UK), 250 
µl of LB broth or 500 µl of BHI broth with 0.5 M sucrose, respectively, was quickly 
added to the bacterial cells. The contents of the cuvettes was transferred into 
microfuge tubes and incubated at 37˚C, with shaking at 200 rpm for 1 h. After this 
time, transformed competent cells were transferred onto BHI agar plates containing 
appropriate antibiotic and incubated at 37˚C until the appearance of single bacterial 
colonies.  
 
5.2.6 SITE-DIRECTED MUTAGENESIS OF PRFA GENE 
 
 Complementation plasmids pPL2prfAWT and pPL2prfA*, carrying the wild-
type prfA and the prfA* gene, respectively, were constructed. The prfA gene, 
including its regulatory regions, of L. monocytogenes P14 and P14A, was amplified 
by PCR using oligonucleotides MR2SalI and MR10SalI (both carrying SalI 
restriction sites), purified and cloned into pTOPO T-vector (Invitrogen, UK) to give 
pTOPOprfA and pTOPOprfA*, respectively. After transforming into E. coli, the 
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plasmid was extracted and sequenced. The prfA and prfA* inserts were released by 
restriction with SalI (2 h at 37°C), purified and transferred to the site-specific phage 
integration vector, pPL2 (Lauer et al., 2002), (the ligation time was 17 h at 16°C), 
giving pPL2prfA and pPL2prfA*, respectively. Both of these complementation 
plasmids were used in subsequent steps to construct pPL2prfAA129T and 
pPL2prfA*A129T, respectively. A point mutation (GCC→ACC) was introduced 
resulting in an amino acid substitution (Ala→Thr) in codon 129 of the prfA and 
prfA* (Gly145Ser) allele carried by pPL2prfA and pPL2prfA*, respectively.  
 
Site-directed mutagenesis was carried out by overlap extension (Ho et al., 
1989) using oligonucleotides: Ala129Thrforward and Ala129Thrreverse, which 
carried the point mutation (in capital letters in table 5.3). Firstly, two fragments of 
prfA (or prfA*) gene, including its regulatory regions, were amplified by PCR using 
oligonucleotides: MR2SalI - Ala129Thrreverse and Ala129Thrforward - MR10SalI. 
Both fragments were purified, mixed together by pipetting and, then, amplified by 
PCR using oligonucleotides: MR2SalI - MR10SalI. The amplified insert, which 
carried the desired mutation, was purified, cloned into pTOPO T-vector and 
sequenced. The insert was, then, released by restriction with SalI (2 h at 37°C), 
purified and ligated into pPL2 vector (with the same conditions as described above) 
giving pPL2prfAA129T and pPL2prfA*A129T, respectively. The complementation 
plasmids, pPL2prfA, pPL2prfA*, pPL2prfAA129T and pPL2prfA*A129T were 
introduced into E. coli by electroporation, extracted, sequenced and introduced into 
L. monocytogenes ∆prfA* knock-out mutant by electroporation. The transformants 
were selected on BHI-chloramphenicol (7.5 µg / ml) agar plates. 
 
 Other complementation plasmids carrying prfA mutant genes (table 5.4) were 
constructed using similar technique to the one described above. The 
complementation plasmids pPL2prfA and pPL2prfA* were constructed again using 
oligonucleotides MR2KpnI and MR10SpeI. Site-directed mutagenesis into the prfA 
gene was performed by overlap extension strategy involving two flanking sequences 
using two outside primers (MR2KpnI, MR10SpeI) as well as the corresponding 
internal primers harbouring the relevant mutations (forward, reverse). The two 
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intermediate products with terminal complementarity formed a new template DNA 
used for the recombinant PCR (MR2KpnI + MR10SpeI), which was digested by 
KpnI and SpeI, and cloned in the integrative plasmid vector pPL2, digested by the 
same enzymes. The prfA mutant genes were under the control of the PprfA1 and 
PprfA2 promoters (Mengaud et al., 1991, Freitag et al., 1993). Selected plasmids 
were checked by digestion and sequencing and, then, electroporated into L. 
monocytogenes ΔprfA*. Transformants were selected on chloramphenicol containing 
plates. Oligonucleotides used to generate the mutants are listed in table 5.3. 
 
5.2.7 CONSTRUCTION OF ∆SIGB IN-FRAME DELETION 
MUTANTS IN LISTERIA 
 
 In order to construct in-frame deletion mutants in L. monocytogenes 4b, a 
homologous recombination technique was used as previously described in 
Dominguez-Bernal et al. (2006), with modifications. E.coli(pLSV101∆sigB) strain 
(DH10b) was a gift from Prof. W. Goebel (Biocenter, Microbiology; University of 
Würzburg, Germany). Plasmidic DNA from the E.coli(pLSV101∆sigB) was 
introduced by electroporation into the wild-type L. monocytogenes P14 and L. 
monocytogenes prfA* (P14A) for construction of ∆sigB mutants or into L. 
monocytogenes P14A∆prfA for construction of a P14A∆prfA∆sigB mutant. The 
transformants were incubated at 30˚C on BHI plates supplemented with 5 µg / ml of 
erythromycin (ery), presence of plasmid was confirmed by PCR. A positive clone 
was chosen and grown over-day at 30˚C in 10 ml BHI-ery 5 µg / ml broth. Then, the 
culture was diluted 1:100 into fresh BHI-ery 5 µg / ml broth and grown at 37˚C 
overnight. The next day, bacteria were subcultured, as previously, into the fresh 
broth and grown at 42˚C (to inhibit the plasmid replication) for 7 h. The bacteria 
were subcultured once again into fresh BHI-ery broth and grown overnight at 37˚C. 
Dilutions of this culture were plated onto BHI-ery agar plates and incubated at 37˚C 
until the appearance of bacterial colonies. The integration of plasmids into the 
chromosome of the first recombinant bacteria was confirmed using PCR (with 
following PCR conditions: 1) 95˚C for 5 min., 2) 94˚C for 1 min., 3) 55˚C for 1 min., 
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4) 68˚C for 2 min., 5) repeat steps 2-4 30 times, 6) 68˚C for 10 min., 7) hold at 4˚C) 
with oligonucleotides: sigBF-plsv1B and sigBR-plsv1C (table 5.3). The first 
recombinant was re-isolated on BHI-ery agar plates and blood agar plates to check 
purity. To select the second event of recombination that leads to the mutant strain (or 
revertant strain to the wild-type genotype), the chosen clone was grown over-day in 
BHI broth without antibiotic selection at 37˚C, and subsequently subcultured every 
12 h for the next couple of days under the same conditions. Each day, a sample was 
plated on BHI agar and incubated at 37˚C until colonies appeared. Bacterial clones 
were streaked on BHI agar plates with and without antibiotic selection (by replica 
plating) and incubated at 37˚C. Erythromycin-sensitive bacterial colonies were 
checked for the presence of deletion in sigB gene by PCR using chromosomal 
primers (sigBF and sigBR), designed in the flanking sequence of the recombination 
regions inserted into pLSV101 vector. 
 
5.2.8 CONSTRUCTION OF EGD∆PLCAB(PPL2) AND 
EGD∆PLCAB(PPL2SMCL) MUTANTS.  
 
 Listeria monocytogenes EGD∆plcAB strain was a gift from Prof. J. Kreft 
(Biocenter, Microbiology; University of Würzburg, Germany). EGD∆plcAB(pPL2) 
strain was obtained by electroporating the pPL2 plasmid (Lauer et al., 2002) into 
electrocompetent EGD∆plcAB. To obtain EGD∆plcAB(pPL2smcL) strain, the smcL 
gene, including its regulatory regions, of L. ivanovii ATCC 19119 was amplified by 
PCR using oligonucleotides: smcL-XmaI (forward) and smcL-SalI (reverse) (table 
5.3), purified, digested by XmaI and SalI and cloned into the integrative plasmid 
vector pPL2 (previously digested by the same restriction enzymes). pPL2smcL 
plasmid was checked by PCR and sequencing and finally electroporated into L. 
monocytogenes EGD∆plcAB. Transformants were selected on chloramphenicol (7.5 
µg / ml) containing BHI plates. Correct insertion of the plasmid into the chromosome 
of Listeria was checked by PCR using primers NC16 and PL95 (table 5.3). 
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5.3 BIOCHEMICAL TECHNIQUES 
 
5.3.1 RECOMBINANT PRFA PROTEIN PRODUCTION 
AND PURIFICATION 
 
 The prfA alleles were amplified by PCR using the oligonucleotide pair 
prfAH1-P14 and prfAH2-P14 (table 5.3), which contain respectively the NdeI and 
SalI restriction sites, and the corresponding pPL2 plasmid as a template. The 
resulting prfA-containing DNA fragments were digested by NdeI and SalI restriction 
enzymes and cloned in the pET28a plasmid (Novagen) digested by the same 
restriction enzymes. The resulting prfA genes were cloned in frame with a His-tag in 
N-terminal extremity and electroporated in E. coli Bl21DE3 (Invitrogen) for the 
overproduction of the recombinant PrfA proteins. Host bacteria were grown at 37°C 
in 500 ml of LB medium containing kanamycin (50 µg / ml) until OD600 = 0.8, and 
the protein expression was induced by adding 1 mM of IPTG. After 3 h, the induced 
bacteria were pelleted and resuspended in 500 µl of lysis buffer (50 mM NaH2PO4, 
NaCl 300 mM, 20 mM imidazole) containing protease inhibitor cocktail (Roche). 
After addition of lysozyme 1 mg / ml, the bacteria were incubated 30 min. on ice and 
lysed (using Lysing Matrix B; Q-Biogen) three times by FastPrep® Instrument (Q-
Biogen) for 30 sec. at a setting of 6.5. The cell debris was removed by centrifugation 
at 10,000 x g for 20 min. at 4°C (3K30C Lab Centrifuge). Recombinant PrfA 
proteins were purified from the bacterial soluble extract by column affinity 
chromatography using a HiTrap IMAC FF nickel column in an AKTA system (GE 
Healthcare), according to the manufacturer’s instructions. The eluted fractions were 
analyzed by SDS-PAGE with Coomassie blue staining. The fractions containing 




5.3.2 ANALYTICAL ULTRACENTRIFUGATION (AUC) 
 
 Equilibrium sedimentation experiments were carried out at the Department of 
Biochemistry of the University of Cambridge with help from Zbigniew Pietras using 
a Beckman Optima XL-I ultracentrifuge (Beckman Coulter UK Ltd.). The purified 
PrfA proteins stock was buffer exchanged into 10 mM HEPES pH = 7.4, 150 mM 
NaCl, 3 mM EDTA, 1 mM TCEP and 10% glycerol. The concentration of each 
sample was quantified by Nanodrop® Spectrophotometer ND-1000 
(ThermoScientific, USA). A 400 µl of samples in the range of OD280 = 0.8 - 1.0 were 
centrifuged at 60,000 rpm (Beckman Optima XL-I ultracentrifuge) for 3 h at 22°C. 
Data were analyzed with the Sedfit Analysis Software v1180. The average protein 
molecular mass was determined for each sample. 
 
5.3.3 FLUORESCENCE-BASED PROTEIN THERMAL 
STABILITY ASSAY 
 
 Assays were performed at the Department of Biochemistry of the University 
of Cambridge with help from Zbigniew Pietras using an IQ5 96-well format real-
time PCR instrument (Bio-Rad) over a temperature range starting at 25°C and 
ranging up to 95°C with a heating rate of 0.5°C / min.. Assay samples of 25 µl 
consisted of 3.5 µg of each PrfA variant, and 5 µl of 12.5X Sypro Orange solution 
(Invitrogen) diluted 1:400 in the protein buffer. Excitation and emission wavelengths 
of SYPRO Orange are 470 nm and 570 nm, respectively. Protein thermal unfolding 
curves were monitored through closed-circuit device camera detection of changes in 
fluorescence for the SYPRO Orange environmentally sensitive dye (Pantoliano et al., 
2001). The inflection point of the melting transition from folded and unfolded states 
(melting temperarature, Tm) was determined from the first derivative of the plot of 
fluorescence intensities (Lo et al., 2004). 
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5.3.4 SURFACE PLASMON RESONANCE 
 
 The DNA-binding affinity of purified PrfA proteins was determined by SPR 
at the Biophysical Characterization facility (Centre for Translational and Chemical 
Biology) of Edinburgh University using a Biacore biosensor system T100 (Biacore, 
GE Healthcare). Biotinylated oligonucleotides (40 bp) containing the PrfA box of 
plcA or actA promoters in a central position (table 5.3) were immobilized to a 
streptavidin-coated sensor chip (SA Chip, Amersham-Pharmacia Biotech). To create 
double-stranded DNA, saturating amounts of non-biotinylated complementary DNA 
was flowed over the chip. Binding assays were performed at 25ºC in 10 mM HEPES 
pH = 7.4, 150 mM NaCl, 3 mM EDTA, 0.005% v/v P20 surfactant (HBS-EP buffer, 
Biacore Life Sciences) containing 1mM tris(2-carboxyethyl)phosphine. PrfA 
proteins were injected at concentrations ranging from 0.3 nM to 6 µM at a flow rate 
of 75 µl / min.. DNA binding was measured for 240 sec. until binding approached a 
steady state, followed by dissociation for another 120 sec. and surface regeneration 
with 0.1% SDS 3 mM EDTA for 60 sec. at 100 µl / min.. The reference signal 
(oligonucleotide-free streptavidin-coated cell) was subtracted from each sensorgram 
and the resulting curves were aligned to a common baseline. Some experiments 
included a flow cell coated with a random 40-mer oligonucleotide, and no significant 
binding was detected. For kinetic constants and binding affinity determinations, the 
1:1 Langmuir binding model was selected as fitting model in the Biacore T100 
Evaluation software. The fits showed chi-square values between 1 and 10. 
 
5.3.5 STRUCTURAL ANALYSES AND MODELLING 
 
 Theoretical models of the structures of PrfA mutants were obtained using 
MODELLER (Sali & Blundell, 1993), which generates protein structures by 
satisfaction of spatial restraints with simultaneous optimization of CHARMm 
energies, conjugate gradients and molecular dynamics with simulated annealing. 
Comparative models were validated with PROCHEK (Laskowski et al., 1993), 
WHAT_CHECK (Hooft et al., 1996), VERIFY3D (Luthy et al., 1992), and JOY 
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(Mizuguchi et al., 1998). The crystal structure of PrfAWT at 2.7Å resolution (pdb 
entry: 2BEO, [Eiting et al., 2005]) was used as template for modeling the structures 
of the PrfA mutants. The interactions of the new side chains with surrounding 
residues, and the accessible surface areas (ASA), gap volumes and gap volume 
indexes were calculated from the models of the PrfA mutants to infer possible 
changes in the relative position of the two protomers of the dimeric PrfA structure. 
Dimer interface surfaces were calculated as variation of the ASAs on complexation 
(Jones & Thornton, 1996). Gap volumes between the two chains of the PrfA dimer 
was calculated using the program SURFNET (Laskowski, 1995). Interface ASA, gap 
volume and gap volume index values were obtained from the server PROTORP 
(http://www.bioinformatics.sussex.ac.uk/protorp/) (Reynolds et al., 2009). 
Electrostatic interactions between charged residues, and contact atoms and type of 
interactions, were identified using ELECINT and CONTACTS in-house programs 
(Núñez Miguel, R., unpublished data). Coordinate superimposition of proteins was 
carried out using the program MNYFIT (Sutcliffe et al., 1987). The graphical 
program MacPyMOL (DeLano Scientific LLC, http://www.pymol.org) was used for 
visualization of protein structures. 
 
5.4 CELL-BASED TECHNIQUES 
 
5.4.1  MAMMALIAN CELL CULTURES 
 
 The human cervix epithelial cell line -HeLa- (CCL–2) and Madin-Darby 
Bovine Kidney -MDBK- (CCL-22) epithelial-like cells were obtained from the 
ATCC repository. L929 (mouse fibroblasts derived from normal subcutaneous 
areolar and adipose tissue) cell line was a gift from Prof. T. Chakraborty's laboratory 
(Justus-Liebig-University, Institute of Medical Microbiology, Germany). All cell 
lines were routinely cultured in 25 or 75 cm2 plastic flasks (Costar®-Corning; New 
York, USA) and grown at 37°C in HeraCell incubators (Heraeus; Hanau, Germany) 
under 5% CO2 atmosphere in Dulbecco’s modified Eagle’s medium (DMEM, Gibco 
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BRL) supplemented with 10% heat-inactivated foetal bovine serum (FBS, 
BioWhittaker, Cambrex Co.), 2 mM L-glutamine (BioWhittaker, Cambrex Co.) and 
25mM glucose. All cell culture manipulations were carried in a HeraSafe class II 
laminar flow cabinet (Heraeus). Cell lines were regularly inspected using an inverted 
light microscope (DM IL, Leica Microsystems GmbH; Wetzlar, Germany). Aliquots 
of low-passage cell lines were prepared in a medium supplemented with 20% FBS 
and 10% dimethyl sulfoxide (DMSO, Sigma) and kept at -80˚C (U410 Ultra Low 
Temperature Freezer; New Brunswick Scientific, Hertfordshire, UK) or at -196˚C in 
liquid nitrogen for short- and long-term storage, respectively.  
 
5.4.2 CELL VIABILITY DETERMINATION 
 
 Trypan blue dye exclusion method was used to determine the cell viability. 
Cell monolayers grown in 24-well plates, 6-well plates or 60 x 15 mm tissue culture 
dishes (TPP, Switzerland) were washed twice with Dulbecco’s phosphate-buffered 
saline (DPBS; BioWhittaker, Cambrex Co.) and incubated with 100 µl, 200 µl or 300 
µl trypsin-EDTA (BioWhittaker, Cambrex Co.), respectively until detachment. To 
neutralise the trypsin, DMEM was added appropriately up to 1 ml. 50 µl aliquot was 
diluted 1:2 in trypan blue and viable cells (unstained) were counted using a Thoma’s 
chamber after 5 min. incubation at room temperature. 
 
5.4.3  CELL INVASION AND INTRACELLULAR 
PROLIFERATION ASSAYS 
 
 As far as invasion and proliferation assays (or bacterial intracellular growth 
assay) were concerned, both techniques involved similar initial steps of the 
procedure. Both HeLa and MDBK cells were cultured in a 24-well plate (Costar®-
Corning; New York, USA) at 37°C under 5% CO2 in DMEM medium containing 
10% foetal bovine serum (FBS; BioWhittaker) until 80% confluence (for detecting 
the bacterial apoptosis through fluorescent microscopy, additional 24-well plate 
[Costar®-Corning; New York, USA] with MDBK cells was prepared containing a 
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slide cover in each well). Bacteria were added to cells at appropriate multiplicity of 
infection (MOI). Infected monolayers were centrifuged immediately for 3 min. at 
145 x g (4K15C Sigma Lab Centrifuge) at room temperature and incubated for 30 or 
40 min. (for L. ivanovii and L. monocytogenes, respectively) at 37°C in 5% CO2 
atmosphere. Cell monolayers were washed twice with DPBS to remove non-adherent 
bacteria, and incubated during 1 hour in DMEM containing 100 µg / ml gentamicin 
(Sigma) to kill extracellular bacteria. Cell monolayers were, then, washed twice with 
PBS, lysed by incubation with 1% Triton X-100 (Sigma) for 3 min., eluted in 400 µl 
of PBS (final volume = 500 µl) and, then, appropriately diluted. The lysates were 
plated for bacterial counting on BHI agar. Invasion was determined 1 h after 
gentamicin addition (t = 0). For proliferation assay, immediately after t = 0 the cell 
culture medium was changed to contain 10 µg / ml gentamicin and at the specified 
time points the cells were washed, lysed, as indicated above and the number of CFU 
determined. For apoptosis determination experiments, at specific time points, the 
coverslips from additional 24-well plate were also taken out from each well and 
treated as described in section 5.4.7. Each assay was performed in at least duplicate 
(or triplicate) for each experiment. The number of intracellular bacteria was 
calculated as the percentage of the bacteria inoculated that were internalized, 










5.4.4 INTRACELLULAR INFECTIONS FOR RT-QPCR 
EXPRESSION ANALYSES 
 
 HeLa cells were grown to 90% confluence in 60 x 15 mm tissue culture 
dishes (TPP, Switzerland) and infected with an appropriate MOI for each strain 
(ranging from 20:1 to 150:1 depending on the invasiveness of the strain to obtain 
similar amounts of intracellular bacteria at the sampling time point). The cell 
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monolayers were processed as described in the previous section 5.4.3. After 6 h of 
infection the gentamicin containing medium was removed and cells were washed, 
detached from the culture dishes by adding 700 µl of PBS and sweeping with a cell 
lifter (Fisher Scientific). The suspension was transferred into a 1.5 ml 
microcentrifuge tube and placed immediately on ice. The suspension was used for 
RNA isolation (500 µl) and for determination of intracellular number of bacteria 
(100 µl). 
 
5.4.5 PLAQUE ASSAY 
 
 Plaque assays were carried out as described by Sun et al. (1990), with 
modifications (Sun et al., 1990). L929 cell line was grown at 37ºC in 5% CO2 in a 6-
well plate (Costar) in RPMI (Roswell Park Memorial Institute; BioWhittaker, 
Cambrex Co.) supplemented with 10% FBS (BioWhittaker, Cambrex Co.) and 2 mM 
L-glutamine (BioWhittaker, Cambrex Co.) until 100% confluence. For 
characterization of prfA mutants, frozen bacterial inocula (prepared as described in 
section 5.1.2) were used to infect a monolayer of L929 cells at appropriate MOI 
(ranging from 0.005:1 to 2:1, to obtain equal distribution of single plaques). After 1 h 
incubation at 37°C in 5% CO2 atmosphere, cell monolayers were washed twice with 
1 ml of DPBS and 2 ml of fresh RPMI medium (containing 10 % FBS, 2 mM L-
glutamine), supplemented with 50 µg / ml of gentamicin was added to kill 
extracellular bacteria. Cells were incubated for 1 h in the same conditions as above, 
after that washed 3 times with 1 ml of DPBS. Each cell monolayer was overlaid with 
1.5 ml of agar solution prepared by mixing equal volumes of RPMI (with 10 % FBS, 
2 mM L-glutamine, and 5 µg / ml of gentamicin) and 2% cell culture agar (Sigma) 
and incubated under cell culture conditions for up to 5 days for plaque formation. On 
the third day, RPMI medium containing appropriate concentration of antibiotic was 
added to each well to avoid the agar to dry out. For plaque visualization, each well 
was overlaid with 10% neutral red solution (Sigma) in DPBS and incubated for 2 h at 
37°C in 5% CO2 atmosphere.  
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 The plaque assay technique used to determine cell-to-cell spread in section 
3.2.2.2.2 was slightly different. Overnight bacterial culture grown in BHI broth was 
diluted in 1:50 in BHI and finally grown to OD600 = 1. One ml of bacterial 
suspension was centrifuged at 1,100 x g (Eppendorf MiniSpin 5452, Eppendorf AG, 
UK) for 3 min. and washed twice in 1 ml of RPMI medium. The bacterial suspension 
was diluted in 1:10,000 and 5 µl were added into the wells. Infected cells were 
incubated for 2 h under cell culture conditions. The next steps are the same as 
described above (with exception of 30 min. incubation time with the antibiotic 
instead of 1 h). After 3 days of incubation, plaques were visualized as described 
above.  
 
 Images of the plates were taken using an Arcus II scanner (Agfa; Mortsel, 
Belgium). The two perpendicular axes of a minimum of 20 plaques per strain were 
measured by appropriately amplifying digital images of the plates (x200), using 
Adobe Photoshop CS3 Standard software (Adobe Photoshop CS3 Standard, USA).   
 
5.4.6 APOPTOSIS DETERMINATIONS BY FLOW 
CYTOFLUOROMETRY 
 
 Apoptosis was quantified by flow cytofluorometry using Annexin V-FITC 
staining (Beckman Coulter, UK). MDBK cells were seeded on 6-well plate (Costar) 
10-12 h before infection with 3 x 105 cells per well (1.5 x 105 cells / ml). Cell 
monolayers were infected as described in section 5.4.3. At the specific time points, 
infected monolayers were washed twice with DPBS and treated for 3 min. at 37°C in 
5% CO2 atmosphere with 400 µl of Trypsin-EDTA solution (BioWhittaker). The 
detached cell suspension was brought up to 2 ml with 1,600 µl of DMEM 
(supplemented with 10% FBS) and split into two 1 ml aliquots, one for apoptosis 
determination and another for bacteria counting. For determination of apoptosis, the 
cells were spun at 155 x g (Sigma 3K30C centrifuge) at 4°C during 5 min., washed 
once in 5 ml ice-cold binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2) 
and spun again. The supernatant was removed until ∼300 µl were left and 1 µl of 
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Annexin V-FITC solution and 5 µl of propidium iodide (PI) were added to each 
sample and incubated during 15 min. on ice. Cells were washed and resuspended in 
approximately 1 ml of cold binding buffer and analyzed in an argon-ion flow 
cytometer (Epics® XL-MCL, Coulter), recording 15,000 events per sample. Annexin 
V-FITC and PI are absorbed at 488 nm and 536 nm, respectively, giving green (520 
nm) and red (617 nm) emissions, respectively. Data were analyzed to obtain the 
percentage of fluorescing cells using uninfected cells as controls by System II 
Software v.3.0. Cells treated with 200 nM staurosporine (Sigma) for 3-4 h were used 
as positive control. Untreated cells were used as a negative control. To determine the 
CFU, the cells were lysed with 1% Triton X-100 (Sigma) in PBS and the lysates 
were plated for bacterial counting on BHI agar. 
 
5.4.7 MICROSCOPICAL TECHNIQUE FOR APOPTOSIS  
 
 Coverslips with monolayer of infected eukaryotic cells (see section 5.4.3) 
were washed by immersing them 10 times in a beaker containing PBS, dried on a 
tissue paper and fixed by treating with 1.5 ml of 2% paraformaldehyde (Sigma) in 
12-well plates. They were stored at 4°C until use. Prior to staining, the coverslips 
were washed by immersing them 10 times in a beaker containing either binding 
buffer (for staining with Annexin V-FITC) or PBS (for staining with Hoechst), dried 
on a tissue paper and put in wells of 12-well plate (Costar). Cells attached to the 
coverslip surface were stained with 200 µl of Annexin V-FITC (Beckman Coulter) at 
a concentration of 25 µg /ml and/or Hoechst no. 33258 (Sigma) at a concentration of 
1 µg / ml and kept in the dark for 10 min.. After this time, the cells were washed as 
described before and dried on a tissue paper (keeping away from the light). The 
coverslips were mounted upside down onto a slide using a mounting solution 
(Vectashield®, Vector Laboratories, Inc.) and fixed to the slide by surrounding with a 
layer of a nail polish, thus, avoiding the movement of coverslips during microscopic 
examination, drying out of the preparation and preventing air trapping between the 
coverslip and the slide. The coverslips were examined under an inverted fluorescence 
microscope (Leica DMIRE2) and images were captured and processed using 
OpenLab software (Improvision, USA). Changes in phosphatidylserine asymmetry in 
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apoptotic cells were detected by the binding of Annexin V-FITC (bright green 
fluorescence), Hoechst, which is absorbed at 360 nm with emission at 465 nm 
enabled to visualize chromatin aggregation fluorescing bright blue. 
 
5.5 STATISTICAL ANALYSES 
 
 Statistical analyses were carried out using two-tailed unpaired Student’s t-test 










Strain  Other designationsa 
Collection 
no. b  Description Source (reference) 
L. monocytogenes     
P14 prfAWT PAM 14 Wild-type strain of serovar 4b, clinical isolate Our laboratory (Ripio et al., 1996; 1997a) 
P14A prfA*G145S PAM 50 prfA* derivative of strain P14  Our laboratory (Ripio et al., 1996; 1997a) 
P14AΔprfA ∆prfA PAM 373 In-frame prfA deletion mutant of P14A Our laboratory (Vega et al., 2004) 
ΔprfA* (pPL2) vector PAM 3293 ΔprfA* complemented with pPL2 vector Our laboratory c  
ΔprfA* (pPL2prfAWT) prfAWT PAM 3294 ΔprfA* complemented with pPL2prfAWT Our laboratory c  
ΔprfA* (pPL2prfA*G145S) prfA*G145S PAM 3295 ΔprfA* complemented with pPL2prfA*G145S Our laboratory c  
ΔprfA* (pPL2prfAV80L) V80L  PAM 3296 ΔprfA* complemented with pPL2prfAV80L Our laboratory c  
ΔprfA* (pPL2prfAS71L) S71L PAM 3297 ΔprfA* complemented with pPL2prfAS71L Our laboratory c  
ΔprfA* (pPL2prfA*S71L) S71L* PAM 3298 ΔprfA* complemented with pPL2prfA*S71L Our laboratory c  
ΔprfA* (pPL2prfAL48F) L48F PAM 3299 ΔprfA* complemented with pPL2prfAL48F Our laboratory c  
ΔprfA* (pPL2prfA*L48F) L48F* PAM 3300 ΔprfA* complemented with pPL2prfA*L48F Our laboratory c  
ΔprfA* (pPL2prfAY63W) Y63W PAM 3301 ΔprfA* complemented with pPL2prfAY63W Our laboratory c  
ΔprfA* (pPL2prfA*Y63W) Y63W* PAM 3302 ΔprfA* complemented with pPL2prfA*Y63W Our laboratory c  
ΔprfA* (pPL2prfAI69W) I69W PAM 3303 ΔprfA* complemented with pPL2prfAI69W Our laboratory c  
ΔprfA* (pPL2prfAE36Q) E36Q PAM 3304 ΔprfA* complemented with pPL2prfAE36Q Our laboratory c  
ΔprfA* (pPL2prfAE36R) E36R PAM 3305 ΔprfA* complemented with pPL2prfAE36R Our laboratory c  
ΔprfA* (pPL2prfAF29M) F29M PAM 3306 ΔprfA* complemented with pPL2prfAF29M Our laboratory c  
ΔprfA* (pPL2prfAL120V) L120V PAM 3307 ΔprfA* complemented with pPL2prfAL120V Our laboratory c  
ΔprfA* (pPL2prfAE173G) E173G PAM 3313 ΔprfA* complemented with pPL2prfAE173G Our laboratory c  
ΔprfA* (pPL2prfA*E173G) E173G* PAM 3314 ΔprfA* complemented with pPL2prfA*E173G Our laboratory c  
ΔprfA* (pPL2prfAC229Y) C229Y PAM 3315 ΔprfA* complemented with pPL2prfAC229Y Our laboratory c  
ΔprfA* (pPL2prfA*C229Y) C229Y* PAM 3316 ΔprfA* complemented with pPL2prfA*C229Y Our laboratory c  
ΔprfA* (pPL2prfAA129T) A129T PAM 3317 ΔprfA* complemented with pPL2prfAA129T Our laboratory d 
ΔprfA* (pPL2prfA*A129T) A129T* PAM 3318 ΔprfA* complemented with pPL2prfA*A129T Our laboratory d 
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Table 5.1: Bacterial strains used in this thesis (continued). 
 
 
Strain  Other designationsa 
Collection 
no. b  Description Source (reference) 
P14AΔactA ∆actA PAM 185 In-frame actA deletion mutant of P14A Our laboratory (Suarez et al., 2001) 
P14∆sigB   PAM 3187 In-frame sigB  deletion mutant of P14  Our laboratory d 
P14A∆sigB   PAM 3185 In-frame sigB deletion mutant of P14A   Our laboratory d 
P14AprfAA129T   PAM 3184 In-frame sigB deletion mutant of P14A with a naturally occurring point mutation A129T in prfA  Our laboratory
 d 
EGDe   PAM 3120 Wild-type strain of serovar 1/2a Glaser et al. (2001) 
EGDe∆sigB   PAM 3121 In-frame sigB  deletion mutant of EGDe Stritzker et al. (2005) 
EGDe∆prfA   PAM 225 In-frame prfA  deletion mutant of EGDe Böckmann et al. (1996) 
EGD∆plcAB   PAM 648 In-frame plcA and plcB  deletion mutant of EGD (referred as WL-106) Hauf et al. (1997) 
EGD∆plcAB(pPL2)   PAM 3097 EGD∆plcAB complemented with pPL2 vector Our laboratory d 
EGD∆plcAB(pPL2smcL)   PAM 3096 EGD∆plcAB complemented with pPL2smcL Our laboratorye 
L. ivanovii         
ATCC 19119   PAM 424  Special Listeria Culture Collection strain 2379, (serovar 5) (referred as ATCC 19119) 
Institut fur Hygiene und Mikrobiologie, 
University of Würzburg, Federal Republic of 
Germany) 
E.coli         
Bl21DE3   PAM 3484 E. coli strain Invitrogen 
Bl21DE3 (pET28a)   PAM 3485 E. coli complemented with pET28a vector Our laboratory 
Bl21DE3 (pET28aprfAWT)   PAM 3486 E. coli complemented with pET28aprfAWT 
Dr. Mark Banfield (University of 
Newcastle) 
Bl21DE3 (pET28aprfA*)   PAM 3487 E. coli complemented with pET28aprfA* Our laboratory c  
Bl21DE3 (pET28aprfAV80L)   PAM 3488 E. coli complemented with pET28aprfAV80L Our laboratory c  
Bl21DE3 (pET28aprfAS71L)   PAM 3489 E. coli complemented with pET28aprfAS71L Our laboratory c  
Bl21DE3 (pET28aprfA*S71L)   PAM 3490 E. coli complemented with pET28aprfA*S71L Our laboratory c  
Bl21DE3 (pET28aprfAL48F)   PAM 3491 E. coli complemented with pET28aprfAL48F Our laboratory c  








a - Some strains were on occasions referred to in the text by their genotype / relevant mutation 
b- PAM refers to our internal central isolate / recombinant strain collection 




Strain  Other designationsa 
Collection 
no. b  Description Source (reference) 
Bl21DE3 (pET28aprfAY63W)   PAM 3493 E. coli complemented with pET28aprfAY63W Our laboratory c  
Bl21DE3 (pET28aprfA*Y63W)   PAM 3494 E. coli complemented with pET28aprfA*Y63W Our laboratory c  
Bl21DE3 (pET28aprfAI69W)   PAM 3495 E. coli complemented with pET28aprfAI69W Our laboratory c  
Bl21DE3 (pET28aprfAE36Q)   PAM 3496 E. coli complemented with pET28aprfAE36Q Our laboratory c  
Bl21DE3 (pET28aprfAE36R)   PAM 3497 E. coli complemented with pET28aprfAE36R Our laboratory c  
Bl21DE3 (pET28aprfAF29M)   PAM 3498 E. coli complemented with pET28aprfAF29M Our laboratory c  
Bl21DE3 (pET28aprfAL120V)   PAM 3499 E. coli complemented with pET28aprfAL120V Our laboratory c  
Bl21DE3 (pET28aprfAE173G)   PAM 3505 E. coli complemented with pET28aprfAE173G Our laboratory c  
Bl21DE3 (pET28aprfA*E173G)   PAM 3506 E. coli complemented with pET28aprfA*E173G Our laboratory c  
Bl21DE3 (pET28aprfAC229Y)   PAM 3507 E. coli complemented with pET28aprfAC229Y Our laboratory c  
Bl21DE3 (pET28aprfA*C229Y)   PAM 3508 E. coli complemented with pET28aprfA*C229Y Our laboratory c  
Bl21DE3 (pET28aprfAA129T)   PAM 3509 E. coli complemented with pET28aprfAA129T Our laboratory c  
Bl21DE3 (pET28aprfA*A129T)   PAM 3510 E. coli complemented with pET28aprfA*A129T Our laboratory c  
DH10b (pLSV101∆sigB)   PAM 3123 E.coli complemented with mutagenesis plasmid pLSV101∆sigB Stritzker et al. (2005) 
DH5-α   PAM 3511 Cloning host strain Our laboratory 
TOP10     Cloning host strain Invitrogen 
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Compound Amount per litre 
KH2PO4 6,56 g 
Na2HPO4* 7 H2O 30,96 g 
MgSO4 * 7 H2O 0,41 g 
Ferric citrate 88 mg 
L – Glutamine 0,6 g 
L – Leucine 0,1 g 
DL – Isoleucine 0,1 g 
DL – Valinie 0,1 g 
DL – Methionine 0,1 g 
L – Arginine HCl 0,1 g 
L – Cysteine HCl 0,1 g 
L – Histidine HCl 0,1 g 
L – Tryptophan 0,1 g 
L – Phenylalanine 0,1 g 
Adenine 2,5 mg 
Biotin 0,5 mg 
Riboflavine 5 mg 
Thiamine HCl 1 mg 
Pyridoxal HCl 1 mg 
Para – aminobenzoic acid 1 mg 
Calcium panthothenate 1 mg 
Nicotinamide 1 mg 
Thioctic acid (α – lipoic acid) 5 µg 
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Table 5.3: Oligonucleotides used in this thesis. 





Name 5'-3' sequence Purpose Restriction site Modification 
F29Mforward aacttattATGaaccaatggga   
F29Mreverse tcccattggttCATaataagtt Mutagenesis Phe29Met of PrfA   
E36Qforward atccacaaCAAtattgtatttt   
E36Qreverse aaaatacaataTTGttgtggat Mutagenesis Gly36Gln of PrfA   
E36Rforward atccacaaAGAtattgtatttt   
E36Rreverse aaaatacaataTCTttgtggat Mutagenesis Gly36Arg of PrfA   
L48Fforward tatcacaaagTTTacgagtatt   
L48Freverse aatactcgtAAActttgtgata Mutagenesis Leu48Phe of PrfA   
Y63Wforward ttacaatacTGGaaaggggctt   
Y63Wreverse aagcccctttCCAgtattgtaa Mutagenesis Tyr63Trp of PrfA   
I69Wforward gctttcgttTGGatgtctggct   
I69Wreverse agccagacatCCAaacgaaagc Mutagenesis Ile69Trp of PrfA   
S71Lforward cgttataatgTTAggctttatt   
S71Lreverse aataaagccTAAcattataacg Mutagenesis Ser71Leu of PrfA   
V80Lforward agaaacatcgTTAggctattat   
V80Lreverse ataatagccTAAcgatgtttct Mutagenesis Val80Leu of PrfA   
L120Vforward tccaaaccGTTcaaaaacaagt   
L120Vreverse acttgtttttgAACggtttgga Mutagenesis Leu120Val of PrfA   
A129Tforward caagtttcatacagcctaACCaaatttaatg   
A129Treverse cattaaatttGGTtaggctgtatgaaacttg Mutagenesis Ala129Thr of PrfA   
E173Gforward caatgcagGGCttaggctattc   
E173Greverse gaatagcctaaGCCctgcattg Mutagenesis Glu173Gly of PrfA   
C229Yforward tatttagcaTATcctgctacttg   
C229Yreverse caagtagcaggATAtgctaaata Mutagenesis Cys229Tyr of PrfA   
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Table 5.3: Oligonucleotides used in this thesis (continued). 
 
 
Name 5'-3' sequence Purpose Restriction site Modification 
MR2SalI (forward) GTCGACcaactaacatatattattcct  SalI  
MR10SalI (reverse) GTCGACcttggcgaagcaatcgttcgc  Amplification of prfA for pPL2 SalI  
MR2KpnI (forward) ctagGGTACCcaactaacatatattattcct KpnI  
MR10SpeI (reverse) ctagACTAGTcttggtgaagcaatcgtacgc Amplification of prfA for pPL2 SpeI  
prfAH1-P14 atgaCATATGaacgctcaagcagaag NdeI  
prfAH2-P14 gaGTCGACattgagacatcctgtttt Ampilfication of prfA for pET28a SalI  
Promo28plcA-P14 ttatcgtcgTTAACAaaTGTTAAtgcc  5'biotin-TEG 
Promo40plcA-P14 tgtccctttatcgtcgTTAACAaaTGTTAAtgcctcgaca  5'biotin-TEG 
Promo40actA-P14 ggtcggagttaactgaTTAACAaaTGTTAGagaaaactta  5'biotin-TEG 
Random atgtatctatgtatgcagatgttcaatacgtcaagctatt  5'biotin-TEG 
Promo28plcAREV ggcaTTAACAttTGTTAAcgacgataa   
Promo40plcAREV tgtcgaggcaTTAACAttTGTTAAcgacgataaagggaca   




lmoldh-491F (forward) atgctcgtaacgtccatggtt   
lmoldh-555R (reverse) gctccatgctgggaattctg   
lmoldh-P (probe) FAM-catccttggcgaacacggcga-BHQ   
rpoB1-QF (forward) tggttcttagatgaagggctacgt   
rpoB1-QR (reverse) acccgcaaaatcctcaattg   
rpoB1-P (probe) FAM-aatatcgcggaacatct –BHQ   
actA38F (forward) aagaaattgatcgcctagctgatt   
actA109R (reverse) gtaaaaaacccgcatttcttgagt   
actA64p (probe) FAM-tttcctgttcctctatctct-MGB-NFQ   
inlA1-204F (forward) aataagtgatataactccacttgggattt   
inlA1-294R (reverse) cgccaatgtgcctatatcttttaact   














Name 5'-3' sequence Purpose Restriction site Modification 
inlB4b-QF (forward) ccagggaatgcagtttgga   
inlB4b-QR (reverse) tggtagacggaaagcttgttca   
inlB4b-P (probe) FAM-aatacagctggcgcaac–MGB–NFQ   
plcA-11F (forward) caggtacacatgatacgatgagctataa   
plcA-99R (reverse) gtacaatgacatcgtttgtgtttgag   




sigBF (forward) attatcaggaattgcaagtcgcg   
sigBR (reverse) cgcgagaaagaacaagtccatc   
pLSV1-B gatgtgctgcaaggcgat   
pLSV1-C ccttcgacagtcatcatata 
sigB deletion mutants construction 
check 
  
smcL-XmaI (forward) tcccCCCGGGctttgtttccaaactcatgt XmaI  
smcL-SalI (reverse) acgcGTCGACgatactttttagctttcacacg Amplification of smcL for pPL2 SalI  
NC16 (forward) gtcaaaacatacgctcttatc   
PL95 (reverse) acataatcagtccaaagtagatgc 
integration of pPL2 into Listeria 
chromosome check   
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Plasmid Description Source (reference) 
pPL2 site-specific phage integration vector, derivative of pPL1 vector Lauer et al. (2002) 
pPL2prfAWT pPL2 inserted with the wild-type prfA allele from P14 Our laboratorya 
pPL2prfA*G145S pPL2 inserted with the prfA*G145S allele from P14A Our laboratorya 
pPL2prfAV80L pPL2 inserted with the prfA allele with a point mutation Val80Leu Our laboratoryb 
pPL2prfAS71L pPL2 inserted with the prfA allele with a point mutation Ser71Leu Our laboratoryb 
pPL2prfA*S71L pPL2 inserted with the prfA*G145S allele with a point mutation Ser71Leu Our laboratoryb 
pPL2prfAL48F pPL2 inserted with the prfA allele with a point mutation Leu48Phe Our laboratoryb 
pPL2prfA*L48F pPL2 inserted with the prfA*G145S allele with a point mutation Leu48Phe Our laboratoryb 
pPL2prfAY63W pPL2 inserted with the prfA allele with a point mutation Tyr63Trp Our laboratoryb 
pPL2prfA*Y63W pPL2 inserted with the prfA*G145S allele with a point mutation Tyr63Trp Our laboratoryb 
pPL2prfAI69W pPL2 inserted with the prfA allele with a point mutation Ile69Trp Our laboratoryb 
pPL2prfAE36Q pPL2 inserted with the prfA allele with a point mutation Glu36Gln Our laboratoryb 
pPL2prfAE36R pPL2 inserted with the prfA allele with a point mutation Glu36Arg Our laboratoryb 
pPL2prfAF29M pPL2 inserted with the prfA allele with a point mutation Phe29Met Our laboratoryb 
pPL2prfAL120V pPL2 inserted with the prfA allele with a point mutation Leu120Val Our laboratoryb 
pPL2prfAE173G pPL2 inserted with the prfA allele with a point mutation Glu173Gly Our laboratoryb 
pPL2prfA*E173G pPL2 inserted with the prfA*G145S allele with a point mutation Glu173Gly Our laboratoryb 
pPL2prfAC229Y pPL2 inserted with the prfA allele with a point mutation Cys229Tyr Our laboratoryb 
pPL2prfA*C229Y pPL2 inserted with the prfA*G145S allele with a point mutation Cys229Tyr Our laboratoryb 
pPL2prfAA129T pPL2 inserted with the prfA allele with a point mutation Ala129Thr Our laboratorya 
pPL2prfA*A129T pPL2 inserted with the prfA*G145S allele with a point mutation Ala129Thr Our laboratorya 
pPL2smcL pPL2 inserted with the smcL allele from L. ivanovii ATCC 19119 Our laboratoryc 
pET28a His-tag vector Novagen 
pET28aprfAWT pET28a inserted with the wild-type prfA allele from P14 Our laboratoryb 





Table 5.4: Plasmids used in this thesis (continued). 
 
Plasmid Description Source (reference) 
pET28aprfAV80L pET28a inserted with the prfA allele with a point mutation Val80Leu Our laboratoryb 
pET28aprfAS71L pET28a inserted with the prfA allele with a point mutation Ser71Leu Our laboratoryb 
pET28aprfA*S71L pET28a inserted with the prfA*G145S allele with a point mutation Ser71Leu Our laboratoryb 
pET28aprfAL48F pET28a inserted with the prfA allele with a point mutation Leu48Phe Our laboratoryb 
pET28aprfA*L48F pET28a inserted with the prfA*G145S allele with a point mutation Leu48Phe Our laboratoryb 
pET28aprfAY63W pET28a inserted with the prfA allele with a point mutation Tyr63Trp Our laboratoryb 
pET28aprfA*Y63W pET28a inserted with the prfA*G145S allele with a point mutation Tyr63Trp Our laboratoryb 
pET28aprfAI69W pET28a inserted with the prfA allele with a point mutation Ile69Trp Our laboratoryb 
pET28aprfAE36Q pET28a inserted with the prfA allele with a point mutation Glu36Gln Our laboratoryb 
pET28aprfAE36R pET28a inserted with the prfA allele with a point mutation Glu36Arg Our laboratoryb 
pET28aprfAF29M pET28a inserted with the prfA allele with a point mutation Phe29Met Our laboratoryb 
pET28aprfAL120V pET28a inserted with the prfA allele with a point mutation Leu120Val Our laboratoryb 
pET28aprfAE173G pET28a inserted with the prfA allele with a point mutation Glu173Gly Our laboratoryb 
pET28aprfA*E173G pET28a inserted with the prfA*G145S allele with a point mutation Glu173Gly Our laboratoryb 
pET28aprfAC229Y pET28a inserted with the prfA allele with a point mutation Cys229Tyr Our laboratoryb 
pET28aprfA*C229Y pET28a inserted with the prfA*G145S allele with a point mutation Cys229Tyr Our laboratoryb 
pET28aprfAA129T pET28a inserted with the prfA allele with a point mutation Ala129Thr Our laboratoryb 
pET28aprfA*A129T pET28a inserted with the prfA*G145S allele with a point mutation Ala129Thr Our laboratoryb 
pLSV101∆sigB Mutagenesis plasmid, derivative of pLSV1 vector, inserted with the ∆sigB recombination fragment Stritzker et al. (2005) 
pHsmcL pHPS9 inserted with the L. ivanovii ATCC 19119 smcL gene Gonzalez-Zorn et al. (1999) 
 
a, b, c - These plasmids were constructed in collaboration for the projects described in this work (a, Magdalena Bielecka; 
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7.2 APPENDIX II 
 
Derivation of Apoptosis Index (AI): 
(Developed by Dr. Nick Savill, Centre for Infectious Diseases and Immunity, 
Infection & Evolution, University of Edinburgh) 
 
 




 To establish an index describing the occurrence of apoptosis it is important to 
consider the factors that influence the outcome variable. The number (or percentage) 
of apoptotic cells observed after a certain time depends on how quickly bacteria 
invade host cells, grow in the cell monolayer, and cause apoptosis. To determine the 
apoptogenic potential of a specific bacterial species it is important to know how the 
rate of apoptosis depends on the number of bacteria (B) in an infected cell. This rate 
may be independent of the number of bacteria, or may rise linearly, quadratically, or 
exponentially, or even show threshold behaviour. If the apoptosis rate goes as Bβ, β = 
0 means that the apoptosis rate is independent, β = 1 that the relationship is linear, 
etc.  
 
 The rate of change of the net number of apoptotic cells (dA/dt) is proportional 






"B#C  (1) 
 
Variable Description 
N total number of cells 
A net number of apoptotic cells (after subtraction of spontaneous apoptosis) 
C number of infected cells 
B average number of bacteria per infected cell 
a =100A/N net % apoptotic cells (after subtraction of spontaneous apoptosis) 
c =100C/N % infected cells 
b =BC total number of intracellular bacteria 
α apoptosis rate per bacterium 
β determines how the number of bacteria in a cell affects apoptosis 
rate 
AI apoptosis index 
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 To rewrite this equation in terms of percentages of cells rather than numbers 






























"B#c  (4) 
 






="B#c  (5) 
 
 By, definition, 1/(αBβ) is the half-life of infected cells containing B bacteria. 
If B = 1 (i.e. one bacterium per cell), then, 1/α is the half-life of infected cells 
containing a single bacterium. α is, therefore, a measure of the apoptogenic potential 
of a bacterial species; the bigger α is, the shorter the half-life of infected cells and the 
faster these cells become apoptotic. α is independent of the species’ growth and 
invasion rates.  
 
 Because B may not be known, it can be removed from Equation 5. This can 
be done considering that the number of intracellular bacteria (b) equals the average 




b = BC  (6) 
 











































c  (10) 
 
 Since N (the total number of cells) is not different across experiments, we can 
















c  (11) 
 









1#"  (12) 
 













 To estimate the apoptotic index we need to estimate the slope of apoptotic 
cell growth curve (da/dt). According to Equation 5, the growth of a is dependent on c 
and B, which are both changing in time. Therefore, the form of a is unlikely to be 
simple (e.g. linear, exponential), but we can approximate it. 
 
 If we assume that the rate of growth of apoptotic cells is linear from the start 
of the experiment (which may not be true), then, the slope is constant over time. Let 













 (The vertical line indicates that the slope is calculated at a specific time t 

















 where bt and ct are the number of intracellular bacteria and the % infected 
cells at time t, respectively, and β determines how the number of bacteria in a cell 
affects apoptosis rate. 
 
 A more accurate method would be, however, to measure a at two time points, 












































Potential problems and additional assumptions 
 
 The first problem is that the AI changes as β changes (can be β = 0 if 
apoptosis rate is independent of the number of bacteria per cell, β = 1 if the 
relationship is linear, β = 2 if the relationship is quadratic, etc.). The second problem 
is that the two methods of approximating da/dt can give different conclusions, 
particularly when β is in the range 0.5 to 1. It is, therefore, important to accurately 
estimate the rate of change of % of a. Therefore, it is not possible to estimate the 
relative apoptogenic potential of two species unless it is known how the apoptosis 
rate of infected cells depends on the number of bacteria in cells. Moreover, for 
simplicity it has been assumed that the apoptosis rate goes as Bβ, but it could be more 
complicated than this. For example, apoptosis rate could increase sharply when the 
number of bacteria pass a threshold, or apoptosis rate saturates at high bacterial 
loads.  
 
 The following assumptions have been also considered in the analyses. One is 
that the probability of an infected cell (with a fixed number of bacteria) becoming 
apoptotic is constant in time. The implications of this are that the lifespan of infected 
cells is exponentially distributed and that cells can become apoptotic immediately 
upon infection. Another assumption is that the number of apoptotic cells that have 
died (disappeared) is negligible at the time points sampled. Finally, the background 
rate of apoptosis of uninfected cells is unaffected by the presence of infected cells. 
 
